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Abstract
Malnutrition and nutritional deprivation are common in hospital patients. Consequent 
dysfunction is exacerbated in the presence of an inflammatory state and leads to 
increased morbidity, mortality and treatment cost. This thesis tested the hypothesis 
that clinical outcome could be improved, and treatment cost reduced, if enteral 
nutritional (EN) was: a) initiated earlier after the pathological event, and b) when > 
50% of a patient’s estimated energy and nitrogen requirements were met by EN (ie. 
aggressive EN).
A Preliminary Investigation found that patients starved for < 5 days compared to > 5 
days, had a lower mortality (p < 0.003) and shorter duration of nasogastric (NG) 
feeding (p = 0.049). The population studied was heterogenous and no account was 
taken of disease severity. The hypothesis was therefore re-tested in burned patients, 
controlling for disease severity. The delay before attempting aggressive EN was 
associated with major complications excluding (p <0.001) and including mortality (p =
0.018), length of (hospital) stay (LOS) (p = 0.011), and treatment cost (p < 0.001). 
Finally, a prospective randomised controlled trial (PRCT) was used to test the 
hypothesis. A study of patients undergoing major Gi surgery failed due to poor 
recruitment, but useful aspects of this protocol were adapted for a similar trial in 
head-injured patients. In this group, early aggressive EN was associated with a 
reduction in infective complicatiafrs (p = 0.0195), duration of mechanical ventilation (p 
= 0.019) and treatment cost (p = 0.006).
In certain conditions at least, early aggressive EN is associated with improved clinical 
outcome and reduced treatment cost. Much of this improvement appears to be due to 
a reduction in infective complications.
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1Introduction
1.1 incidence o f  malnutrition
Signs of malnutrition are apparent in between 25-50% of hospital patients 
(Bistrian et al, 1976; Hill et al, 1977; Robinson et al, 1987). This is despite 
the availability of modern nutritional support techniques, including oral 
supplementation, enteral (tube) nutrition (EN) and parenteral nutrition (PN). 
Protein-energy malnutrition (PEM) is the most common form of malnutrition 
and is due to an overall reduction in nutrient intake. For example, in 100 
medical paediatric patients, 40% were malnourished and 19% had 
borderline malnutrition (Robinson et al, 1987). In another study, out of 100 
adults suffering a cerebrovascular accident (CVA) 16% had two or more 
nutritional risk factors at admission rising to 22% at discharge (Axelsson et 
al, 1988). Similarly, cancer, particularly that affecting the upper 
gastrointestinal (Gi) tract (Sitges-Serra et al, 1990), is associated with a 
high incidence of malnutrition. In contrast, PEM is rare at the occurrence of 
major trauma, excluding fractured neck of femur in the elderly, but rapidly 
develops in the absence of nutritional support (Newsolme, 1973; 
Sutherland, 1976). Thus malnutrition is common in many groups of hospital 
patients.
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1.2 Causes of malnutrition
The causes of malnutrition are multifactorial and several causes may 
operate in the same patient (Tables 1.1 and 1.2). Some causes of reduced 
food intake are specific to the patient’s clinical state. For example, patients 
undergoing major but uncomplicated GI surgery start eating an average of 
4.7 days post-surgery. Furthermore, by day 14, they have attained less than 
50% of their energy requirements and are in negative energy balance 
(Figure 1.1) (Hackett et al, 1979). In addition, certain surgery, especially 
oesophageal, gastroduodenal, and pancreato-biliary, precludes food intake 
for about 10 days, with normal intake often not achieved for 3 weeks. In the 
absence of EN or PN, post-surgery starvation will incur a 9-14Kg weight 
loss. Weight loss of this magnitude is associated with impaired organ 
function and necessitates a period of nutritional rehabilitation (Keys et al, 
1950). The occurrence of postoperative complications, especially peritonitis, 
abdominal abscess and ileus, will prolong starvation. Although surgical 
intervention may resolve some of these complications and improve the 
patient’s clinical condition (for example drainage of an intraabdominal 
abscess), food intake is unlikely to be significant for at least another week. 
Similarly, following a large burn injury, wound debridement and grafting 
necessitate repeated operations with reduced nutritional intake pre- and 
post-surgery. Lastly, following CVA or trauma, loss of consciousness, 
endotracheal intubation, paresis and cognitive deficits make self feeding 
impossible. It is also common for dysphagia or poor gastric emptying to 
preclude safe oral and gastric feeding, respectively. A patient’s tolerance of 
this starvation depends on their clinical condition and initial nutritional and 
physiological state.
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Table 1.1 Idiopathic causes of malnutrition.
Condition Cause
1. Poor intake-quantity • Physical problems feeding,
chewing, swallowing.
® Anorexia, possibly secondary to 
nausea, due to disease, drugs, 
psychological problems, eg. 
because of anxiety over new 
environment or unsuitable food 
or meal distribution.
2. Poor intake- quality <E> Ignorance (patient or carers)
0 Therapeutic diet
© Institution food
© Poor income
3. Increased metabolism © Trauma (including surgery, 
fracture, or burns).
O Fever
o Infection (especially sepsis)
o Malignancy
© Hyperthyroidism
& Hyperactivity
4. Increased loss o Vomiting
Q Diarrhoea, steatorrhoea, protein- 
losing enteropathy and pan 
malabsorption.
© drug-nutrient interactions eg. 
antacids and iron.
5. Defective utilisation © Inborn errors of metabolism
© Organ failure (especially liver, 
kidney, heart and lungs).
o Endocrine disorders eg. 
uncontrolled Diabetes Mellitus.
0 Drug-nutrient interactions, eg. 
isoniazid and pyridoxine.
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Table 1.2 Iatrogenic causes of malnutrition.
• Unnecessarily prolonged starvation perioperatively or during tests.
• Badly timed ward-rounds or painful procedures that interrupt mealtimes.
• Catering department not informed of the patient's requirements.
• Between meal supplements and snacks not available or not given to the 
patient.
6 The necessary assistance and aids for feeding not given to the patient 
(Backstrom, 1987).
• Professional jealousy or poor communication between staff.
Figure 1.1 Average energy balance after major surgery (adapted 
from Hackett et al, 1979).
Kcal
Out
In
Energy loss
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1.3 Effects of Malnutrition and Refeeding
From the above it can be seen that malnutrition is the synergistic result of 
starvation (of whatever aetiology), and/or increased nutritional requirements. 
These states are superimposed on the normal physiology of feeding and 
fasting and have progressively more profound effects on body organs and 
physiology. A delay before starting nutritional support will thus have specific 
and quantifiable consequences.
1.3.1 Normal Physiology: Feed/ fast cycle 
In the normal physiological state a change in blood glucose concentration is 
the predominant factor controlling insulin secretion. The effects of insulin 
are tissue-specific. In muscle, insulin has three actions: it accelerates the 
transport of glucose into the cell, enhances the synthesis of glycogen, and 
increases the synthesis of muscle protein. Protein anabolism is principally 
due to inhibition of peripheral protein breakdown (Gelfand et al, 1987), with 
increases in synthesis of selective proteins, for example liver albumin. In 
adipose tissue, insulin stimulates membrane transport and 
phosphorylation of glucose, inhibits lipolysis and promotes uptake of fatty
j
acids from lipoproteins, through stimulation of fat cell lipoprotein lipase. In 
the liver insulin stimulates glycogen synthesis and is a strong inhibitor of 
glycogenolysis and gluconeogenesis. The net effect of these actions is to 
produce significant glucose gradients across the hepatocyte membrane 
and a rapid increase in glucose uptake. Hepatic glucose extraction is much 
higher in response to oral versus IV glucose. In the kidney, insulin reduces
6
energy expenditure and increases sodium retention which may be a cause 
of oedema during refeeding.
The post-absorptive period begins from 6 hours after the last meal (Cahill, 
1976). Insulin concentration declines as glucagon concentration increases. 
Glucagon increases the concentration of cyclic adenosine monophosphate 
(cAMP) within the hepatocyte, inducing glycogenolysis. Skeletal muscle 
lacks glucose-6 phosphatase, so that glucose from muscle glycogen 
cannot escape into the circulation. Insulin directly antagonises the effects of 
glucagon on the liver. Thus the insulin: glucagon ratio appears to determine 
the final metabolic behaviour.
1.3.2 Effects of Malnutrition
1.3.2.1 Acute starvation and prolonged fasting 
Acute starvation extends beyond 12-18h. Insulin levels decline and 
glucagon levels remain the same or rise slightly. Increased levels of growth 
hormone (GH) inhibit the insulin-stimulated uptake of glucose while 
increased free fatty acid (FFA) concentration increases muscle uptake and 
oxidation of fat during starvation. After 4 days of fasting, protein metabolism 
is less sensitive to insulin (Frexes-Steed et al, 1990), allowing muscle to 
release amino acids. Reduced triiodothyronine (T3) levels reduces the 
metabolic rate (MR), and therefore energy expenditure (EE), and protein flux 
(Cahill, 1976). The liver co-ordinates the resulting changes in glucose and 
ketone production. Increased glucagon levels lowers malonyl CoA
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concentration within the hepatocyte, thus stimulating ketone synthesis from 
FFA. Blood levels of ketoacids become elevated during the first week and 
are used by the brain in preference to glucose. This reduces glucose 
utilisation and spares protein but nitrogen balance remains negative as 
skeletal muscle is mobilised to replace obligatory nitrogen loss (eg. skin, 
faeces) and fuel anapleurotic reactions. Muscle branched-chain amino 
acids (BCAAs) provide the nitrogen moiety for transforming pyruvate to 
alanine. Alanine, lactate and glycerol are used as 3-carbon substrates for 
hepatic gluconeogenesis fuelled by FFA oxidation. After several weeks of 
starvation the kidney utilises glutamine to provide up to half of total 
gluconeogenesis (Cahill, 1976). This is effectively suppressed by insulin. 
Therefore the rate of loss of body cell mass (BCM) falls from 300g/day to 
125g/day by the fourth week of starvation (Figure 1.2). The cumulative loss 
over this time is 5.7Kg representing 38% of skeletal muscle, or 23% of BCM. 
It has been estimated that a loss of 50-60% of BCM is incompatible with 
survival. Thus starvation induces a progressive selection of fat as body fuel 
but with continued loss of muscle protein with resultant changes in organ 
function.
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Figure 1.2 Cumulative loss of body cell mass with total starvation in the normally 
nourished, non-catabolic 70 Kg man (adapted from Owen et al, 1969).
Body cell 
mass (Kg)
S ta rva tion  (days)
1.3.2.2 Immune Function 
The haemopoietic and thymolymphatic systems have a high turnover and 
are therefore suppressed by PEM. This results in anaemia and reduced 
cell-mediated immunity (CM1). Depressed CMI leads to opportunistic 
infections (Chandra, 1974). Refeeding quickly, and completely, reversed 
these abnormalities confirming that the defect was nutritional rather than 
primarily thymic. In inflammatory states hepatic protein production is 
reprioritised from plasma transport proteins (albumin, pre-albumin) to 
positive acute phase proteins (C-reactive protein (CRP), c^-acid glycoprotein
(AGP), fibrinogen, haptoglobin). This acute phase protein response is 
optimised by the fed state (Miller and John, 1970) but depressed by 
malnutrition (Dominioni etal, 1981) leading to reduced immunoglobulin (Ig) 
levels (Dominioni and Dionigi, 1987). Subsequent infection fails to elicit a
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full acute phase protein response and leaves the patients 
immunocompromised. The reduction in hepatic synthesis of plasma 
transport proteins in inflammatory states and acute phase protein response 
in malnutrition may be due to substrate competition and deficiency, 
respectively. Support for these findings is found in patients undergoing 
major GI surgery (Windsor and Hill, 1987). Those who lost an average of 
37%, versus 3%, of their body protein, had increases in pneumonia by four­
fold, sepsis by two-fold and length of stay (LOS) by five days. An integrated 
immune response is therefore dependent upon adequate nutrition.
1.3.2.3 Organ Function 
Malnutrition affects all human organs. In starvation organ function 
deteriorates initially because of biochemical change but is progressively 
affected by loss of functional organ mass. Acute starvation markedly 
reduces muscle function, due to relative hypoglycaemia, dehydration and 
mild acidosis but these effects are quickly reversed by refeeding (Taylor and 
Keys, 1958). However, chronic starvation causes gross muscle loss. 
Resultant debilitation causes immobility which accentuates the risk of 
pressure sores, chest infections and deep vein thrombosis. Muscle 
strength decreases and fatiguability increases, possibly caused by deficits 
in muscle fibre types and levels of enzyme activity (Church et al, 1984; 
Russell and Jeejeebhoy, 1983). Furthermore, muscle function is impaired 
by negative energy balance irrespective of non-nutritionai factors such as 
sepsis or trauma (Brough etal, 1986). However, 14 days of PN can reverse 
muscle atrophy, the reduction in type li muscle fibres and depressed
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phosphofructokinase activity (a determinant of maximal glycolytic rate) 
(Church et ai, 1984). Thus refeeding can quickly reverse the effect of short­
term starvation on muscle function. Conversely, it required 150 days of 
refeeding to reverse abnormal muscle function following severe and chronic 
malnutrition (Brough etal, 1986).
Prolonged starvation results in massive weight loss and ultimately death. 
During 60-70 days starvation the 30 IRA hunger strikers lost 38% of their 
body weight and 10 died (Allison, 1992). Weight loss or gain is not linearly 
associated with functional changes. When healthy volunteers were fed 20- 
60% of their estimated energy requirements for 24 weeks average losses 
included: body weight 23%, fat 65% and fat-free mass 17% (Figure 1.3) 
(Keys et al, 1950). Original body weight was regained after 16 weeks of 
refeeding but body composition remained abnormal up to 24 weeks with an 
increased fat: fat-free mass ratio. Within this time depression score and 
muscle strength, fitness and maximal oxygen intake had not returned to 
normal (Figure 1.4). Injury plus starvation causes weight loss of 10% and 
20% in 15 and 26 days, respectively (Keys et al, 1950; Kinney, 1976). Loss 
of between 37g and 150g of nitrogen incurs a loss of fitness but the time 
required for recovery is independent of nitrogen loss (Taylor and Keys, 
1958). Weight loss of more than 5-8%, progressively impairs autonomic 
function including thermoregulation (Mansell et al, 1990) and causes 
depressed mood (Brozek, 1990). There is also a reduction in vital capacity 
and pulmonary ventilation leading to impaired pulmonary efficiency (Keys, 
1950). Neuroventilatory drive is impaired and inspiratory and expiratory
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muscular weakness is demonstrable (Rochester and Esau, 1984). This 
results from respiratory muscle wasting (Arora and Richester, 1977). These 
phenomenon can impair C02 expiration, and leave the patient prone to 
tracheobronchial colonisation with Pseudomonas aeruginosa (Niederman 
et al, 1989; 1984) and postoperative pneumonia (Garibaldi et al, 1981); 
respiratory failure appears to be a major cause of death in PEM (Brough et 
al, 1986). In addition starvation causes cardiac atrophy (Wharton et al, 1969) 
and a reduction in heart volume and cardiac output (Heymsfield et al, 1978; 
Keys, 1950). Lastly, the kidneys lose their concentrating capacity, leading to 
polyuria, and are inefficient at excreting acid which exacerbates the 
development of metabolic acidosis. These changes in organ function 
increasingly place a patient at risk of physiological decompensation and 
may be critical when refeeding the cachectic patient.
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Figure 1.3 Changes in body composition as a percentage of basal values during 24
weeks of semistarvation followed by refeeding (n= 12) (Keys et al, 1950).
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Figure 1.4 Changes in weight and body function as a percentage of basal values
during 24 of semi- starvation followed by refeeding (Keys et al, 1950).
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Wound healing, as measured by collagen deposition, is impaired when
food intake is inadequate over the week pre-surgery (Haydock and Hill,
1986; 1987; Windsor et al, 1988). This is regardless of absolute fat and
protein stores and suggests that wound healing is dependent on recent
substrate (amino acid) supply.
1.3.2.5 Effect of starvation and inflammatory states on body composition 
During pure starvation, preferential use of fat as body fuel reduces the rate 
of protein loss whereas inflammatory states prevent this adaptive response. 
This difference is reflected in the change in tissue composition. When active
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soldiers were given a hypocaloric diet, the tissue composition of weight loss 
rose from 2500 Kcal/ Kg to 5000 Kcal/ Kg over three weeks (Grande and 
Keys, 1980) but in injured or il! patients the value remains at 3000 Kcal/ Kg 
(Duke et al, 1970). The latter reflects preferential use of protein (4Kcal/ g; 
1Kcal/ g hydrated tissue) and moderate use of fat (9 Kcal/ g) as fuel and 
causes the more rapid weight loss, particularly lean tissue, which is 
apparent in inflammatory states.
Extracellular composition also changes during starvation. Extracellular fluid 
(ECF) volume relatively increases (23% to 34% of the body weight) but 
without a significant absolute increase (Keys et al, 1950). However, 
depleted postoperative patients show an absolute increase of ECF volume 
(Elwyn et al, 1975). Several mechanisms are responsible for ECF 
expansion in starvation and inflammatory states (Sitges-Serra etal, 1992):
1. Increased capillary permeability and 'albumin leak' into the interstitium 
resulting in hypoaibuminaemia. Hypoalbuminaemia results in a lower 
oncotic pressure and reduced blood volume.
2. Hypovolaemia and pain activate the water and sodium retaining 
mechanisms (anti-diuretic hormone and renin-angiotensin-aldosterone 
axis) which cause ECF expansion.
3. Excessive sodium and water administration during resuscitation and 
overfeeding (especially high glucose: low protein diets) promote sodium 
and water retention when there is a simultaneously reduced capacity to 
excrete sodium and water (MacFie et al, 1981).
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Expanded ECF and associated interstitial oedema may cause detrimental 
sequalae:
• Organ, particularly lung, dysfunction (Tellado et al, 1989),
• An increased ratio of exchangeable sodium: potassium (Nac/ Kc) in 
cancer patients (Shizgal, 1985) which is associated with increased 
mortality in surgical patients (Tellado et al, 1989).
• Altered fluid distribution can cause abnormal pharmacokinetics of many 
drugs and hypovolaemia which can precipitate heart failure in 
susceptible individuals.
• Flypoalbuminaemia which increases surgical risk and impairs wound 
healing (Pettigrew et al, 1987; Windsor and Hill, 1988; Sitges-Serra et al, 
1990; Christou etal, 1989)
Three factors largely determine albumin concentration: rate of secretion, 
catabolism and equalibrium between intravascular and extravascular 
compartments. Extravasation of albumin is a short term response and 
cannot be implicated in prolonged hypoalbuminaemia after the stress 
response (Bistrian, 1986). Usual hepatic production rates are 0.12-0.27g/ 
Kg body weight/ day (Gersovitz et al, 1968), about 15g/ day in a 70Kg man. 
Nutrient supply affects albumin synthesis more than catabolism (James 
and Hay, 1968). Thus, during an inflammatory state the normal synthetic 
rate is unable to restore normal levels (Desai et al, 1985). Substrate supply 
therefore largely determines the long-term response to albumin 
concentration and subsequent fluid shifts.
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1.3.2.6 Influence of inflammatory states on the metabolic response
Starvation is characterised by a hormone profile which promotes fat 
utilisation for fuel and minimises protein breakdown. However, in hospital 
patients this adaptive response is frequently inhibited, by an inflammatory 
state, even in the presence of severe starvation. This is caused by 
increased insulin resistance and increased levels of counterregulatory 
hormones compared to pure starvation (Table 1.3). Adrenaline, through its 
beta-adrenergic effect, stimulates hepatic gluconeogenesis and blocks 
peripheral glucose uptake, especially in skeletal muscle (Miles, 1995; Shaw 
and Wolfe, 1987). Alpha-adrenergic stimulation, associated with 
noradrenaline, inhibits insulin secretion. Elevated cortisol is associated with 
glucose intolerance, hypergiycaemia, increased lipolysis in adipose tissue 
(Divertie et al, 1991), increased protein catabolism and negative nitrogen 
balance. Conversely, cortisol induces hyperphagia and reduces splanchnic 
proteolysis, resulting in a growth of the liver and G! tract at the expense of 
muscle wasting. The effect of growth hormone (GH) is dependent on 
whether a person is in the fed or fasted state, that is, on the prevailing 
insulin levels. The catabolic functions of GH are to increase blood glucose 
levels by inhibiting peripheral uptake and stimulation of lipolysis in adipose 
tissue. However, in the fed state GH acts in concert with insulin to stimulate 
protein synthesis, promoting a positive nitrogen balance (Clemmons et al, 
1987; Ziegler etal, 1988).
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Table 1.3 Hormonal changes and effects during pure starvation and 
inflammatory states (± starvation) (summarised from 
Newsholme and Leech, 1983).
Parameter Starvation Inflammatory
state
j
Hormonal ! » Insulin i ± relative 1
changes: j # Insulin resistance T ft
i * Insulin: glucagon ratio i 1
I & T3 i i
I * glucagon f f
i « growth hormone f t
; & catecholamines T ft
I « glucocorticoids f ft
Effects on I • gluconeogenesis f ft
intermediary \ 0 lipolysis ft ftmeiaooiism. i i ® ketogenesis ft f
Blood fuel levels: | • glucose normal or | f
} © fatty acids f f
i • ketone bodies TTf f
Fuel utilisation: j • glucose 11 f
\ • fat and ketone bodies H f
Nitrogen loss f ff to ffff
Response to j * weight gain ft f (if overfed)
refeeding: j . muscle mass f -
i « fat mass t f (if overfed)
A second major component of the stress response is the release of 
cytokines which elicit the acute phase protein response (Baue et al, 1984). 
In the first stage of the inflammatory response phagocytes release 
endogenous mediators, interleukin-1 (IL-1) and IL-2 (Scrimshaw, 1991). IL- 
1 stimulates fever, proteolysis, neutrophilia, decreased serum iron and iron-
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binding capacity and zinc (removed by the liver and reticuloendothelial 
system), increased serum copper due to reduced hepatic synthesis of 
caeruloplasmin, leukocyte count, T- and B-cell activation, insulin and 
glucagon release, acute phase protein response, reduced albumin 
synthesis, whole body protein flux, and oxidation (Dinarello, 1984). The 
capacity of isolated mononuclear cells to synthesise IL-1 is diminished by 
severe hypoalbuminaemic malnutrition (Keenan, 1982; Hoffman-Goetz, 
1981) which carries a disadvantage to survival (Keenan, 1982). Tumour 
necrosis factor (TNF), but not IL-1, is directly lipolytic and increases blood 
glucose well above lipolytic and gluconeogenic thresholds. IL-2 acts on the 
hypothalamus to cause fever and to stimulate the increased production of 
adrenocorticotrophic hormone (ACTH) by the anterior pituitary- ACTH 
stimulates cortisol secretion. Anorexia is induced and hepatic synthesis of 
glycoprotein is increased. Vitamin utilisation is increased as is riboflavin 
and ascorbate excretion. Overall, inflammatory states increase serum 
glucose, FFA, and glycerol levels and protein flux. These changes increase 
levels of circulating fuel and induce the acute phase protein response which 
temporarily improves immunocompetence and wound healing. Supply of 
exogenous amino acids and energy would enable continued expression of 
the acute phase response while ameliorating catabolism until the 
inflammatory state resolves (Shaw and Wolfe, 1987).
1.3.2.7 Consequences of Delaved Nutritional Support 
There is evidence that debilitation, resulting from malnutrition, occurs more 
quickly than restoration by refeeding. By implication nutritional support early
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in the course of an inflammatory process should be more beneficial. 
Moderate catabolism is associated with a 20% increment in energy 
expenditure (see Figure 2.3) and loss of about 12-15g of nitrogen per day, 
whereas optimal nutritional support, in a non-catabolic state, can only 
induce a nitrogen balance of +3-5g per day (American Society of Parenteral 
and Enteral Nutrition, 1987). Thus one day's starvation during moderate 
catabolism requires 3-5 day's refeeding, once anabolism prevails, to make 
good the deficit. Nutritional support during the catabolic phase would 
therefore be beneficial because it would reduce, not prevent, the rate of 
nitrogen loss and thus reduce debilitation. In support of this hypothesis it 
was found that patients who initially presented with markers for malnutrition 
still had more markers for malnutrition one year later when compared to 
those initially well-nourished (Linn, 1984). In addition, patients classified as 
malnourished have an increased hospital LOS (Robinson et al, 1987) and 
those suffering CVA are less likely to achieve discharge (Axelsson et al,
1988). Lastly, PEM predisposes to refeeding syndrome (Rudman et al, 
1975) (Appendix 8.1.1). These data suggest that once malnutrition is 
established it is difficult to reverse, causes prolonged LOS and reduces the 
efficacy and safety of refeeding.
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Nutritional support has been shown to give definite clinical benefit to 
selected groups of patients. For example, elderly patients with hip fractures 
are more quickly rehabilitated when given overnight NG feeding in addition 
to their daytime meals (Bastow et al, 1983). Patients with short bowel 
syndrome would otherwise die or, in the case of children, suffer growth 
retardation without enteral and/or parenteral nutritional support. In addition, 
malnourished patients often look and feel better when given nutritional 
support (Hill, 1987). Unfortunately many studies have failed to prove the 
clinical efficacy of nutritional support because:
® Patient numbers were small;
• Groups studied were heterogenous for disease-type and -severity or 
nutritional status (Koretz, 1986; Veterans Affairs, 1991); and
• Nutritional support was inadequate in amount and/or duration.
Although nutritional support may be indicated in certain patients it is not 
always possible or ethically feasible to provide it. Furthermore, EN may be 
precluded by lack of access or GI dysfunction. PN is almost universally 
possible but with a higher incidence of complications. Lastly, nutritional 
support must be continued until the patient has either fully recovered or is 
capable of doing so using oral feeding alone. Premature termination of 
nutritional support may prolong recovery or cause relapse. The following 
section reviews patient selection for nutritional support, its proven efficacy in 
certain diseases, and the potential routes of delivery.
1.4 Efficacy of Nutritional Support
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1.4.1 Patient Selection 
Nutritional support is only of net benefit where the reduction in malnutrition 
associated complications is greater than the increase in iatrogenic 
complications. When considering only those complications associated with 
malnutrition, or those caused by nutritional support, there are three 
alternative strategies for treating PEM (Figure 1.5). When no treatment is 
given the complication rate will be entirely due to malnutrition. When aii 
patients receive nutritional support malnutrition-associated complications 
will be minimised but the risk of iatrogenic complications is equal to that 
associated with the method of nutritional support used. Overall complication 
rate can be minimised by selecting only those patients in whom nutritional 
support reduces malnutrition-associated complications to a greater extent 
than causing iatrogenic complications. The threshold at which nutritional 
support is of net benefit will be determined by the incidence of malnutrition- 
associated complications, the efficacy of the nutritional support method in 
reversing or preventing malnutrition, its associated complication rate, and 
the accuracy of patient selection. Patient selection must identify al! of those 
patients at risk from malnutrition to optimise the benefit of nutritional 
support, whilst de-selecting patients who would not benefit in order to avoid 
unnecessary iatrogenic complications.
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Figure 1.5 Three strategies for treating malnutrition (adapted from Detsky, 1984).
Expected total 
complication rates =
A)Treat none
‘Treatment’
strategy
B) Treat all
malnutrition
associated
complications
I j  I malnutrition 
associated 
complications 
+
111 iatrogenic 
complications
C) Treat some
i i  malnutrition 
associated 
complications 
+
t iatrogenic 
complications
t and 1 are only relative between the different Treatments’, not 
quantitative.
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1.4.2 D isease specific efficacy o f nutritional support
1-4.2.1 Surgery
Nutritional support has been widely used before and following surgery to 
reduce postoperative complications.
1.4.2.1.1 Preoperative nutritional support 
Early clinical trials of perioperative PN generally demonstrated improved
nutritional status in those patients treated relative to untreated controls.
Furthermore, PN was associated with a reduction in major complications
(Heatley et al, 1979; Mueller et al, 1982) and mortality (Mueller et al, 1982).
However, other studies failed to demonstrate any beneficial effect from PN
(Holter and Fischer, 1977; Holteretal, 1977; Lim et al, 1981; Moghissi et al,
1977; Schildtetal, 1981; Simms et al, 1980) and more recently benefit has
been found to be restricted to malnourished patients (see below).
Additionally, in a cost analysis, PN had been shown to be associated with a
net increase in treatment cost (£50/ patient) (Twomey and Patching, 1985).
However, under the same conditions, use of EN resulted in a cost saving
(£350/ patient).
The divergent results found in studies of perioperative nutritional support 
may be partly explained by the inappropriate use of weight gain as a sign of 
clinical improvement, which is misleading in hypoalbuminaemic patients 
(Starker et al, 1983). In this study 32 patients with various GI diseases and 
an albumin concentration less than 32g/ L were given PN for 5-14 days
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before surgery. Major postoperative complications occurred in 6% of 
patients (responders) whose weight decreased as serum albumin 
concentration rose and in 50% of patients whose weight increased as 
albumin concentration fell (‘non-responders’) (Starker et al, 1983). In a 
second study ‘non-responders3 were operated upon after 7 or 33 days of 
total parenteral nutrition (TPN). Major complications occurred in 45% and 
12%, respectively (Starker et al, 1986). Thus some hypoalbuminaemic 
patients, especially those suffering from malnutrition, are unable to 
adequately excrete sodium (Klahr and Alleyne, 1973) when given PN. This 
results in weight gain as a result of an increased ECF volume (Sites-Serra 
etal, 1988). In such patients postoperative risk is increased after one week 
of PN but then falls after nearly five weeks of PN. Preoperative PN therefore 
requires a minimal duration to effect beneficial physiological change. For 
example, the IL-1-induced acute phase protein response is depressed after 
a period of PEM but significantly restored by one day of PN (Drabik et al,
1987). After seven days of TPN, liver and muscle glycogen are restored, with 
a significant increase in plasma prealbumin, haptoglobin and complement 
C3 (McMahon, unpublished) and hydroxyproline accumulation as a measure 
of wound healing (Haydock and Hill, 1987). Two to three weeks of TPN 
improves muscle function (Russell et al, 1983a, b) and reduces the 
complication rate in very malnourished patients (Veterans Administration 
study, 1991). Thus nutritional support may reduce postoperative 
complications in certain patients provided it is given for a sufficient period. 
Current evidence suggests that at least 7-10 days of perioperative PN is
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required for clinical effect. However, PN alone is only effective as an adjunct 
to treatment of the primary condition.
1.4.2.1.2 Postoperative nutritional support 
Several research groups have studied the effect of postoperative nutritional 
support on the incidence of complications. Bellantone et al (1988) studied 
100 hundred patients who underwent major GI surgery randomised to 
seven days of TPN or IV hydration. The incidence of complications was 
similar between groups until analysis was restricted to the patients with 
abnormal ‘Instant Nutritional Assessment (INA) (serum albumin < 35g/ L 
and/or total lymphocyte count < 1500 cells/ mL) (Seltzer et al, 1979). In this 
sub-group the incidence of sepsis was lower in the TPN group. In a larger 
study, 395 malnourished patients requiring major abdominal or thoracic 
surgery were randomised to 7-15 days pre- and 3 days postoperative TPN 
or standard IV hydration (Veterans Affairs, 1991). Overall the TPN group had 
a higher incidence of complications, especially infective (though not 
catheter-related) complications, with a non-significant (ns) reduction in non- 
infective complications. Increased infection rate was confined to patients 
categorised as borderline or mildly malnourished. In contrast, in patients 
with severe malnutrition (5% of the candidates) there was a lower incidence 
of non-infective complications, with no concomitant increase in infective 
complications. In another PRCT, septic complications in malnourished 
patients receiving at least 10 days pre-operative TPN (n = 51) or EN (n = 50), 
were similar to non-depleted controls (n = 49) but in malnourished controls 
(n= 50) there was a higher incidence of complications. In high risk patients,
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with weight loss of more than 10% of body weight and over 500ml blood 
loss during surgery, nutritional support was associated with fewer major 
complications (Meyenfeldt et al, 1992). Compared to the Veterans Affairs 
Study (1991) this population was more homogenous, with inclusion 
restricted to nutritionally depleted patients under 80 years, requiring GI 
resection for gastric and colorectal carcinoma, and whose surgery was 
carried out by surgeons at a single hospital and with a low mortality (5% vs. 
10% in the \A-trial). These studies indicate that perioperative PN is 
associated with an overall reduction in complications only if its use is 
restricted to patients in whom malnutrition is significant.
Relatively few studies have been conducted on the effect of perioperative EN 
on postoperative complications. Early postoperative EN has been found to 
improve nitrogen balance (Fairfull-Smith et al, 1980; Hoover et al, 1980; 
Sagar etal, 1979) but without reducing postoperative complications (Fairfull- 
Smith et al, 1980; Hoover et al, 1980; Ryan et al 1981; Sagar et al, 1979). 
Specifically, immediate postoperative jejunostomy feeding has been 
associated with a relatively high incidence of complications (2-65%, 
Hayashi et al, 1985; Page, 1981). EN has been associated with a reduced 
analgesic requirement (Magnusson et al, 1989) and use of intravenous 
fluids, but the net treatment cost was increased (Hoover et al, 1980; Ryan et 
al, 1981). The effect of early postoperative EN on LOS is equivocal; Fairfull- 
Smith et al (1980) and Hoover et al (1980) found no difference in LOS 
whereas Sagar et al (1979) reported a reduction of 5 days which could 
potentially reduce overall cost. In addition, EN, compared to PN, appears to
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preserve glucose tolerance and insulin response, usually abnormal 
following surgery (Magnusson et al, 1989), and can produce a positive 
nitrogen balance and maintain similar serum albumin, prealbumin and 
plasma transferrin levels at a lower intake of energy and nitrogen (see 
1.4.2.2) (Hamaoui et al, 1990). These data suggest that EN may be more 
effective at treating malnutrition, per se, but its effect on the incidence of 
complications has not been adequately tested.
1.4.2.2 Trauma
Trauma patients are usually well-nourished on admission but can rapidly 
become malnourished if nutritional support is not given. Patients with an 
abdominal trauma index (ATI) of more than 15 are at high risk of 
postoperative complications (Moore and Jones, 1986). To determine the 
effect of nutritional support, 75 such patients were prospectively randomised 
to jejunal EN or 5% IV dextrose from 18 hours (postoperatively) and then 
TPN from day 5 (non-protein energy: g nitrogen, NPE:gN, ratio 133: 1) 
(Moore and Jones, 1986). Total lymphocyte counts were better maintained 
and the incidence of major septic complications was lower (4% EN vs. TPN 
26%) in patients given EN. In a second study of 98 patients, with an 
abdominal trauma index (ATI) of >15, those randomised to EN, compared to 
PN, sustained fewer episodes of pneumonia, intra-abdominal abscess, 
and catheter sepsis and sustained fewer infections per patient, as well as 
significantly fewer infections per infected patient (Kudsk et al, 1992). 
Although there were no differences in infection rates in patients with an 
injury severity score (ISS) < 20 or an ATI <24, there were fewer infections in 
patients with an ISS >20 and an ATI >24. Confirming these results a meta­
28
analysis of data from eight prospective trials found that patients randomised 
to TPN had more septic complications than those given EN (Moore et ai, 
1992). EN is therefore associated with a lower incidence of complications 
compared to TPN. This does not exclude the possibility that TPN increases 
the complication rate compared to EN, rather than EN reducing the 
complication rate compared to starvation. However, a comparison of EN 
versus starvation in severely traumatised patients would be required to test 
this hypothesis. The strong anecdotal evidence that starvation would 
increase morbidity in such patients ethically precludes such a study.
The apparent TPN-associated increase in infection may result from adverse 
neutrophil response (Meyer et a!, 1988), exaggerated cytokine response to 
an endotoxin challenge (Lowry, 1990) and, in animals, inability, compared 
with EN, to maintain lymphocyte function (Birkhahn and Renke, 1984). 
Certainly compared with PN, EN improves survival to a standard Echerichia 
coli (E. coli) peritonitis, in both malnourished and well-nourished rats 
(Kudsk etal, 1983; Kudsk et al, 1981). Furthermore, normal biliary levels of 
secretory IgA (S-lgA), in rats, are maintained on EN but fali precipitously on 
TPN (Alverdy et al, 1985). S-lgA is the principle immunoglobulin produced in 
response to antigens delivered via the gut and prevents binding of 
endotoxins and microorganisms to the intestinal microvilli, initial intestinal 
antigen processing occurs in Peyer’s patches from where stimulated p cells
then migrate to distant mucosal sites (eyes, oropharynx, bronchial tree, 
breasts) so that the same protective S-lgA response occurs in response to 
secondary antigen challenge. Thus, EN appears to maintain immune
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response to infection, whereas its absence, during TPN, is associated with 
immunosuppression. Furthermore, though nitrogen balance was higher in 
the TPN patients, plasma protein levels were similar or higher in the EN 
group (Kudsk et al, 1992; Moore et al, 1992). This may be due to better 
utilisation of porta! versus peripheral nitrogen (Piccone et al, 1980) and the 
amelioration of the acute phase protein response and fall in plasma protein 
levels (hepatic reprioritisation) that accompany trauma or infection 
(Peterson etal, 1988).
Overall EN is associated with a reduction of septic complications, compared 
to PN, in blunt trauma patients (Moore et al, 1992). These patients are at 
greatest risk if immunocompromised as multiple injuries necessitate 
prolonged immobilisation; the 'horizontal crucifix' position promotes 
nosocomial pneumonia (Borderetal, 1987; Christou etal, 1980 Moore et al, 
1990). Consensus suggests that EN, in preference to PN, should be started 
early, particularly in the most severely injured patients (Kudsk et al, 1992; 
Moore et ai, 1992).
1.4.3 Route: Efficacy of Enteral versus Parenteral Nutrition  
Benefits of TPN including early administration and absence of GI 
intolerance or malabsorption must be balanced by risk of catheter sepsis, 
pneumothorax, haemothorax, hyperglycaemia and hyperosmolality due to 
greater insulin resistance (Chiolero et al, 1989a). Heyland et al (1993) 
abstracted data from MEDLINE to determine the optimal route of nutritional 
support and nutritional composition and pH of EN in critically ill patients
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(Table 1.4). The ‘level of evidence’ was determined by the study type 
(Appendix 8.1.2) based on rules of evidence as endorsed by consensus 
conferences (Sackett, 1989). Overall EN reduced morbidity and mortality of 
critically ill patients. All the primary studies were randomised, some used 
objective criteria to define infective outcomes, but few were blinded. All 
studies using pneumonia as an outcome, employed non-specific criteria. 
This approach is an inaccurate method of diagnosis (Andrews et al, 1981), 
thus weakening the inferences that one can draw from such studies. 
However, there was sufficient ‘level 2 evidence’ to recommend that, unless 
specifically contraindicated, EN should be commenced as early as possible 
in the course of a patient’s illness (Heyland et al, 1993). These authors 
suggest that EN should be started at a low infusion rate (eg. 10ml/ h) and 
increased as tolerated. The goal of early EN is not to meet the nutritional 
requirements but rather the objective is to stimulate gut immunological 
function (Zaioga et al, 1992). Patients can be supplemented with TPN to 
meet their nutritional requirements if necessary until higher rates of EN are 
tolerated. There is no evidence to suggest that specific types of feed have 
advantages over others, though polymeric feeds are cheaper, equally well 
tolerated (level 2 evidence) and may reduce bacterial translocation 
compared to predigested feeds (level 5 evidence). However, the effect of 
early aggressive, rather than minimal, EN has not been adequately 
investigated.
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Table 1.4 Clinical efficacy of different aspects of nutritional support as 
defined by the level of evidence and the present clinical 
recommendations for their use (Heyland etal, 1993).
Aspect of nutritional 
support
Level of 
evidence
Clinical recommendation
1. EN vs. TPN 2 • EN is preferred where possible
2. Early EN • Begin within 24h at low rates
3. Stomach or small bowel * Either choice acceptable
4. Optimal composition?
* fats 5 • not indicated; benefit not proven
• arginine 5 • not indicated; benefit not proven
• glutamine 5
O  r*
• not indicated; benefit not proven
• elemental vs. 2,5 • choose polymeric
polymeric
5
• fibre • not indicated; benefit not proven
5. Acid feeds - • not indicated; benefit not proven
1.4.4 When to feed 
Many patients requiring nutritional support will have general anaesthesia 
during part of their treatment. This could affect the use of EN as gastric and 
colonic function take 1-2 and 3-5 days to return, respectively. Gastric 
(emptying) function has traditionally been monitored by regularly checking 
the volume of gastric aspirate (Figure 1.6). However, a large residual 
volume is not always an indication of poor gastric emptying (McClave et al, 
1992). Furthermore, small intestinal function usually returns within 24 hours 
of general anaesthetic and continues even in the presence of 
gastroparesis. In addition the absence of bowel sounds does not 
necessarily indicate ileus in ventilated patients as these patients do not
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swallow air (Shelly and Church, 1987). Overall gut motility and the feasibility 
of gastric feeding is indicated if aspirates do not exceed 200mL (100mL in 
gastrostomy feeding) twice in 24h (Payne-James et al, 1987). Small 
intestinal function should be monitored by symptoms of abdominal 
distension. An increase in abdominal girth of more than 10cm above 
baseline, indicating possible ileus, may necessitate temporary slowing or 
cessation of feeding. A number of studies, mostly using jejunostomy 
feeding, confirm the feasibility of early EN and suggest that it is associated 
with an improved outcome (Table 1.5). The efficacy of early PN is less good 
(Kudsk etal, 1992; Moore etal, 1992; Zaloga etal, 1991a).
Figure 1.6 Gastric (NG) feeding and aspiration.
Pyloric sphincter
Feed emptying from 
the stomach into the 
small intestine.
Air bubble in 
the fundus
Body of the 
stomach
NG tube
Gastric residual and 
feed pool
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Table 1.5 Effect of early enteral feeding.
Disease or 
injury type
Effect of early enteral feeding Reference
Burn
(animals)
• improved nitrogen balance
• shortened burn care period
• reduced catabolism
• reduced translocation
Wood et al, 1988 
Inoue et al, 1989a
Abdominal
surgery
(animals)
• improved nitrogen balance
• improved wound strength
Fletcher and Little, 
1986; Moore et al, 
1886
Zaloga et al, 1992
Head-injured • improved nitrogen balance
• reduced infection 
reduced intensive care stay
Grahm et al, 1989
1.4.4.1 Abdominal sureerv 
After abdominal surgery it has been standard practise to decompress the 
stomach through a NG tube and not allow oral or enteral feeding. However, 
in patients undergoing colonic surgery in those randomised to having the 
NG tube left in situ or taken out post-surgery, complication rates are the 
same (Bauer etal, 1985; Colvin etal, 1986; Olesen et al, 1983) or higher in 
the NG group (Essenhigh, 1973). However, NG decompression and the risk 
of anastomotic leak has not been investigated in humans.
Following upper Gl surgery EN can only be given via the jejunum. Barium 
‘follow through’ and xylose excretion studies have shown that the small
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intestine is capable of peristalsis and absorption following aortic aneurysm 
repair (Barker et al, 1991) and colonic resection (Catchpole, 1989). In 20 
patients undergoing colorectal resection and randomised to receive 
immediate IV or nasojejunal (NJ) infusion of 25g of glucose in 2.5L of fluid 
per day for 4 days, the enteral group suffered less postoperative distress 
and required less analgesia (p < 0.05) (Magnusson et al, 1989). This may 
have resulted from fewer obstructions where enteral feeding-induced 
peristalsis prevents adhesive kinking, which occurs when the bowe! lies in 
one position for a length of time (Schroeder et al, 1991). In this study of 
patients undergoing colonic resection those given NJ feeding for 56h post­
surgery had a tendency (ns) to faster passage of first flatus and bowel 
action and reduced LOS. Failure of bowel function to return significantly 
faster may have been be due to use of a low residue feed. In addition the 
surgeons’ reluctance to allow discharge prior to the recognised time when 
complications are likely to occur (ie 5 days for colonic anastomotic leakage), 
social reasons or training in stoma care may preclude a reduction in LOS 
and invalidate its use as a rigorous outcome marker. However, NJ feeding 
was associated with greater accumulation of wound hydroxyproline, a 
marker of wound healing and, in animals, improves anastomotic strength 
(Ward et al, 1982; Zaloga et al, 1992). Schroeder et al (1991) concluded that 
technical difficulty and intolerance are likely to prevent jejunal feeding from 
being successful in much more than 75% of cases. Furthermore, GI 
intolerance might be more prevalent if patient’s had a poor dietary intake 
prior to admission. Early NJ feeding for the first 56h only partially preserved 
body protein (Schroeder et al, 1991) but a longer period of feeding to counter
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the 2 weeks post-surgery catabolism might delay discharge or increase the 
burden of care at home. Early jejunal feeding is feasible and associated 
with a reduced incidence of obstruction and improved wound healing. 
However, the efficacy of NJ feeding has not yet been adequately tested in 
patients undergoing elective GI resection.
1.4.4.2 Burn
Until recently it was assumed a burn injury would cause temporary 
gastroparesis and that EN should not be started until after fluid 
resuscitation (Goodwin, 1985). However, recent recommedations are that 
patients requiring IV fluid resuscitation (see 4.1.3.1) should be considered 
for nutritional support (Copley and Glencourse, 1992). Furthermore, early 
EN has been shown to improve clinical outcomes (Chiarelli et al, 1990; 
McArdleetal, 1984; McDonald etal, 1991; Mochizuki etal, 1984).
1.4.4.2.1 Effect of early feeding oil metabolism  
Burn injury induces hypermetabolism, hypercatabolism (see 4.1.4.1-.2) and
immunosuppression which can have a deleterious affect on patient
outcome. McArdle et al (1984) conducted one of the first studies of early
postburn EN in 12 burned (40-70%) patients. These patients received
nasoduodenal feeding and reached positive nitrogen balance in 10 days.
Hyperglycaemia and hypoinsulinaemia, characteristic of hypermetabolism,
were absent, and neutrophilia and leukocytosis were short-lived with a
reduction in the percentage of juvenile neutrophils and an increased
lymphocyte count from day 0 to 14 of the study. Normally postburn peripheral
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blood profile shows prolonged neutrophil dysfunction (Alexander and 
Wixson, 1970; Yetgin, 1978), T-lymphocyte depression (Roitt et al, 1969), 
and an inadequate granulocyte response (Alexander and Wixson, 1970). 
More recently burned patients randomised to be fed at 4h, versus 58h, 
postburn had significantly lower urinary catecholamine and serum glucagon 
levels up to day 12, earlier positive nitrogen balance, reduced weight loss at 
4 weeks, and reduced LOS (Chiarelli et al, 1990). Elevated plasma 
glucagon concentrations correlated with glycogen depletion (Chiarelli et al,
1990), amino acid mobilisation from muscle and visceral protein, and 
increased gluconeogenesis and lipid mobilisation (Aulick and Wilmore, 
1979; Spitzer, 1979; Watchel et al, 1979; Wilmore, 1981). Wound tissue is 
glucose fuel dependent and therefore glycogen depletion impairs wound 
survival (Wilmore, 1974). Very early supplementation of carbohydrates and 
other nutrients pre-empts inhibition of insulin secretion, and higher plasma 
insulin concentrations in the first 12 days post-burn contribute to enhanced 
glucose utilisation in burned tissues and reduced hepatic gluconeogenesis 
(Chiarelli etal, 1990). These effects of early EN result in energy expenditure 
being 18% to 25% less than predicted, in part, explained by a lower 
incidence of infective complications (Jenkins et al, 1988; Jenkins et al,
1989). Furthermore, in patients fed within 1 (n= 13) versus 7 (n= 12) days 
postburn, the length of burn care, and by implication wound healing, was 
much shorter (38.8 versus 75.8 days) (Garrel et al, 1991). Finally, in 
severely burned patients aggressive protein feeding was associated with 
reduced sepsis and mortality (Alexander et al, 1980). Thus EN given within 
12-24h postburn improves nitrogen balance and immunocompetence and
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ameliorates metabolic derangements (Mochizuki et al, 1984). These 
changes are associated with improved clinical outcome.
1.4.4.2.2 Practicality  
The feasibility of early EN was tested in 106 burned (40% ± 21%) patients 
(McDonald et al, 1991). NG feeding was started within 6 hours postburn and 
was well tolerated. From the feed absorbed 99% of patients’ energy 
requirements were met by day 3. Vomiting occurred on only 2.8% of patient 
days with no aspiration pneumonia. However, large burn size or old age 
were associated with poor gastric emptying and a higher mortality. Stress 
ulcer prophylaxis was not used but there was no instance of GI bleeding. 
Thus most patients with medium to large burns can be successfully NG fed 
within 12h and their estimated energy requirements met within 24h. Early 
EN is associated with relatively few, minor complications and may reduce 
the incidence of gastroparesis (McDonald etal, 1991). Where gastroparesis 
persists jejunal feeding may be used. Some intestinal malabsorption 
occurs when the burn size exceeds 60% but this could be accommodated 
by reduced infusion rates of EN. A further cause of interruption to EN is the 
perioperative period of ‘nil per gut’ in order to reduce the risk of aspiration. 
On average, 6 hours of NG feeding time is lost, with a 32% reduction in 
energy intake on that day (Hansborough and Hansborough, 1993). 
However, in a retrospective analysis, patients fasted for 2, 2 to 8 or more 
than 8 hours, before induction of anaesthesia, achieved 28%, 11% and 6% 
of their estimated 24-hour energy goals (p< 0.0001) (Pearson et al, 1992). 
This was confirmed prospectively when patients fasted for 1 or 4 hours
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achieved 30% or 15% of their energy needs (p = 0.0001). Of the 99 patients, 
regurgitation occurred in 1% but no patient had evidence of pulmonary 
aspiration. Two further studies confirmed the absence of aspiration and 
improvement in nutritional intake during perioperative intestinal feeding 
(Buescher etal, 1990; Jenkins et al, 1994). These studies indicate that it is 
feasible to start EN within a few hours of injury and that the period of 
perioperative starvation can safely be reduced.
1.4.4.2.3 Bacterial Translocation
Many of the effects of burn injury may be mediated by bacterial 
translocation. The GI mucosal barrier comprises a layer of mucus, 
pancreatic enzymes, and gastric acid; the ‘immunological’ layer contains 
gut-associated lymphoid tissue, IgA, and IgM. This barrier prevents 
antigenic invasion, induction of local inflammation, and translocation of gut 
bacteria to the portal or lymphatic circulation (Gottschlich et al, 1990a; 
Rollandelli et al, 1990). Trauma with retained necrotic tissue promotes 
bacterial translocation in animals (Deitch McKintyre Bridges, 1987). 
Specifically, burn injury is associated with gut hypoxia which leads to 
atrophy and translocation proportional to burn size (Redan et al, 1990a). 
Translocation of C. albicans was inversely correlated with the blood flow of 
individual intestinal of villi (Gianotti et al, 1993). Bacteria! translocation may 
also occur in patients with multiple organ failure syndrome (Marshall et al,
1988). Critical illness and functional and structural alterations of the bowel 
are associated with the escape of microorganisms and endotoxin from the 
gut lumen to extraintestinal sites (Alexander et al, 1990; Border et al, 1987;
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Rush et al, 1988; Tancrede and Andremont, 1985). This process may be 
exacerbated by increased plasma corticosteroid levels, during sepsis and 
trauma, which may increase bacterial adherence to the gut mucosa and 
improve the survival of translocated bacteria (Alverdy and Aoys, 1991; Jones 
etal, 1991). Moreover, the magnitude of translocation of 14C-labelled E. coli 
4h postburn was positively correlated, in individual animals, with the 
number of viable bacteria recovered from organs and with an increased 
mortality rate (Fukushima et al, 1992). However, early EN improves 
intestinal blood flow (Inoue et al, 1989b) and prevents the hypovolaemia 
and ischaemia which promote translocation (Redan et al, 1990a, b). 
Preventing translocation may reduce activation of the complement cascade 
(which releases immunosuppressive products such as C3a, C3b, C3c, 
C3d), decrease the stimulation of macrophages (which can produce large 
amounts of cytokines such as interleukins 1, 6, and 8, TNF, and 
immunosuppressive thromboxanes and prostaglandins), and decrease 
production of catabolic and stress hormones. Early EN reduces gut hypoxia 
a primary cause of bacterial translocation. Thus early EN may reduce the 
infective and metabolic sequalae of bacterial translocation.
The presence of food in the intestinal lumen is essential for the 
maintenance of mucosal trophism (Gleeson et al, 1972). Conversely, 
starvation is associated with the loss of small intestinal weight and length, 
and reduced RNA, DNA, protein, and total cell numbers (Steiner et al, 1968; 
Brown et al, 1963). However, when, in mice, 18h and 24h of pre-burn 
starvation was followed by a gavage of E. coli and a 20% burn injury,
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bacterial translocation increased only to the mesenteric lymph nodes, but, 
paradoxically, bacterial killing was enhanced in all tested tissue (Gianotti et 
al, 1994). In addition, when, in Guinea pigs, a 40% burn is followed by EN 
bacteria! translocation to mesenteric lymph nodes, liver, spleen and lungs 
is lower compared with animals infused with lactated Ringer's solution 
(Gianotti et al, 1994). After 6h of postburn EN, E. coli translocation was 
reduced by almost 90% possibly as a result of EN preserving jejunal and 
ileal mass (Saito et al, 1987). After 24h or 48h of EN the percentage of 
viable bacteria in the tissues had decreased. In man, brief nutritional 
deprivation enhances monocyte bactericidal activity, natural killer cell 
cytolytic activity, and serum immunoglobulin (Ig) concentration (Wing et al, 
1983) and reduces susceptibility to infection with viruses, malaria, and 
some bacteria (Doran, 1992). In contrast, when bacterial translocation is 
measured by the number of viable bacteria in the tissues it was found that it 
was not increased by either 72h of starvation or protein malnutrition even 
when coupled with burn injury or artificial disruption of the indigenous 
intestinal microflora (Deitch et al, 1987). This apparent contradiction of 
other work is because measuring bacterial translocation by the number of 
viable bacteria does not differentiate between the role of the gut barrier and 
the immune system (Alexander et al, 1991). It appears that starvation or 
malnutrition before trauma may not increase the number of viable bacteria 
in tissues because the increased rate of translocation is cancelled by 
increased immunocompetence. However, post-trauma starvation is 
associated with both increased bacteria! translocation and reduced
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bacterial killing. Both these effects are reversed by EN given early following 
trauma.
Both the chemical composition and route of nutritional support can 
influence gut barrier function. In rats the number of positive mesenteric 
lymph node cultures following IV solution, gastrostomy feed, or oral chow 
followed the order: most > fewer > none (Alverdy et al, 1988). This positive 
effect of polymeric EN contrasts with increased bacterial translocation 
when switching from chow to elemental feeds, due to loss of mucosal 
mass and disruption of the microflora (Barber et al, 1991; Wells et al,
1991). In addition, the effect of enteral substrate on bacterial translocation 
and outcome appear to be time dependent. Braga et al (1994) studied this 
effect in mice given a gavage of E. coli, a 20% burn and randomised to 
different feeds. At day 1 mortality was lower in animals given EN rather than 
Ringer’s solution (Braga et al, 1994). No animal died after day 3 postburn 
and at this point mortality was lower (5%) in animals fed EN enriched with 
arginine, cd3 fatty acids, and RNA compared to those fed standard EN or
Ringer’s solution (10%). Bacterial translocation to the liver and lungs was 
higher in those fed Ringer's solution than EN. These data suggest that EN, 
per se, reduces early mortality possibly by reducing bacterial translocation 
from the gut to the systemic organs (Fukushima et al, 1992). The reduction 
in late mortality appears to be substrate dependent and may result from 
enhanced immunocompetence. These studies suggest than EN (versus 
PN) containing whole protein and possibly fibre and special substrates, 
confer most protection against bacterial translocation. This effect may be
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ascribed to two interacting mechanisms: a) maintenance of gut barrier 
function, limiting translocation of enteric organisms and endotoxin; and b) 
augmentation of host defence and bacterial killing. This hypothesis 
supports aggressive administration of whole protein EN immediately post­
injury.
1.4.4.3 Head iniurv
Severe head injury, as with burn injury, causes hypermetabolism and 
hypercatabolism and is associated with a high incidence of mortality and 
morbidity (see 6.0). However, better neurological outcomes were 
associated with energy deficits of less than 8000 Kcal compared with more 
than 11000 Kcal (Waters et al, 1986), and with aggressive versus non- 
aggressive, feeding, leading to a high energy and protein intake, within 10 
days of injury (Balzola et al, 1980). In contrast improved nitrogen intake in 
patients given TPN instead of EN did not affect overall morbidity and 
mortality (Hadley etal, 1986) and it is suggested that neurological outcome 
is most influenced by initial neurological status (Kaufman et al, 1987). 
However, these studies were small (n = 5) and retrospective, respectively, 
and therefore unconvincing. Unfortunately it is often difficult to deliver 
adequate EN because of poor gastric emptying. In one study (n = 20), 35% 
of patients starting NG feeding by day 2 post-injury, did not achieve the goal 
of 1.5 x resting energy expenditure (REE) until 2 weeks after injury (Clifton et 
al, 1985) (Figure 1.7). In another study 39% of patients started on NG 
feeding eventually required TPN because of intolerance (Young et al, 1987). 
Thus preliminary studies suggest that head-injured patients benefit from
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adequate nutritional support. However, intolerance to NG feeding is 
common and intestinal feeding may be advantageous.
Figure 1.7 Time to tolerance (daily aspirate < 200mL) of enteral feeding in severely head 
injured patients (peak GCS 4- 10, n= 23) (Norton et al, 1988).
Tolerance (%)
Days post-in ju ry
PN and jejunal feeding can be used to deliver nutrition despite delayed 
gastric emptying. Rapp et al (1983) randomised patients to TPN or NG 
feeding within three days of injury (total n = 38). At day 18 survival was better 
in the TPN group with a tendency to improved outcome (Glasgow outcome 
scale- see 2.2.4.3) at one year (63% versus 39%). Nutritional intake from 
NG feeding was lower due to GI intolerance as defined by the absence of 
bowel sounds and/or gastric residuals of more than 100mL per hour. It was 
hypothesised that the increased energy and nitrogen intake and nitrogen 
balance in the TPN group may prevent early death and provide opportunity 
for eventual neurological recovery (Rapp et al, 1983; Young et al, 1987).
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Another possibility is that improved nutrition may suppress the inflammatory 
response and thus reduce brain swelling. An alternative to TPN would be 
jejunal feeding and simultaneous gastric decompression (Rombeau, 
1986). However, jejunal intubation may be difficult to achieve and the tube 
can frequently translocate back into the stomach (Norton et al, 1988). 
Nevertheless jejunal feeding started at 36h post-injury delivered more 
energy (2100 Kcal versus 1100 Kcal), and was associated with a reduced 
cumulative energy deficit (3000 versus 10000 Kcal), and better mean 
nitrogen balance (-4.3 versus -11.8g/ day) when compared with gastric 
feeding given from 72h post-injury or when gastric function returned (Grahm 
et al, 1989). Early nutritional support is therefore associated with an 
improved clinical outcome and jejunal feeding may be an alternative to TPN.
1.5 Rationale for early and aggressive enteral feeding in hospitalised 
patients
Malnutrition is still common in hospitalised patients. It is often a 
consequence of a disease process, trauma or the side-effects of treatment. 
The effects of malnutrition are progressive, a person becoming increasingly 
debilitated and prone to organ failure and systemic infection. Unchecked, 
pure starvation will kill within 60 to 70 days. However, starvation is often 
associated with an inflammatory process secondary to trauma or infection. 
Inflammation induces hypermetabolism and hypercatabolism which prevent 
adaptation to reduced nutritional intake. As a result wasting of body tissue 
and physiological decline are more rapid.
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Oral, enteral and parenteral nutritional support can be effective in preventing 
and treating malnutrition. However, overall, clinical outcome was only 
improved in patients undergoing major surgery, who also had a significant 
degree of malnutrition, or those suffering high-risk trauma. Nutritional 
support was started within 24h of surgery or injury. In patients undergoing 
major Gl surgery the efficacy of PN is limited by the high incidence of 
associated infection whereas early NJ feeding has not been tested in a 
large enough number of patients. Early EN has been extensively used in 
patients following burn injury. However, the relationship between the delay 
before attempting aggressive EN and the incidence of mortality and 
complications and treatment cost have not been studied. Lastly, in patients 
suffering head injury NG feeding is often unsuccessful due to poor gastric 
emptying. Conversely early TPN has been shown to reduce early mortality 
and improve neurological outcome. However, to date, intestinal feeding has 
not been tested as an alternative to TPN. This is despite studies which 
show that early intestinal feeding is well tolerated.
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Methods
2.1 Introduction
This chapter sets out the aims and objectives of the thesis. It then goes on 
to give a background to the methodology chosen and finally the statistical 
analysis undertaken to test the hypothesis.
2.1.1 Aims and objectives 
The overall aim of the thesis was to test the hypothesis: “Is early aggressive 
EN; 1) feasible and 2) associated with improved clinical outcomes 
(mortality, major complications and LOS) and reduced treatment cost?” 
Secondary aims were to establish whether these associations were dose- 
dependent relative to requirements and whether any established efficacy 
was limited to certain types of disease or levels of disease severity. The 
common factor in all the thesis studies was that patients required EN, by 
tube or oral supplementation, due to disease or injury. In addition, patients 
in the Burn, GI and Head Injury studies were selected according to specific 
demographic, disease and injury severity criteria. The method of testing the 
hypothesis was made more rigorous in subsequent studies. Below are 
described, chronologically, the basic study designs and objectives used to 
test the thesis hypothesis.
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2.1.1.1 Preliminary Investigation: The effect of early enteral feeding on mortality
and hospital stay at two Acute Hospitals.
This was an observational study conducted to find out if there was any 
association between the delay of NG feeding and:
1. Mortality
2. Duration of subsequent NG feeding and
3. LOS.
These associations were tested to determine whether they were 
independent of age, sex and diagnosis of CVA. Confirmation of these 
associations implies that earlier NG feeding may improve outcome. 
However, this study did not control for disease severity and this was taken 
into account in the next (Burn) study.
2.1.1.2 Aggressive Early Enteral Feeding in Bum Patients Requiring IV Fluid 
Resuscitation
This observational study investigated the effect of the delay before 
attempting aggressive EN in burn patients requiring IV fluid resuscitation. By 
using univariate multivariable regression analysis it was possible to control 
for factors affecting disease severity and treatment variables. In addition to 
the delay before attempting aggressive EN, associations were also tested 
for the delay before attempting EN, per se (including non-aggressive EN), 
and aggressive EN attempted before or after the arbitrary time of 24h 
postburn. Associations were tested between these nutritional variables and 
the following outcomes:
1. Mortality
49
2. Complications (excluding and including mortality, by type, and by time 
after injury)
3. LOS (in survivors)
4. Cost of drugs, IV fluids and PN (‘drug-IV fluid-PN cost’) (in all patients 
and survivors, by type, and by time after injury).
This study design was weakened by the inclusion of retrospective data and 
the possibility of bias through lack of randomisation. It was then decided to 
test the above outcomes in a PRCT in patients undergoing GI surgery.
2.1.1.3 The Effect of Perioperative Starvation and Early Enteral Feeding in Patients 
undergoing Major Lower GI Surgery 
This was a PRCT of immediate postoperative NJ feeding, versus standard 
IV hydration, in patients undergoing resection of colorectal cancer. The 
patient population was clinically homogenous. It was therefore expected that 
randomisation would ensure that the two groups could be compared for 
changes in the following outcomes up to 90 days post-surgery:
1. Mortality
2. Major complications
3. LOS
4. £Drug-IV fluid-PN cost’ and
5. Functional recovery.
A randomise-then-consent protocol was used (Appendix 8.2.1). 
Unfortunately, the high rate of consent refusal by potential treatment patients 
caused the treatment group to be contaminated with a high proportion of 
‘refusers’ and it became obvious that the recruitment target could not be
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met. It was decided that a similar study should be attempted in a patient 
group from which consent was more likely. The data collection protocols 
and parameters found to be useful in the GI study, were subsequently 
applied to a PRCT of head-injured patients.
2.1.1.4 The Effect of Early Enteral Feeding in Patients suffering Severe Head 
Iniurv and Requiring Mechanical Ventilation 
This was a PRCT of early aggressive nasointestinal (Nl) or NG feeding 
versus standard (non-aggressive) NG feeding in patients suffering severe 
head injury (HI) and requiring mechanical ventilation. The patient population 
was homogenous for disease type. It was therefore expected that 
randomisation would ensure that the two groups could be compared for 
changes in the following outcomes up to six months post-injury:
1. Mortality
2. Major complications
3. LOS
4. ‘Drug-IV fluid-PN cost’ and
5. Neurological recovery.
An interim analysis was done for the purpose of the thesis. The study is 
expected finish in late 1997.
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2.1.2 Ethical Approval 
The Preliminary Investigation (3.0) was done retrospectively from dietetic 
records and did not alter patient treatment or require active patient 
participation. Ethical approval was therefore not required. Ethical approval 
was obtained from the Frenchay hospital ethics committee before 
commencement of ail other studies. Formal consent was obtained from 
patients or their relatives to allow participation in the Gl and Head Injury 
studies.
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2.2 Background to Methodology
This section reviews the background and rationale for the choice of 
methods used in the above mentioned studies.
2.2.1 Disease Severity Scores
Disease severity scores are objective and reproducible methods for 
describing disease. Their use allows disease severity to be controlled for in 
regression analysis, and, in controlled studies, enables statistical 
comparison of the patient groups to ensure that they are matched. Their 
other use is to allow stratification of the population in order to determine 
what level of disease severity is most influenced by nutritional deficit and 
support.
2.2.1.1 Burns
The two disease severity scores commonly used for predicting mortality are 
the ‘Bull score’ and the ‘Clark score’. The ‘Bull score’ is a probability chart 
constructed from probit analysis of age and percentage burned body 
surface area (BBSA) (Appendix 8 .2.2.1.1) subsequent to 1964 when 
prophylactic use of 0.5% silver nitrate solution reduced mortality due to 
Pseudomonas aeruginosa infection (Bull, 1971). The Clark (probability) 
score, in addition, takes into account smoke inhalation (Clark et al, 1986) 
(Appendix 8.2.2.1.2). When the probability was set at 0.66 the equation 
correctly classified 94% of patients; at a probability of < 0.66 100% (102) 
survived and at a probability of > 0.66 74% of those dying (19) had died. All 
patients with a probability of < 0.17 survived. However, there is
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disagreement over the importance of inhalation injury (Vico and Papillon,
1992) therefore it was decided to test both scores as well as individual 
factors affecting burn injury (age, BBSA, % full-thickness lesion (FTL), 
inhalation score).
2.2.1.2 Surgery
American Society of Anaesthetists (ASA) grading (see Appendix 8.2.2.1.3) 
has an overall relationship with perioperative mortality. ASA classification 
alone cannot be applied as a predictive factor for anaesthetic risk (Goldstein 
and Keats, 1970; Keats, 1978) but is one of the few universally applied and 
prospective assessments of a patient's anaesthetic risk.
2.2.1.3 Head Iniurv and Multiple Trauma
Impaired consciousness is an expression of dysfunction in the brain as a 
whole. This may be due to the combination of remote and local effects 
produced by brain damage or agents acting diffusely, such as drugs or 
metabolic imbalance. The Glasgow Coma Scale (GCS) (Teasdale and 
Jennett, 1974) assigns points to the best motor, verbal and conscious acts 
(Appendix 8.2.2.1.4). A lower GCS indicates increased neurological 
impairment and thus the GCS is a general tool for measuring the severity of 
head injury and recovery. A more comprehensive scoring system was 
developed by Gibson and Stephenson (1989) to identify moribund patients 
who will not benefit from active treatment (Appendix 8.2.2.1.5). 
Uncomplicated cases of extradural haemorrhage, depressed skull 
fractures, gunshot wounds, or patients managed on the unit for <12h or in
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whom intracranial pressure (ICP) was not monitored were excluded. The 
highest score achieved by a survivor was 11 (mean 5.03, SD 2.35). Any 
patient with a score >14 has a > 99.97% chance of dying, according to this 
scale. This is sufficiently high for 13 to be adopted as the upper limit of 
survival. In a prospective series of 52 comparable patients no patient with a 
score of >13 survived, therefore a ‘Leeds score’ of >13 can be used to 
identify moribund patients.
The extent and severity of trauma must be assessed separately using the 
Abbreviated Injury Scale (AIS) and Injury Severity Score (ISS). The AIS 
assigns every injury a six-digit code depending on severity: 1 = minor; 2 = 
moderate; 3= serious, not life-threatening; 4 = severe, life-threatening; 5 = 
critical, survival uncertain; and 6 = maximum, fatal. Injuries are divided into 
five anatomical regions (Appendix 8.2.2.1.6). ISS was used as an overall 
measure of injury in multiple trauma patients (Baker etal, 1974). Every injury 
has an AIS code assigned and is classified into one of six regions: head 
and neck; face; thorax; abdomen and pelvic contents; extremities and pelvic 
girdle; external and burns. The ISS is the sum of the squares of the highest 
AIS from three regions using the highest scoring injury for any particular 
region. Use of squares converts a probable quadratic relationship between 
AIS and mortality into a linear relationship, resulting in a significant 
correlation of ISS with mortality, morbidity and other measures such as 
length of hospital stay (Baker and O’Neill, 1976). However, to predict 
mortality in all ITU patients whatever their condition requires measurement 
of the Acute physiology and chronic health evaluation (APACHE) score. This
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combines an acute physiology score (APS) with a chronic health evaluation 
(CHE) (APACHE, Knaus etal, 1981; APACHE II , 1985; and III, 1991). Points 
are assigned to the worst 12 physiologic measurements (including the 
lowest GCS) within 24 hours of admission, age and previous health status 
(CHE). An increasing score (range 0-71) correlates with subsequent 
hospital mortality rates. However, APACHE misclassifies 12-14% of patients 
due to problems not disclosed until more than 24h post-ITU admission 
(Lemeshow etal, 1988). Serial measurement overtime reduces this error 
but is only of use in patients staying on ITU for several days (ie. of 
intermediate injury severity). In patients with blunt and penetrating trauma 
APACHE II was poorly correlated with ISS (McAena et al, 1992) possibly 
because APACHE II lacks an anatomic component, which is essential to 
assess the magnitude of acute injury in patients who are typically otherwise 
healthy.
The GCS and pupillary reactivity (Price and Knill-Jones, 1979) were used in 
the Head Injury study to select patients on the basis of neurological 
impairement. Retrospective measurements of the AIS, ISS and APACHE II 
were used to determine extent of injury, severity of trauma and general 
disease severity, respectively.
2.2.2 Nutrition-Related Disease Severity Scores  
These scores reflect the effect of primary disease and nutritional status or 
nutritional support on outcome.
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2.2.2.1 Subjective Global Assessment (SGA)
SGA comprises a dietary and medical history with a functional assessment 
and a physical examination, in which skin lesions specific for vitamin 
deficiencies and the presence of muscle wasting, fat loss, oedema and 
ascites were identified. Patients classified as being 'malnourished' by two 
clinicians, had more episodes of sepsis, more antibiotics prescribed and a 
longer hospital stay than patients classified as not being malnourished 
(Baker et al, 1982). SGA gave the best combination of sensitivity and 
specificity, 78% and 70%, respectively, in predicting infection compared to 
seven objective techniques of nutritional assessment, including serum 
albumin and transferrin, and creatinine-height index (CHI) (Detsky et al,
1984). In a second study of 202 patients admitted for elective Gl surgery, 
SGA and albumin were found to be useful in predicting postoperative 
complications whereas transferrin, CHI, percent ideal weight, percent body 
fat, and total lymphocyte count were not (Detsky et al, 1987). However, in 198 
surgical patients clinical examination only correctly identified 40% and 80% 
of malnourished and non-malnourished patients, respectively (Pettigrew et 
al, 1984). Also the authors point out that patients classified as being 
'malnourished' were identified by clinical signs that are not pathognomonic 
for malnutrition and thus are not necessarily measures of nutritional status 
alone.
2.2.2.2 Operative Risk
Pettigrew and Hill (1986) used a ‘Clinical assessment' to identify those 
patients at high risk of developing major postoperative complications
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following major GI surgery (Appendix 8.2.2.2.1). From 218 patients 17% 
were identified as being at high risk, 32% of whom went on to develop a 
major complication (p< 0.025; sensitivity = 41%, specificity = 85%). In 
another study the surgeon ranked the risk of postoperative complications on 
a linear analogue scale immediately pre- and post-surgery (Appendix 
8.2.2.2.2) (Pettigrew et al, 1987). This ‘Surgeon’s assessment’ was used in 
113 patients having elective GI resection. Postoperative complications 
occurred in 53% (20/38) of patients selected as being high risk or who 
increased their risk ranking postoperatively, compared with 9% of (6/65) 
patients selected as being at low risk or who decreased risk ranking post­
surgery (p < 0.001). The authors concluded that operative performance is 
the main factor in the development of complications and that malnutrition, 
with less fat to obscure vital structures, may be seen as an advantage. 
However, this conclusion ignores malnutrition-associated surgical risk, 
which preoperative nutritional support may ameliorate, and that 
postoperative assessment is of limited usefulness; post-surgery the 
chance to affect postoperative outcome may have been lost because it is too 
late to implement preoperative nutritional support or place the necessary 
catheters for postoperative feeding.
2,2.2.3 Prognostic 'Nutritional* Index (TNI)
Single nutritional measurements fail to accurately predict outcome (see 
2.2.3). To improve predictive accuracy regression analysis has been used to 
develop multi-variable formulae (indices). The PNI was the first widely used 
index (Mullen et al, 1979). In a prospective study of 100 patients undergoing
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major elective GI surgery, the incidence all complications was associated 
with PNI in the order: 8%, 30% and 46% for a PNI of <40%, 40-49%, and 
>50%, respectively (Buzby et al, 1980). However, in the presence of an 
inflammatory response (eg. preoperatively), with its associated fall in 
plasma transport protein levels, PNI loses its prognostic accuracy (Brenner 
etal, 1983). In addition, the PNI-complications relationship is non-linear (ie. 
few complications when < 40% rapidly rising when > 40%), limiting its 
usefulness in assessing individual patient risk. Overall these changes give 
post-trauma PNI a falsely high prediction of mortality in the immediate 
postoperative period (Moore and Jones, 1983). In conclusion, PNIs are only 
applicable in the patient group in which they are developed and tend to be 
inaccurate in the presence of an inflammatory response.
2.2.2.4 Prognostic Inflammatory and Nutritional Index (PINI)
The PINI was determined from seven acute phase proteins and four visceral 
proteins which best predict death or complications (Ingenbleek and 
Carpentier, 1985). a1-acid glycoprotein (AGP) and C-reactive protein (CRP)
constituted the most sensitive markers of inflammation in hospital patients, 
revealing up to 85-90% of true positive reactions in inflammatory conditions 
of any cause. Importantly, the 10-15% of false reactions with either AGP or 
CRP in some otherwise proven inflammatory states are not 
superimposable. Thus, screening using the product of both brought the 
power of detection up to 98-99% of positive cases. No single infected 
patient remained undetected using the product of AGP and CRP. The peak 
CRP level is proportional to tissue damage (Kushner et al, 1978) whereas
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AGP response to inflammation correlates with improved life expectancy 
(Bienvenu et al,1981; Philip, 1979) and may have antibody properties. 
Combining slow (AGP, t1/2 = 5-7 days) and fast (CRP, t1/2 = 4-6 hours) 
reacting markers provides both stability and sensitivity to the long- and 
short-term changes in inflammatory response. CRP may reflect the 
immediate treatment efficacy and AGP the patient's healing condition (Sann 
etal, 1984). Albumin and prealbumin (PA) were the most reliable plasma 
protein markers. PEM and nutritional support would be expected to affect 
prealbumin first followed by albumin. The four selected variables were 
aggregated within the following formula:
PINI = AGP (mg/ L)xCRP (mg/ L)
Alb. (g/ L) xTBPA (mg/ L)
Thus the numerator and denominator increase and decrease, respectively, 
in inflammatory states and malnutrition and, vice versa, during healing and 
nutritional support. This and the presence of fast and slow reacting markers 
in both gives greater sensitivity to change whilst using a ratio cancels 
hydration effects. The PINI correlated well with clinical outcome to allow 
stratification by risk of complications or death:
• >30 : life-risk patients
• 21-30 : high-risk patients
• 11-20 : medium-risk patients
• 1-10 : 1ow-risk patients
• *< 1 : non-infected subjects
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Serial measurements are thought to give more information (Ingenbleek and 
Carpentier, 1985).
It has been suggested that since CRP has a large impact on PINI (Brown et 
al, 1988a; Vehe et al, 1991) the same information could be obtained from 
CRP alone. Furthermore, in traumatised patients AGP and albumin 
concentrations contribute little to variations in PINI (Vehe et al, 1991) and 
AGP was not useful in predicting infective complications or fatal outcome in 
burned patients (Gottschlich et al, 1992). Conversely, CRP offered a 
reasonable indicator of death compared with albumin, AGP, and 
prealbumin. In addition a prealbumin of <100mg/ L had the best predictive 
accuracy of single tests correctly separating 70% of patients into outcome 
groups, particularly for selecting non-survivors. However, although its 
sensitivity was 92% specificity was only 40%, which was still higher than 
that of CRP. The ratio of CRP: prealbumin gave the best predictive score, 
slightly better than PINI; albumin and AGP did not significantly contribute to 
the sensitivity, specificity and accuracy of PINI and added to cost. It was 
suggested that for this group of burned patients a high risk of mortality 
should be defined as a PINI >175. Set against this data, increased levels of 
AGP in infants discriminated those who were infected (Bienvenu et al, 1981) 
and in septic patients a depressed acute phase AGP response is 
associated with poor survival (Dominioni et al, 1987). Furthermore, IV 
albumin given to hypoalbuminaemic patients requiring TPN, maintained 
higher serum albumin concentration and reduced complications 
suggesting that albumin is a determinant of clinical outcome (Brown et al,
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1988b). Lastly, a retrospective study of 18 traumatized patients receiving EN 
showed that PINI decreased significantly from 158 at baseline to 79 at day 
14 (Brown etal, 1988a). The PINI of these acutely ill patients contrasted with 
scores of only 22-30 where patients had a lower disease severity or were in 
the convalescent stage of disease/injury (Ingenbleek and Carpentier, 1985). 
Thus there is dispute over the importance of albumin and AGP as 
components of PINI and about the level which indicates risk. Nevertheless 
PINI, in contrast to PNI, reflects transport and acute-phase protein response 
to disease and trauma, both of which are influenced by nutritional state and 
substrate supply.
2.2.2.5 Oral Nutrient Intake and Outcome: Inadequate Oral Nutrient Intake Period 
QONIP)
The duration of IONIP was defined as the number of days post-surgery until 
the patient is eating 60% of his/her predicted energy requirement (Harris- 
Benedict) on two consecutive days (Meguid et al, 1988). This was taken to 
mean:
1. Restoration of GI function sufficient to allow the patient to eat enough 
nourishment to meet resting energy requirements; and
2. A stage of convalescence following which readmission for nutritional 
problems would not occur.
Retrospective stepwise linear regression on 464 consecutive patients 
undergoing abdominal surgery identified three mutually exclusive groups of 
patients in terms of condition, nutritional status and IONIP:
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1. High risk patients in whom PN should be started perioperatively, 
including those with carcinoma of the upper Gl tract, pancreas and 
hepato-biliary system;
2. Moderate risk patients not normally requiring PN, older than 40 years and 
with malignant disease (excluding 1.); and
3. Low risk patients not normally requiring PN, younger than 40 years and 
with malignant disease (excluding 1.).
IONIP was useful in identifying those groups of patients who should receive 
perioperative nutritional support because of their high risk of prolonged 
postoperative starvation. IONIP is not a prognostic indicator but allows 
stratification of risk from a nutritional point of view.
2.2.2.6 Choice of score 
Subjective assessments have only been validated for surgical patients and 
require trained observers, not available in the present studies. To date, PNIs 
only indirectly relate to nutritional status, are influenced by hydration, and do 
not account for inflammation or non-PEM. In contrast, PINI measures both 
nutritional and inflammatory status and accurately predicts outcome over a 
range of disease states. There is dispute over whether its component parts 
are as effective predictors as the whole score and the cut-off point signifying 
risk. Therefore, the whole score was used in the Gl and Head Injury studies. 
Lastly, IONIP could not be incorporated into the study protocols, but the 
principle, that nutritional intake is related to subsequent outcome was 
studied retrospectively in the Burn, Gl and Head Injury studies.
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2.2.3 Nutritional A ssessm ent 
Nutritional status and organ function comprise the baseline information 
from which patient response to injury, disease, or treatment will be 
determined. A diet which meets nutritional requirements will maintain body 
composition and function of otherwise healthy persons within the normal 
range. This equilibrium is disturbed by:
1. Decreased intake;
2. Increased requirements; and
3. Altered utilisation (Table 1.1). Loss of fat and protein results in a reduction 
in body weight, fat-fold thickness, and muscle bulk. Loss of body mass will 
not differentiate malnutrition from other causes. Malnutrition may therefore 
be defined as 'the presence, in a body system, of abnormalities observed 
upon withdrawal of nutrients and correctable by refeeding' (Jeejeebhoy,
1988). A major determinant of nutritional status is the nature of the 
presenting disease. Conditions which affect the GI tract, particularly the 
upper G! tract, and those associated with prolonged periods of sepsis or 
inflammation carry a greater risk of malnutrition, the risk being greater when 
the diagnosis is cancer (Hill et al, 1977). In addition, certain clinical 
conditions, for example advanced peripheral vascular disease, can induce 
wasting, caused by poor nutrient delivery to tissues, which cannot be 
reversed by nutritional support. Finally, nutritional assessment has four 
main aims:
1. Selection of patients requiring nutritional support;
2. To determine the type and severity of malnutrition which allows 
comparison between patient groups;
64
3. To determine nutritional requirements; and
4. To determine the efficacy of nutrition support.
The main parameters used in nutritional assessment are anthropometry, 
nutrient intake, plasma protein levels, immunological assessment, muscle 
function, nitrogen balance and subjective functional assessment. These 
methods are briefly discussed and the choice of methods for the present 
studies explained.
2.2.3.1 Anthropometry 
Anthropometry measures the quantity of body tissues. Severe weight loss 
(ie. about 20-28%) has been associated with an increase in postoperative 
mortality (Heymsfield and Casper, 1987; Rich, 1982; Studley, 1936), but 
postoperative mortality is poorly correlated with mid-upper arm 
circumference (MUAC), triceps skinfold thickness (TSF), and mid-upper arm 
muscle circumference (MUAMC). Lack of correlation is due to:
1. The size of body cell or fat mass, except in extreme reduction, being less 
important than, and not necessarily related to organ function 
(Jeejeebhoy, 1984);
2. Anthropometry only indirectly measures BCM (eg. MUAMC includes 
bone, MUAC includes bone and fat, and TSF only measures fat) and only 
BCM is critical in terms of survival; and
3. Anthropometric measurements tend to be inaccurate due to intra- and 
inter-observer error, changes in hydration state, and body posture and 
tone. Furthermore, weight increase due to increased ECF was 
associated with poor outcome (Starker et al, 1983) showing that
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measurement of overall size is misleading without knowing 
composition. This may be one reason why weight loss is a very poor 
discriminator of those at risk from complications (Halliday et al, 1988). 
However, weight loss of more than 10% with clear evidence of 
dysfunction of two or more organs is associated with a higher incidence 
of complications (Windsor and Hill, 1988).
2.23.2  Body Composition 
Isotopic , neutron activation analysis and total body electrical studies can be 
used to accurately measure body composition and predict outcome 
(Halliday et al, 1988). However, they are limited to research studies 
conducted in a few centres. Body impedance analysis is not an accurate 
technique for measuring changes in total body water over short periods of 
time (Pullicino etal, 1992).
2.2.3.3 Nutrient Intake 
Food intake of less than 50% of the recommended energy and protein 
intake is associated with less hydroxyproline accumulation (Windsor et al,
1988) and therefore may be an indirect measure of nutritional status. 
Weighing two identical portions of the same diet and chemically analysing 
the uneaten portion gives the most accurate estimate of nutrient intake but 
is impractical for large numbers of patients. Recall is least accurate as it will 
include memory error. Keeping a record for up to three days over a 
representative period of food intake was the practical compromise used in 
this project.
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2.2.3.4 Plasma transport proteins 
Plasma proteins commonly used for nutritional assessment include:
• Albumin
• Transferrin
• Prealbumin (PA, or thyroxin-binding prealbumin; TBPA)
• Retinol-binding protein (RBP)
All are synthesised in the liver and are affected by nutritional state. However, 
to reflect changes in nutritional intake, and therefore be of use as a 
nutritional marker, a plasma protein would need to have a:
• Rapid turnover;
s Smail body pool;
• Short half-life; and
• Specificity for nutritional modulators alone.
None of the above proteins satisfies these criteria (Appendix 8.2.2.3).
Albumin's long half-life and large (60% extravascular) body pool cause the 
plasma level to only slowly reflect changes in nutritional state. Prolonged 
fasting resulting in a body weight loss of 24% only results in a 10% fall in 
albumin concentration (Aukland and Nicolaysen, 1981; Shires et al, 1972). 
However, albumin levels fall very rapidly during an inflammatory response to 
trauma or infection due to:
• Increased ECF volume
• Extravasation; and
• Increased catabolism/ decreased synthesis.
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Furthermore, organ failure can cause chronic severe hypoalbuminaemia 
due to :
• Increased renal loss (eg. glomerulonephritis, nephrotic syndrome) and
• Decreased production (eg. liver cirrhosis) (Rothschild et al, 1969).
Thus, except in pure starvation, albumin is affected more by non-nutritional 
variables. However, albumin is a good predictor of complications, mortality 
and LOS (Apelgren etal, 1982; Murray etal, 1988; Starker etal, 1983; 1986).
Transferrin, has a faster turnover than albumin and changes more rapidly in 
response to PEM. Its concentration can be measured indirectly by 
extrapolation from total iron-binding capacity (TIBC):
transferrin (mg/ dL) = 0.8 x TIBC (mg/ dL) -43 (Blackburn and Thornton,
1979).
However, transferrin is an inaccurate measure of PEM in pregnancy, iron 
deficiency and hypoxemia when the concentration rises due to increased 
synthesis. Conversely concentration decreases in hepatic disease, 
pernicious anaemia, nephrotic syndrome, neoplasia and infection 
independent of PEM.
Prealbumin has a fractional rate (ie. the percentage of the pool) of synthesis 
six-times faster and a rate of exchange, with tissue spaces, almost double 
that of albumin (Fleck, 1988). This makes it more responsive to nutritional 
intake. However, pre-albumin concentration still falls in inflammatory states
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and energy deficiency alone as well as PEM. It is a sensitive indicator of liver 
protein synthesis (Hutchinson et al. 1980), but is altered by sepsis and 
obstructive jaundice (Halliday et al, 1988). Nevertheless, prealbumin, quickly 
falls during short periods of starvation.
RBP has a faster turnover than prealbumin but is still negatively affected by 
inflammatory conditions. In addition, RBP concentration increases in renal 
failure due to reduced catabolism and decreases in zinc or vitamin 
deficiency, hypothyroidism and liver disease. RBP is more profoundly 
affected by energy deficiency than PEM per se.
2.2.3.5 Immunological Assessment
Nutritional status has been assessed by measuring total lymphocyte count 
(TLC) and delayed cutaneous hypersensitivity (DCH). TLC <3000/mL 
reflected immuno-deficiency (Blackburn et al, 1977) and negative DCH 
shows a strong association with morbidity (Harvey et al, 1981). However, 
both TLC and DCH are affected by non-nutritional factors.
2.2.3.6 Skeletal Muscle Function
Static parameters of muscle protein mass or the LBM (eg. CHI or MUAMC 
weight loss, weight related to height, skinfold thickness, arm muscle 
circumference and serum albumin - see 2.2.3.4) are not good predictors of 
outcome. In comparison, hand grip strength was a more sensitive predictor 
of postoperative complications in patients undergoing major abdominal 
surgery (Klidjian etal, 1980); 66% (29/44) developed complications with a
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hand grip strength below 85% of standard values, compared to 5% (3/58) of 
those >85% of standard values. Unfortunately a decrease in hand grip 
strength can be a disease-related phenomenon due to consciousness, 
motivation, paralysis, arthritis, trauma, pain, circulatory changes, drug 
administration and/or decreased motivation to perform the test (Martin et al,
1985). Electrical stimulation of the ulnar nerve of the wrist has been used to 
overcome these difficulties by reproducing voluntary contraction and 
relaxation patterns of the adductor pollicis muscle. However, there is a wide 
variation in response in the normal population (Zeiderman and McMahon,
1989) and the technique is not as easily applied as hand-grip dynamometry.
2.23.1 Nitrogen Balance 
Nitrogen balance can be used to determine the efficacy of nutritional support 
by measuring the balance between nitrogen input and output (see 2 .2 .6 .5).
2.2.3.8 Subjective Functional Assessment 
PEM is ‘the state induced by alterations in dietary intake resulting in 
changes in subcellular, cellular and/or organ function which exposes the 
individual to increased risks of morbidity and mortality and which can be 
reversed by adequate nutritional support' (Grant, 1986). Important body 
functions affected by the loss of body protein and relevant to the hospitalised 
patient include: wound healing for tissue repair, skeletal muscle function for 
mobilisation, respiratory muscle function for ventilation and expectoration, 
liver function for protein synthesis, and psychological function for motivation.
70
Weight loss of more than 10% over three months is important (Windsor and 
Hill, 1991). The impact of weight loss on physiological function is sought 
from a history of exercise tolerance and organ function. Muscle function is 
assessed by asking the patient to squeeze two of the examiners fingers and 
grip strength is judged against that expected for the patient's age, sex, and 
body habitus. The patient is asked to cough vigorously, and the cough 
strength is assessed to be normal or reduced. Unhealed cuts or sores 
suggest impairment of wound healing. Finally, the patient is carefully 
observed around the ward for activity level and endurance. From these 
simple techniques, a decision can be made as to whether the patient is 
nutritionally depleted and whether there is an associated impairment of 
physiological function. Nutritional support is warranted if the patient is 
wasted concurrent to a treatment associated with a major complication rate 
of >20%. PN results in protein gain in wasted patients (Hill et al, 1991). 
However, nutritional support in those who are depleted concurrent to an 
inflammatory state is associated with a smaller accretion of protein. In 
patients with an inflammatory state concurrent to mild depletion there is 
continued protein loss indicating that nutritional support should not delay 
treatment of the inflammatory state.
2.2.3.9 Choice of method 
Anthropometric abnormalities are usually diagnosed when the measure is 
2SDs from the ‘healthy’ mean. This 'normal' range is so wide that 
pathological changes are masked by normal variation. Thus anthropometry 
is relatively insensitive in diagnosing significant PEM in individual patients.
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Measurement of functional change is a good screening technique to select 
at risk patients but measurements of muscle function are still prone to error 
and require further description in inflammatory states. Nutritional intake was 
measured in the Burn, Gl and Head Injury studies. Anthropometric and 
functional measures were not considered appropriate.
2.2.4 Outcome Criteria and Scores  
These were end-points used to determine the efficacy of early EN.
2.2.4.1 Maior complications and LOS- All studies 
The Preliminary Investigation (3.0) only examined the effect of early EN on 
mortality, duration of NG feeding and LOS. Subsequent studies examined a 
much larger set of outcomes (Table 2.1) in order to determine which facets 
of disease and injury are likely to be affected by early EN.
Table 2.1 Outcomes used in the Burn, GI and Head Injury studies.
Data item Definition or time of collection
1. Pyrexia (days) During the course of treatment
2. Major complications and organ support Retrospective
up to 28 days and after 28 days
3. ITU: u
0 days (ITU-LOS)
* admission day
• ventilation day
• dialysis day
4. Death and time to. u
5. LOS u
6 . Drug cost (day 1-28, >28 days) u
• Antibiotics
0 GI
• Nutritional
* Neurological (HI study only)
7. Operations ti
Criteria for major complications were precisely defined (Table 2.2), in order 
to minimise observer bias, where complications are not as clearcut as 
death and LOS (Table 2.3). Complications were analysed as ‘episodes’ 
although it is recognised that these may differ in severity, duration and 
importance in a particular patient.
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Table 2.2 Definitions of major complications (adapted from Knaus et al, 1985).
Outcome group Outcome Outcome definition
1. GI 1. Fistula formation |
2. Anastomotic 
dehiscence
3. Acute GI 
bleeding
4. Local abscess 
formation
5. Ileus
3. frank biood or melaena
5. intolerance to oral intake beyond the 10th postoperative day 
despite radiological confirmation of anastomotic patency.
2. Infective 6. Septicaemia
7. Pneumonia
8. UTI
6- • Temperature <35.6 or > 38.3°C and bacteraemia or 
fungaemia or
onset of tachycardia and hypotension (sepsis syndrome). 
7. New pulmonary infiltrate seen on X-ray plus one of the following: 
0 temperature >38.9°C;
8 need for antibiotic treatment;
• documentation of a pathologic organism in the sputum 
and/or pleural fluid; and 
® symptoms persist beyond the fourth day postoperative 
day.
8- (>60 WBC/mm3 or >105 organisms/mL) + clinical symptoms
3. Organ 9. Cardiovascular* 
failure
9- • Heart rate < to 54/ min
6 Mean arterial blood pressure < 49mm Hg
° Occurrence of ventricular tachycardia and/or ventricular 
fibrillation.
• Serum pH < 7.24 with a PaC02 of <49mm Hg.
10. Respiratory* 10. • Respiratory rate < 5/ min or > 49/ min.
8 PaC02 >50mm Hg.
8 (A-a) D02 > 350mm Hg, (A-a) D02 = 713 Fi02-PaC02-a02.
9 Dependent on ventilator after 72h of organ system failure.
11. Renal* 11- • Urine output < 479mL/24h or < 159mL/8h. 
• Serum urea > 35.3m mol/ L.
Serum creatinine > 375umol/ L.
12. Haematological 12. • WBC < 1000/uL, Platelets < 20000/uL, Haematocrit < 20%.
13. Neurological ! 13. • Glasgow Coma Scale <6 (in the absence of sedation at any 
one point in the day).
14. Liver 14. • Bilirubin > 200umol/ L and/or alkaline phosphatase or 
aspartate transaminase > 3x normal level.
4. Wound >J5 Dehiscence 
16. Infection
j 15. • Requires operative closure. 
| 16. • Frank pus
* Presence of one or more of the outcome definitions.
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Table 2.3 Definitions of mortality and length of stay (LOS).
Study Mortality LOS
Preliminary
Investigation
Death during hospital stay Admission up to discharge
Burn (i a u tt Admission up to discharge 
(where burn wound is 
healed or does not require 
further debridement or 
grafting).
Gl surgery Up to 90 days post­
surgery.
As above and including 
admissions up to 90 days 
postoperation.
Head Injury Death up to 6 months post­
injury.
Acute admission up to 6 
months excluding 
admission for relief of 
relatives.
2.2.4.2 Outcomes specific to the Gl study (see Appendix 8.2.2.1-.4)
Three scoring methods were applied to patients in the Gl study. A patient’s 
level of distress associated with Gl discomfort and rehabilitation was 
assessed from eight questions scored by the patient: 0 (no distress) to 10 
(extreme distress). A patients’ fatigue was subjectively assessed by means 
of a modified linear analogue scale. Lastly, functional rehabilitation was 
assessed from the modified Visick mobility index.
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2.2.4.3 Outcomes specific to head-iniurv 
The most often used tool for assessing outcome of head injury is the 
Glasgow Outcome Scale (GOS-see 6.2.2) (Jennett and Bond, 1975). Most 
studies on inter-rater reliability and validity of the GOS involve comparison of 
ratings made by two or more trained assessors after personal contact with 
the patient (Gouvier et al, 1987; Jennett et al, 1981). However, patient contact 
cannot always be achieved in large-scale studies. Patient attendance is 
poor, making it difficult to standardise the time of assessment. To overcome 
this problem contact with relatives or other professionals, either by 
structured telephone interview or by correspondence may prove more 
practicable. Anderson et al (1993) studied the reliability of the Glasgow 
Outcome Scale (GOS) when information was obtained from different 
sources. There was good agreement between the psychologist's score and 
that based on the relatives' information (r = 0.49, p = 0.001). GPs tended to 
make overoptimistic assessments and this was most notable at 6 months 
post-injury when only 50% of the GP’s assessments agreed with those of 
the psychologist. This lack of agreement was due to GPs’ incorrectly 
concentrating on physical and neurological recovery in reiation to the 
severity of the initial injury (Jennett, 1976; Jennett et al, 1981) with less 
attention paid to psychological and behavioural problems. Both methods of 
assessment were less reliable at 6 months than at 12 or 24 months. At 6 
months post-injury the assessor may miss the subtle, yet disabling 
problems being experienced by these patients; problems readily elicited by 
the questionnaire. Nevertheless outcome is frequently reported at 6 months 
post-injury on the basis that few patients improve sufficiently after this period
76
to result in a change of GOS category, but changes do occur well beyond 
this time (Jennett et al, 1976). Anderson et al (1993) concluded that patients 
should be interviewed and tested by staff who have not been involved in the 
acute care of the patient. Failing this, information should be obtained from 
relatives of the patient and used by staff, trained in the use of the GOS, to 
assign a GOS score. In the present study GOS was obtained at 3 and 6 
months post-injury, from the patient’s relative by structured telephone 
interview.
2.2.5 Choice of Feeding Route 
Before starting this series of studies the efficacy of the feeding route was 
considered. For short-term feeding (< 4-6 weeks) the NG route is the 
easiest technique (Figure 2.1) (Taylor and Goodinson-McLaren, 1992a). If 
the patient has poor gastric emptying or is otherwise at risk of aspiration, 
nasointestinal feeding may be used. For long-term feeding (> 4-6 weeks) 
gastrostomy feeding is usually the most convenient (Figure 2.2). A jejunal 
feeding tube can be placed through the gastrostomy if the patient is at risk of 
aspiration. Ajejunostomy must be used if the upper Gl tract is inaccessible 
whether for short-or long-term feeding. When the Gl tract is inaccessible or 
non-functional PN may be used. Peripheral PN carries a lower^sepsis risk 
but when the anticipated duration is greater than 10 days or the substrate 
load is high, and therefore likely to cause thrombophlebitis, central PN must 
be used. This section reviews the efficacy of nutritional support techniques 
with regards to the studies undertaken.
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Figure 2.1 Routes of short-term nutritional support.
1
2
4
Nasogastric
Nasojejunal
Peripheral
Parenteral
Feeding
3 Jejunostom y
Figure 2.2 Routes for long-term nutritional support.
Central
Parenteral
Feeding
Jejunostomy
1 Gastrostomy
2 Gastrostomy 
-jejunal
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2.2.5.1 Enteral versus Parenteral Nutrition 
Catheter-related sepsis is the most common life-threatening complication 
of PN. Hospital acquired bacteraemia occurs in 44.8, 3.7 and 0.5 patients 
per 1000 admissions with central, peripheral and no venous 
catheterisation, respectively (Nystrom et al, 1983). Aspiration pneumonia is 
reiatively rare but is the most common major complication associated with 
EN. It results from tube misplacement into or near the respiratory tract or 
regurgitation of feed from the stomach. Stress ulceration is associated with 
sepsis, acid-base disturbances and multiorgan failure and, specifically, 
burn and head injury (Curling's and Cushing's ulcers, respectively). EN 
appears to protect against stress ulceration (Lally etal, 1984; Pingleton and 
Hadizma, 1983). Administration of a whole protein feed at 50-125mL/ hour 
into the stomach and duodenum failed to neutralise gastric acid (pH below 
3.5) but overt GI bleeding did not occur (Valentine et al, 1986). This 
suggests that EN-induced cytoprotection may be related to supply of energy 
(Lally et al, 1984) or specific substrates (Dial and Lichtenberger, 1987; 
Valentine etal, 1986) and not necessarily limited to direct acid buffering per 
se. In addition, gut function, as measured by major enzyme activities, is, in 
patients with inflammatory bowel disease, reduced after 21 days of TPN and 
rapidly restored after oral feeding (Guedon et al, 1986). This phenomenon is 
a function of the fact that 90% of gut enzymes are synthesised from luminal 
amino acids (Alpers, 1972; Alpers and Thier, 1972). Lastly, EN costs 10 
times less than PN in terms of solutions, and is associated with less cost 
for labour and complications. For the above reasons, EN was the method of
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choice, in the present studies, except where the gut was non-functional or 
inaccessible.
2.2.5.2 Gastric and Post-pvloric feeding 
Post-pyloric feeding may reduce aspiration risk and overcome poor gastric 
emptying which is common after Gl surgery and head injury. Post-pyloric 
feeding is achieved by nasointestinal (Nl) feeding or jejunostomy feeding.
2.2.5.2.1 Gastric em ptying  
The normal stomach is routinely subjected to large boluses, which induce
isobaric distension with subsequent emptying (Emslie-Smith et al, 1988).
Gastric emptying can be tested by incrementing EN from a low rate up to the
goal in inverse proportion to gastric residuals aspirated to assess
emptying. However, gastric emptying in ITU patients is often delayed.
Normal emptying occurred in less than 30% of studies, while emptying was
absent in 8-10%. Biphasic patterns occurred in 32% and may be associated
with duodenogastric reflux. Inadequate gastric emptying in critically ill
patients may be related to sedation and pain relief, paralytic ileus, gastric
outlet obstruction, or diabetic neuropathy. In normal healthy volunteers
under fasting conditions, residual volumes should be very low, with greater
than 90% of the residual volumes less than 10mL (McClave et al, 1992).
Occasional residual volumes range up to 100ml because of retained
endogenous gastric and salivary secretions and during EN exceed 150 mL
in up to 15%, but the majority (>97%) are below 150ml (McClave et al, 1992).
Furthermore, radiographic abnormalities such as scattered air fluid levels
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and dilated loops of small bowel occur in healthy people without ileus or 
other clinical significance. The residual volume which should raise concern 
about gastric emptying appears to be 200ml for patients with NG tubes and 
100ml for those with gastrostomies; the gastrostomy port may lie above the 
pooled fluids therefore residual volume tends to be underestimated 
(McClave et al, 1992). In postoperative, head-injured and ITU patients post­
pyloric feeding may therefore be advantageous.
2.2.5.2.2 Risks associated with post-pyloric feeding techniques
2.2.5.2.2.1 Jejunostomy feeding
Jejunostmies are usually inserted as adjuncts to abdominal surgery. The 
stoma increases fistulation risk and ingress of bacteria (Page et al, 1985). 
Contraindications to a jejunostomy catheter generally do not preclude 
intraoperative placement of a nasointestinal tube.
2.2.5.2.2.2 Nasointestinal feeding
Per-nasal insertion of wire-guided fine-bore tubes must be done by staff 
trained in the technique. Malposition at the time of insertion occurs in under 
5% of patients but is generally into the trachea or bronchi (McWey et al, 
1988; Wendall et al, 1991). Infusion of feed in such cases can be fatal 
(Wendall et al, 1991). Fine-bore tubes often fail to cause obvious respiratory 
symptoms (Metheny et al, 1990; Saltzbert et al, 1984; Schorlemmer and 
Battaglini, 1984) and in ventilated patients a cuffed endotracheal tube may 
increase the risk of tube malposition (Kiwak, 1984; Muthuswamy et al, 
1982). If a tube is malpositioned, there is a small but definite risk of
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oesophageal or pulmonary perforation, which may cause a subsequent 
pneumothorax (Olbranz et al, 1985). Reinsertion of the guide-wire risks 
penetration of the tube and mucus membrane (Salzberg et al, 1984). Fatal 
intracranial misplacement has occurred in patients with fractured base of 
skull (Bouzarth, 1978). Intubation should therefore done orally or under 
direct vision, using a laryngoscope. However, compared to the jejunostomy 
major complication rate of at least 2% (Page, 1987), nasointestinal feeding, 
per se, is not associated with an increased incidence of major 
complications and should be considered as the route of choice for post­
pyloric feeding in the GI and Head Injury studies.
2.2.5.2.3 Effect of post-pyloric feed delivery
Feed reflux from the intestine into the stomach decreases the more distal
the perfusion site: 20.9% for the duodenum, 11.9% at the ligament of Treitz, 
and 3.6% for the jejunal infusions (Gustke et al ,1970). Thus to minimise 
reflux the catheter tip should be placed distal to the ligament of Treitz. This 
may reduce feed lost by gastric aspiration and reduce the risk regurgitation 
and pulmonary aspiration. However, there is dispute as to whether by­
passing the stomach reduces the overall risk of aspiration and pneumonia 
associated with EN (Heyland et al, 1993; Kirby et al, 1991) suggesting that 
enteral feed may not the causative agent. There is no evidence that jejunal 
feeding reduces pancreatic secretion or causes malabsorption or a need 
for elemental feeds (Hinsdale et ai, 1985). Polymeric feeds cause less 
diarrhoea (Ficketal, 1986) and are cheaper and therefore were the feed of 
choice in the GI and Head Injury studies.
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Techniques for nasointestinal intubation are discussed in detail as they
were essential to developing the method used in the Head Injury study 
(Appendix 8.6.3).
2.2.5.2.4.1 Spontaneous intubation
Spontaneous passage of feeding tubes into the duodenum is uncommon in 
ITU (Marian et al, 1993) and head-injured patients (Norton et al, 1988) due 
to gastric atony. In addition, the tube often spontaneously moves no further 
than the proximal duodenum from where either the tip or feed reflux back 
into the stomach.
2.2.5.2.4.2 Fluoroscopy and Endoscopy
Fluoroscopic placement of feeding tubes is successful in 97-98% of cases 
(Hoffer et al, 1992; Pobiel et al, 1994). Unfortunately fluoroscopy involves 
radiation exposure and usually cannot be done on the ward. Endoscopic 
placement has a 90% success rate, but can raise ICP thereby endangering 
head-injured patients. Furthermore, many patients requiring intestinal tube 
placement cannot be moved to fluoroscopy or endoscopy, the skilled 
personnel required are not always available and both techniques are 
expensive (Ghahremani and Gould, 1986).
2.2.5.2.4.3 Use of prokinetic drugs for duodenal intubation
Prokinetic drugs improve gastric emptying. However, metoclopramide 
(20mg IV) only improved transpyloric intubation if administered 10 minutes 
prior to intubation suggesting that the tube must meet active peristalsis to
2.2.5.2.4 Techniques of intubation
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be carried into the duodenum (Whatley et al, 1984). In a PRCT, 
metaclopramide improved transpyloric passage (64% vs. 20% for controls) 
in diabetics with neuropathy but failed to have effect in non-diabetics 
(Kittinger et al, 1987). In critically ill ventilated patients given 6 hourly IV 
metoclopramide nasoduodenal intubation was only achieved 
radiographically, within 72 hours, in 15% (10/68) (Marian et al, 1993). The 
efficacy of cisapride and erythromycin has not been tested in ITU patients. 
Prokinetic drugs are ineffective or unproven for placement of nasointestinal 
tubes in ITU patients.
2.2.5.2.4.4 Use of weighted versus unweighted tubes
Positioning the patient on their right side has been used to help weighted 
tubes gravitate towards the pylorus. Ugo et al (1992) achieved transpyloric 
intubation in 83% (85/103) with weighted tubes (8 or 10 FG, Silk). Using a 
similar technique Schulz et al (1993) passed 60cm of tube, confirmed 
gastric position by auscultation, placed the patient in the right lateral 
decubitus position, rapidly insufflated 500-1 OOOmL of air and advanced the 
tube to 100cm. Overall success rate was 93%. Fluoroscopy previously 
showed that tubes enter the stomach at an angle to the left. The tube tip 
then often hits the fundus wall, sometimes moving towards the oesophagus 
while the advancing tube coils down into the stomach. Positioning the 
patient in the lateral decubitus position causes the weighted tip to fall away 
from the fundus, through the hollow of the distended stomach and towards 
the pylorus, the lowest point.
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2.2.5.2.4.5 Torque-controlled intubation
This technique necessitates the guide-wire to be bent to 30° 2-3cm 
proximal to the tip. The tube is passed into the stomach and then slowly 
advanced and rotated, thereby cork-screwing the weighted end of the tube 
through the pylorus (Thurlow, 1986). The technique causes little change in 
oxygen saturation and in 30 patients with raised ICP slow and gentle 
intubation kept ICP levels at baseline (Zaloga, 1991b). Blind, wire-guided 
placement is therefore very successful, both in achieving transpyloric 
placement and moving the tube into the distal duodenum (Table 2.4) but few 
operators achieve this level of competence.
Table 2.4 Final tube position in studies achieving transpyloric positioning in 
more than 75% of cases.
Technique Successful transpyloric tube placement (%) Failed
attempts
duodenum (part) jejunum total
1st 2nd 3rd
Study
Weighted 
tube + air 
insufflation 
Torque- 
controlled
103
60
231
39
12 20
25
38
47
22
17
17
83
90
92
17
13
Ugo et al 
(1992)
Thurlow
(1986)
Zaloga
(1991b)
Insertion into the proximal duodenum is aided by the tube having support of 
the guide-wire. However, its stiffness prevents the tube negotiating bends,
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particularly the superior flexure (Taylor, 1996 unpublished) and further 
insertion may result in the tube at this point coiling in the stomach. However, 
if the guide-wire is withdrawn 2cm and then held stationary while the tube is 
advanced 5cm the tube tip will negotiate bends. The guide-wire is then 
gently re-inserted to provide support and check for kinks. Then, the 
procedure is repeated until the tip reaches the proximal jejunum.
2.2.5.2.4.5 pH-guided placement
Instant indication of intestinal pH, given by a pH sensor, helps the operator 
time the forward movement of the tube. In this way tubes fitted with pH 
sensors may increase the chance of transpyloric placement for operators of 
moderate experience. In fasting subjects, pH-metry can localise the pylorus 
to within 1.5cm in 84% of periods studied (Rosenkilde-Gram et al, 1990). 
The characteristic pH of profile across the pylorus disappears in the early 
postprandial phase or during continuous feeding. However, the ability to 
predict gastric position by a pH of less than 3 is increased by waiting 60 
minutes (30 may be insufficient) after feed or medicine has been taken 
orally or by tube and by flushing the tube with 30mL of air (Metheny et al,
1989). Aspiration of the gastric contents would speed up the pH fall. 
Duodenal pH is characterised by predominantly alkaline values (pH 6 to 8) 
with brief periods of very acidic values after gastric emptying (Hannibal and 
Rune, 1983; McCloyetal, 1984; Ovesen et al, 1986). However, even healthy 
adults fasted for a minimum of 8 hours may have a gastric pH outside the 
normal range (SmithKline Diagnostics, Inc., 1990). Radiography is therefore 
recommended to establish the position of newly inserted fine-bore tubes, 
before feeding is initiated. However, a pH of less than 4 should rule out
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inadvertent respiratory placement. Using tubes fitted with a pH-sensor and a 
standard intubation technique (Taylor, 1996) transpyloric placement was 
achieved in 81% (25/31) of which 84% (21/25) were on hh blockers and 44% 
(11/25) were on Hs blockers and 4 hourly antacids (Berry et al, 1994). When 
pH change from initial-to-lowest and lowest-to-highest were both >4 units, 
placement was successful in 91% of placement attempts. When either pH 
change was less than 4 units (4/8), placement was successful in 50% of 
attempts. When pH changes of more than 4 units were used to predict 
intestinal position, the sensitivity and specificity for intestinal placement 
were 84% and 67%, respectively. Overall success of placement seems to 
have been unaffected by anti-ulcer treatment. Tube position confirmed by 
radiograph was correctly estimated by pH sensor in 88% (Heiselman et al,
1993) and subsequent displacements are readily discovered (Strong et al, 
1988). Thus pH sensors accurately confirm intestinal placement when pH 
follows the pattern: pH > 6 (oesophagus) to 1-4 (stomach) to > 6 
(duodenum) (Ireton-Jones et al, 1993). However, the possibility of the tube 
curling back towards the oesophagus giving a false ‘duodenal pH’ 
necessitates radiographic confirmation of position.
2.2.5.2.4.6 Surgical placement
A nasojejunal tube can placed peroperatively by milking it through from the 
stomach (Jensen et al, 1995). This must be done during the abdominal 
phase of operations such as oesophagogastrectomy or when repairing 
abdominal trauma. Unfortunately the Frenchay general surgeons were not 
confident of using this technique, therefore it was not used.
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Fluoroscopic placement was performed by a radiographer (Robert Law) in 
the GI study because it is fast, reliable and these patients could be safely 
moved to X-ray. Head-injured patients were intubated by the method in 
Appendix 8.6.3 using a pH sensor tube. This procedure was chosen and 
developed by the principle investigator (ST) and feeding policy altered for the 
purpose of this study, intubation was carried outsoley by ST or Sheila Fettes 
(research assistant) under ST’s supervision.
2.2.5.3 Feeding protocol
2.2.5.3.1 Checking gastric residuals
Gastric residuals are checked in NG fed head-injured patients in case of
poor gastric emptying and the risk of vomiting. Residuals should be 
checked 4 hourly initially and then once a day when the goal feed volume is 
achieved and tolerance established (Silberman, 1989). Controversy exists 
about whether aspirates from feeding tubes should be reinjected or 
disposed of. Nurses routinely reinject smali volumes but are reluctant to 
reinject >150 mL (Kozier et al, 1989). However, it was decided that residual 
volumes up to 200mL should be reinjected, in the Head Injury study, based 
on the evidence of McClave et al (1992) (2.2.5.2.1).
2.2.5.3.2 Continuous versus intermittent feeding
EN and PN can be administered continuously or intermittently. Continuous
feeding may reduce GI intolerance in those prone to it but in practice there is 
little difference in efficacy between the two methods. Boius feeding is safer
2.2.5.2.4.7 Choice of technique for intestinal intubation
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when a patient cannot safely be left alone. Under resting conditions healthy 
individuals have cardiac and pulmonary reserve capacity that far exceeds 
the fluid flux and increased gas exchange associated with EN or PN. 
However, patients without this capacity are at risk from refeeding syndrome 
(Appendix 8.1.1, 8.2.2.5). In the present study continuous feeding was used 
except where the patient could not be safely left alone. The risk of a patient 
suffering refeeding syndrome was taken into account when introducing EN.
2.2.5.4 How Ions to feed 
Patients should receive EN or PN until oral feeding can meet requirements. 
In practice EN or PN were reduced, especially during the waking hours, as 
oral intake was increased.
2.2.6 Estimating Energy and Nitrogen Requirements 
This section briefly describes the method used for calculating energy and 
nitrogen requirements and estimating nitrogen balance reviewed elsewhere 
(Taylor and Fettes, 1996a; Taylor and Goodinson-McLaren, 1992b).
2.2.6.1 Estimating energy requirements 
Predictive equations require early measurement of weight before post­
trauma oedema occurs. Where measurement of weight or height was 
impossible, the patient, relatives or previous records were consulted to 
determine these parameters. BSAwas determined from a normogram. This 
method may be inaccurate at extremes of weight for height. For infants and
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children it can often be presumed that height is appropriate for weight and 
therefore taken from the same centile. Where there is obvious obesity/ 
emaciation or stunting, measurement must be used to avoid error.
The aim of nutritional support is to supply enough energy to prevent weight 
loss during the catabolic phase of inflammatory states. This does not 
prevent protein breakdown (Jahoor et al, 1988) but overfeeding would cause 
fat gain (Goran et al, 1990; Streat et al, 1987) with no benefit. Therefore, 
during the catabolic phase (determined by nitrogen balance), it is better to 
use a low estimate of energy expenditure. ‘Maintenance’ of admission 
weight until discharge is associated with loss of LBM during the catabolic 
phase which is later masked by fat gain (Goran et al, 1990; Streat et al, 
1987). The latter is associated with periods of overfeeding which may be 
dangerous. Vital organ systems, as part of the BCM, determine prognosis, 
fat mass does not. Therefore, the aim of weight maintenance is not of direct 
clinical benefit. Rather, maintenance of body composition should be the aim 
(Goran etal, 1991). This involves acceptance of a small weight loss (< 5%) 
in adults, or weight maintenance in children.
From previously published data Elia (1990) produced a nomogram to 
estimate energy and nitrogen requirements. The original nomogram gave 
ranges for the stress factor to be added to basal metabolic rate (BMR) or the 
nitrogen requirement to be chosen. The range reflects the fact that patients 
of the same age, weight, sex and injury can have different requirements. 
Figure 2.3 shows an adapted version of the nomogram used at Frenchay
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Hospital. This gives a specific stress factor for a given %BBSA. A combined 
factor for dietary-induced thermogenesis (DIT) and activity is added to give 
an estimate of total energy expenditure (TEE). This normogram was used to 
calculate requirements in all studies except the Preliminary Investigation 
(see 3.2.2). The burn study used the following formulae for children:
energy expenditure = 1800 x BSA + 1300 x BBSA (0-12 years) (Hildreth et al, 1990)
energy expenditure = 1500 x BSA + 1500 x BBSA (13-15 years) (Hildreth et al, 1989).
Nitrogen requirements per Kg body weight are given for %BBSA. Initial 
estimates of energy expenditure and nitrogen requirements are used as a 
starting point and modified once empirical data (weight and nitrogen 
balance) are available.
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Figure 2.3 Energy and nitrogen requirements: making initial estimates 
(adapted from Elia, 1990; Schofield, 1985).
Clinical condition Burn%
TBSA
Stress
factor
gN/Kg/
day
Severe sepsis/ multiple 
trauma patient on ventilator
Head injury (adult) (Bruder et 
al, 1994) or Bone marrow —  
transplant (Annis et al, 1991)
Infection (persistent fever 2C)
Infection (persistant fever 1C)
Single fracture (first week). 
Postoperative (first 4 days). 
Inflammatory bowel disease. 
Mild infection.
Partial starvation (weight 
loss >10% body weight)
90*
80“
70-
50.
40
30-
70
60
50
40
30
20
20 -
■10
-20
0.35
0.3
0.275
0.26
0.25
0.24
0.225
0.21
0.20
0.19
0.14-
0.17
Energy
1. Determine approximate BM 
(Kcal) from sex, age, and bod 
weight (Kg).
Male
0- 3 years (59.3 x Kg) - 30 
>3-10 years (22.6 x Kg) + 502 
>10-18 years (17.6 x Kg) + 656 
>18- 30 years (15.0 x Kg) + 690 
>30- 60 years (11.4 x Kg) + 870 
>60 years (11.7 x Kg) + 585
Female
0- 3 years (58.1 x Kg) - 31 
>3-10 years (20.2 x Kg) + 484 
>10-18 years (13.3 x Kg) + 690 
>18- 30 years (14.8 x Kg) + 485 
>30- 60 years (8.1 x Kg) + 842 
>60 years (9.0 x Kg) + 656
Add the stress factor (%BMR) from 
the nomogram. Inter-individual 
variance is large: 10% TBSA burn 
= 0- 12% stress factor; and a 25- 
90% TBSA burn = 23- 67%.
3. Add the combined factor for 
activity and DIT:
• Bedbound immobile 10%
• Bedbound mobile/sitting 15-20%
• Mobile on ward 25%
4. Once catabolism is over (usually 
>28 days postbum) consider 
inducing anabolism and weight 
gain. Increment to approximately 
125% of the patients maintenance 
requirements.
Nitrogen
1. Determine gN/ Kg/ day from the stress factor.
2. Note that a patient of the same age, weight, sex and injury can have different 
requirements:
Degree of catabolism gN/ Kg/ day*
Normocatabolic 0.14- 0.20
Hypercatabolic: 5- 25% 0.17- 0.25
25- 50% 0.20- 0.30
>50% 0.25- 0.35
Depleted 0.20- 0.40
*F o r  o b e se  ind iv id ua ls  with a B M I o f 30-40 , u s e  about 7 5 %  o f th e  va lue  e stim ated  from  body weight; 6 5 %  If B M I is  >65Kg/m 2.
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2.2.6.2 Non-protein energy (NPE) substrate supply 
People have an obligatory glucose requirement which increases as BMR 
increases. Supplying this requirement (neonates: 5-6mg/ Kg /min, adults: 1- 
1.4mg/ Kg/min (Nordenstrom etal, 1983) minimises gluconeogenesis and 
resultant negative nitrogen balance. The maximum glucose oxidation rate in 
adults is 4mg/ Kg/ min (Watters et ai, 1984; Wolfe et al, 1979). Higher 
glucose infusion rates can induce a more positive nitrogen balance but 
result in the sequalae of overfeeding. Hyperglycaemia may necessitate 
reduction in the carbohydrate and/or energy load. Exogenous insulin 
increases plasma glucose clearance but without a substantial increase in 
glucose oxidation (Burkeetal, 1979), thus increasing futile substrate cycles 
and the risk of hepatic fat deposition.
Maximum recommended IV 006 fatty acid-based fat infusion over24h feeding is:
• low birth weight (LBW) infants: 0.5-2.0g/ Kg/ 24h;
• infants: 0.5-4.0g/ Kg/24h; and
• adults: 3.0g/Kg/24h (KabiVitrum, 1988).
There is some evidence that fat is used preferentially to glucose in 
metabolically stressed patients (Stoner et al, 1983). The optimum glucose 
equivalent: fat ratio supplied as NPE is still debated. However, metabolic 
complications should be minimised by infusing:
® A NPE mixture of 50 to 70% glucose equivalents and 30 to 50% fat,
• Over the longest possible period, and 
® Not exceeding energy expenditure.
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Finally, non-nutritional NPE must be taken into account when calculating 
nutritional input (Taylor, 1994a). This accrues from 10% Intralipid® 
(Pharmacia), used as the carrying agent for the sedative Propofol®, and 
glucose present in peritoneal dialysate and IV hydration.
2.2.63 Estimating nitrogen requirements 
Nitrogen balance can be used to check the extent of catabolism and efficacy 
of nitrogen intake (Bistrian, 1979; Mackenzie et al, 1985). The effect of high 
nitrogen intake is equivocal. It promotes a more positive nitrogen balance 
and enhances protein flux, but in short-term studies does not produce net 
protein synthesis (Wolfe et al, 1983). However, increased protein flux, per 
se, may be responsible for improved immune function, acute phase protein 
response and clinical outcome (Newsholme, 1978).
Nitrogen requirements increase disproportionately, compared to energy 
requirements, as injury severity increases (Elia, 1990). It may be difficult to 
meet estimated nitrogen requirements without overfeeding energy. In 39 
adult burn patients studied on days 1 to 7 post-injury, overfeeding was most 
common in ITU patients, where non-nutritional energy and/or PN were 
concurrent to EN (Taylor, 1994a). Conversely, nitrogen intake rarely met 
requirements. Therefore, in patients with stress factors greater than 20%, 
nitrogen intake should be between 0.22 and 0.35g/ Kg/ day with a NPE: gN 
ratio of about 100: 1 (Taylor and Fettes, 1996a). Head-injured adults (>10 
years) have hypermetabolism and hypercatabolism, and therefore 
nutritional requirements, similar to those of a 20-40% burn injury
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(Robertson et al, 1984). Paediatric feeds have a relatively high NPE: gN ratio 
(-200: 1). If the child can take cow’s milk or other high protein foods the 
overall NPE: gN ratio will be lowered. Otherwise an adult feed is used but 
serum and urinary sodium are regularly checked to guard against overload. 
The vitamin and mineral content of adult feeds is not optimal for children. 
However, attaining energy and nitrogen requirements, post-injury, is usually 
more important.
Nitrogen input may be matched to output up to about 22g per day in adults 
(Lee, 1985). Excess nitrogen intake will not increase protein synthesis but 
leads to increased gluconeogenesis and uraemia. If nitrogen balance does 
not improve or uraemia occurs it may necessary to return to the previous 
intake. Where catabolism is resolving nitrogen intake may be gradually 
reduced while checking that nitrogen balance remains positive or zero, 
depending on the aim. During the anabolic phase nitrogen input in adults 
can exceed output by 3-5g/ day (ASPEN, 1987). 0.2-0.4gN/ Kg/ day is usually 
required to attain nitrogen accretion (Elia, 1990).
2.2.6.4 Response to catabolism 
A changing clinical state affects energy expenditure and nitrogen loss 
differently and this must be considered when working from estimated 
requirements. Energy expenditure is increased by catabolism but this is 
compensated for by reduced physical activity. Thus, a septic patient may 
have a lower energy expenditure, as a result of mechanical ventilation and 
sedation, than a patient beginning to mobilise. Energy expenditure follows a
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biphasic response to trauma, falling as catabolism resolves, then rising 
again as the patient mobilises. In addition, small peaks in energy 
expenditure occur during physiotherapy and nursing procedures. 
Conversely, nitrogen losses quickly peak then gradually fall as catabolism 
resolves. Onset of infection increases nitrogen loss disproportionate to 
energy expenditure, whereas surgery increases both energy expenditure 
and nitrogen loss. In view of these trends the goal of energy supply must be 
to meet predicted requirements. However, after the first three days of 
feeding, nitrogen supply should be incrementally adjusted, to meet 
calculated output, within the limits discussed above.
2.2.6.S Nitrogen balance 
Nitrogen balance determines the gain or loss of the protein component of 
weight. Urinary nitrogen loss increases during inflammatory states as part 
of the generalised alterations of protein metabolism. The rate of loss 
depends upon the presence or absence of infection, the administration of 
exogenous energy to minimise gluconeogenesis, and injury severity (Belcher 
and Judkins, 1988). Nitrogen balance can be calculated according to: 
Nitrogen balance = TUN (0.035 xUUN) + 2 (faecal loss + integumental loss) 
(Blackburn et al, 1977; Wilmore, 1980) + A BUN
where TUN = total urinary nitrogen, UUN = urinary urea nitrogen, BUN = 
blood urea nitrogen.
Injury or infection causes hepatic protein production to be reprioritised in 
favour of (positive) acute phase proteins at the expense of albumin 
(Bauman et al, 1983). This is attenuated by enteral but not parenteral
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nutrition (Peterson etal, 1988). However, hepatic albumin production is only 
about 14-17g per day (West, 1990), therefore the body can only mount a 
limited response to low albumin levels. Infusion of fresh frozen plasma 
(FFP) or albumin is a more efficient method of replacing nitrogen lost as 
plasma proteins. Also by reducing nutritional nitrogen input it reduces 
hepatic workload and the tendency to uraemia. In the present studies, 
nitrogen flux between plasma proteins and urea could not be measured. For 
this reason, an assumption was made that nitrogen lost from wounds or 
gained from blood products, balanced. These factors were excluded from 
nitrogen balance calculations.
2.3 Statistical analysis
The Preliminary Investigation was a 12 month trawl for data and therefore 
population size was not predetermined. The size of other studies was 
calculated to allow the main hypothesis to be tested with a power of 80% 
where a p value of < 0.05 was considered significant (Altman, 1991). Prior to 
analysis, computer records were cross-checked with original records to 
eliminate inputting errors. Summary statistics (n, mean, SD, range) were 
calculated to help guide subsequent analysis and the need for 
transformation was established. Preliminary analysis included linear 
regression between continuous variables to establish possible 
associations. Chi-square was used to analyse discrete variables; Student's 
t test or the Mann-Whitney test were used for continuous variables. Linear 
logistic, multivariable and median regression were used to determine
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whether explanatory variables were independently associated with outcome 
variables. Statistical tests were done on ‘Stata’ (Stata Corporation) 
computer software.
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3Preliminary
Investigation:
The effect of early enteral feeding on 
mortality and hospital stay at two , 
Acute Hospitals.
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The Introduction chapter established, from previous data, the widespread 
occurrence of malnutrition in hospital patients. Furthermore, the effects of 
starvation have been found to be associated with progressive debilitation, 
organ dysfunction and, ultimately, death (Allison et al, 1992; Keyes et al, 
1950). Conversely, nutritional support is of clinical benefit in selected 
groups of patients. In addition, psychological improvement may be 
worthwhile in terminally ill patients where quality of life is the outcome 
measure of most importance. However, despite detrimental effects of 
starvation and the efficacy of nutritional support there is often a clinically 
significant delay between the cessation of ora! intake and commencement 
of nutritional support (Taylor and Fettes, 1996b). However, the effect of the 
delay before attempting nutritional support, on clinical outcome, has not 
been studied systematically.
To date most large studies which have investigated the effect of nutritional 
support have used PN (Veterans Affairs Study Group, 1991), but recently it 
has been shown that EN is at least as effective at preventing or treating 
malnutrition (Meyenfeldt et al, 1992) and is associated with a lower 
incidence of infective complications (Kudsk et al, 1992; Moore et al, 1992). 
Moreover, EN is used in a much larger patient population and is technically 
easier and cheaper to deliver. Thus if earlier EN improves clinical outcome 
then it would benefit a larger population than PN and at a smaller cost.
3.1 Introduction
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This preliminary observational study was intended to test whether the length 
of delay before initiating NG feeding, in patients who ultimately were given 
NG feeding, affects clinical outcome. This patient group was selected 
because it represented the largest population of patients requiring invasive 
nutritional support (EN or PN) in the two study hospitals and also in the UK 
hospital population. It was concluded that the data from the study would 
provide an overview of the efficacy of EN in a large population of patients 
suffering from a wide variety of clinical conditions. Results from the present 
study, and experience gained in data collection and analysis, were 
subsequently used to design a number of protocols involving enteral 
feeding. This was done in discrete patient groups presented in Chapters 4, 
5 and 6 . The aim of the present and future studies was to address the 
hypothesis: “Early aggressive EN improves clinical outcome and reduces 
treatment cost”.
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The aim of this prospective observational study was to examine the effect of 
the delay between the cessation of oral intake and commencement of NG 
feeding (ie. duration of starvation) on clinical outcome. The objectives were 
to determine the association between the duration of starvation before NG 
feeding and:
• Incidence of mortality,
® The duration of NG feeding subsequently required, and
• LOS and implicit cost-effectiveness of nutritional support.
3.2.1 Patient selection
Consecutive patients referred to Bolton Dietetic department for NG feeding 
were recruited between 1.11.89 and 31.10.90. Inclusion criteria for the study 
were:
1. Oral intake of 0-200 Kcal per day and no other form of nutrition except 
hydration and a maximum of 2.0 L 4% dextrose-saline per day at the time 
of referral, and
2. Subsequent NG feeding continued for more than 24 hours.
Eligible patients may have received PN immediately prior to starting NG 
feeding but did not receive it concurrently at recruitment.
3.2.2 Estimation of energy and nitrogen requirements
Individual nutritional requirements were estimated using the "Nutrislide" 
(Kabi-Pharmacia). The Nutrislide derives BMR from body weight based on 
the Harris-Benedict equation fora male of middle age. Energy requirements
3.2 Methods
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are calculated from: BMR + factors for catabolism, activity, and DIT. This 
estimate is adjusted for age, sex, obesity and malnutrition. Nitrogen 
(protein) requirements were derived from the NPE: gN ratio based on the 
degree of catabolism. From this data the dietitian (ST or other) determined 
the most appropriate type of feed and method of administration.
3.2.3 Data collection  
Data collected by the investigator included:
• Age
• Sex
• Diagnosis (primary diagnosis at admission as well as on-going 
disease states)
• Duration of pre-feeding starvation
• Duration of NG feeding
• Duration of hospital LOS subsequent to the start of starvation
• Outcome:
• discharged or dead
• route of nutrition (oral, EN, PN) on discharge. 
Nutritional intake was not measured because this was not routine dietetic 
practice and the study did not have the resources to provide extra 
monitoring.
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3.2.4 Statistical analyses  
Univariate multivariable linear regression analysis was used to determine 
whether age, sex, primary diagnosis of CVA or duration of starvation were 
significant explanatory variables for mortality, duration of NG feeding and 
LOS. Associations described in the results section should read as ‘positive’ 
associations unless otherwise specified. The effect of starvation, age and 
sex on: a) mortality and ultimate route of feeding were tested using Chi 
square or Fishers exact test; and b) duration of NG feeding and LOS were 
tested using Students t test. The Yates correction was applied to Chi square 
due to the small study numbers. The potential importance of some non­
significant (ns) results are discussed as it was thought that, in this 
preliminary study, the clinical effect may be of more importance than a 
statistically significant result.
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One hundred and one patients met the inclusion criteria. NG feeding was 
begun at the clinicians' request based on clinical criteria alone. The time 
between cessation of oral intake and the start of NG feeding varied between 
0 and 24 days (Table 3.1). The study group comprised a disproportionate 
number of medical patients (77%). Large patient sub-groups included: 
cerebrovascular accident (CVA, 38%), trauma (9%) and oral surgery (7%). 
Few patients underwent abdominal or thoracic surgery. The study 
population was relatively old, 42% being over 69 years of age, but equally 
split between male and female.
3.3 Results
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Table 3.1 Breakdown of study group by disease type, age, sex, duration of pre­
feeding starvation and NG feeding, mortality, and LOS.
Condition n Age Sex Duration 
of Pre­
feeding 
starvation
Length 
of NG 
feeding
Mortality (%) 
During:
LOS
(days-
mean)
<65 >65 M F (days-
mean)
(days-
mean)
NG hospital
feeding
stay
Infective disease
AIDS 1 1 0 1 0 7 5 100 100 16
Chest infection 7 1 6 5 2 4 9 0 43 42
Sepsis 2 1 1 1 1 0 15 50 50 33
Malignancy
Myeloma 1 0 1 1 0 7 17 100 100 27
Oesophageal 1 0 1 1 0 7 1 100 100 7
carcinoma
Oropharyngeal surgery/ 7 2 5 2 5 2 6 14 14 14
disease
Rectal carcinoma 1 1 0 1 0 0 7 0 0 18
Neurological/
neuromuscular
disease
Acute neuromuscular 2 2 0 1 1 3 12 0 50 26
disease -ir
CVA 38 10 28 20 18 6 24 39 55 45
Chronic neuromuscular 6 4 2 3 3 3 16 14 42 41
disease
Dementia 1 0 1 0 1 0 17 0 0 53
Organ failure
Acute pancreatitis 3 0 3 2 1 0 5 33 33 19
Chronic liver disease 1 1 0 1 0 0 4 0 0 22
COAD 8 5 3 4 4 4 7 13 50 29
Chronic renal failure 1 1 0 0 1 0 7 100 100 8
Congestive cardiac 3 0 3 1 2 4 8 0 0 18
failure
Myocardial infarction 1 0 1 0 1 24 12 100 100 32
Other
General debilitation/ 5 1 4 2 3 5 35 40 60 58
PEM
Inflammatory bowel 2 2 0 0 2 0 5 0 0 27
disease
Insulin overdose 1 1 0 1 0 3 17 0 0 12
Trauma 9 8 1 6 3 2 7 22 22 33
101 63 51:49 17 41 51 33 51
Univariate multivariable linear regression analysis was used to determine 
whether age, sex, primary diagnosis of CVA or duration of starvation were 
significant explanatory variables for mortality, duration of NG feeding and 
LOS (Table 3.2). Analysis of the duration of NG feeding and LOS were 
limited to survivors only, since if starvation increased mortality, premature
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death would give the false impression that starvation was of benefit leading 
to shorter duration of NG feeding and LOS.
Table 3.2 Univariate multivariable regression of outcome variables death, 
duration of NG feeding (log) and LOS (log) against explanatory 
variables, age, sex, diagnosis of CVA and duration of starvation.
Variable
outcome explanatory (where 
p < 0.05)
n p value Model
Variability
*(%)
1. Mortality age
starvation
101 0.009
0.038
13
2. Duration of NG feeding 
(log) (survivors)
starvation 68 0.027 6
3. Duration of LOS (log) 
(survivors)
CVA 49 0.002 27
4. Mortality (CVA only) all ns 38 - 8
5. Duration of NG feeding 
(log) (CVA survivors 
only)
all ns 20 29
6. Duration of LOS (log) 
(CVA survivors only)
all ns 14 — 32
*Model p value = : 1) 0.0009, 2) 0.10, 3) 0.0012, 4) ns, 5) 0.036 6) 0.08.
The duration of NG feeding and LOS did not have a normal distribution 
(Shapiro-Wilk test) and were logarithmically (natural log) transformed. Only 
age (p = 0.009) and duration of starvation (p = 0.038) were found to be 
significant explanatory variables for mortality. The duration of NG feeding 
was significantly associated with the duration of starvation (p = 0.027), 
whereas LOS was only significantly associated with a primary diagnosis of 
CVA(p = 0.002). The regression models explained between 6% and 32% of 
variability. When analyses were restricted to CVA patients only, none of the 
variables reached significance, possibly because numbers were very small. 
Figures 3.1 to 3.4 to show the simple regression lines of the duration of NG
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feeding and LOS, in all patients or CVA patients, against the duration of 
starvation. All the regression models explained a significant part of the 
residual, but this was smaller for the CVA sub-group compared to all 
patients.
Figure 3.1 Regression of the duration of NG feeding (log) against starvation 
in all patients (n = 68).
Duration of NG feeding (log days)
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Figure 3.2 Regression of the LOS (log) against starvation in all survivors (n = 49). 
LOS (log days)
Figure 3.3 Regression of the duration of NG feeding (log) against starvation in CVA 
patients only (n = 20).
Duration of NG feeding (log days)
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Figure 3.4 Regression of LOS (log) against starvation in CVA survivors only 
(n = 14).
LOS (log days)
Associations between mortality and starvation, and mortality and age are 
shown in Figures 3.5 and 3.6, respectively. To prevent outliers from causing 
bias, the data have been grouped into ranges of starvation and age; each 
range represents >6 patients (starvation) and >8 patients (age), respectively. 
Mortality (%) after 0-5 days starvation is relatively constant, after which it rises 
steeply (Figure 3.5). In addition, mortality during NG feeding was about 20% 
lower than mortality for the total LOS in patients starved for up to five days; 
the difference is reduced to about 10% after longer periods of starvation.
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Figure 3.5 Mortality (%) over different periods of starvation (each
data point represents > 6 patients).
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Patients less than 40 years old had the lowest mortality, but mortality was 
relatively constant over the age range 40-69 years (Figure 3.6). Mortality is 
much higher and plateau’s in patients aged > 69 years.
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Figure 3.6 Mortality (%) within different age groups (each data point
represents > 8 patients).
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Both the duration of starvation prior to NG feeding and increasing age are 
associated with increased mortality. Total and CVA patient groups were 
therefore re-analysed to take into account the apparently critical cut-off points 
of 0-5 days versus >5 days starvation and 0-69 years versus >69 years, 
respectively (Table 3.3). TPN was used more often in patients starved for 
only 0-5 days compared to >5 days but was never used in CVA patients. A 
higher percentage of patients starved 0-5 days ultimately reached the stage 
where they were discharged on oral feeding. Furthermore, mortality during 
NG feeding and the hospital stay was consistently, often significantly, lower 
in the patient groups starved 0-5 days compared to those starved >5 days. 
Statistical significance of the above differences between patients starved 0-5 
versus > 5 days was of the same order or greater in patients aged >69 years 
compared with younger patients.
> 6 0
— ♦ — Mortality 
during NG 
feeding
— * —  Mortality 
during total 
L O S
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Table 3.3 TPN use prior to NG feeding (%), oral feeding at discharge (%), mortality 
during NG feeding (%) and mortality during hospital stay (%) in total 
and CVA patient groups, according to the duration of starvation (0-5 
days versus >5 days) and age (0-69 versus >69 years).
Starvation (days) n Prior use 
of TPN
%
Oral
feeding
at
discharge
%
Mortality 
during NG 
feeding
%
Mortality
during
hospital
stay
%
Total group- all patients
0-5 71 13 56 18 41
>5 30 0 20 67 77
p value 0.055* 0.0017 < 0.00002 0.0026
Total group- 0-69 years
0-5 46 13 65 9 33
>5 13 0 38 46 54
p value ns 0.16 < 0.005* ns
Total group- > 69 years
0-5 25 12 40 36 56
>5 17 0 6 82 94
p value 0.083 0.006 < 0.008 < 0.012*
CVA- all patients
0-5 20 0 50 25 45
>5 18 0 11 72 83
p value - <0.03 <0.01 < 0.04
CVA- 0-69
0-5 10 0 70 10 30
>5 6 0 33 33 50
p value - ns ns ns
CVA- > 69 years
0-5 10 0 30 40 60
>5 12 0 0 92 100
p value - < 0.08* < 0.02* 0.03*
Chi-square tests were used with the Yates correction to test for significance
except where * indicates use of Fisher’s exact test.
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In patients starved 0-5 days, compared to >5 days, the duration of NG 
feeding and LOS (ns) are much shorter (Table 3.4). Log transformed values 
for ‘duration of NG feeding’ and ‘LOS’ were used in the t test because the 
actual variables did not have a normal distribution.
Table 3.4 Duration of NG feeding and LOS (mean ± SD) in survivors starved 
0-5 versus >5 days.
Starvation
(days)
Survivors of NG feeding* 
n duration (days) n
Survivors of LOS
duration (days)
0-5 58 12.7 (15.6) 42 41.3(37.5)
>5 10 29.7 (30.9) 7 74.6 (58.8)
p value** - 0.049*** - 0.061
* Including those who died subsequent to NG feeding but during the hospital stay.
** t test of the log of the duration of NG feeding (***unequal variance) and log of LOS.
Median time to death by prior starvation and age are shown in Figures 3.7 
and 3.8. To prevent outliers from causing bias, the data have been grouped 
into ranges of starvation and age; each range represents >6 patients 
(starvation) and >4 patients (age), respectively. The time to death increases 
to a peak in those starved for only 1-2 days and then gradually falls again. 
There is no clear trend in the time to death for different age groups.
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Figure 3.7 Median time to death in patients suffering different
periods of starvation (each data point represents >
6 patients).
Time to  
death (days)
S ta rva tion  (days)
Figure 3.8 Median time to death in different age groups (each data 
point represents > 4 patients).
Time to  death 
(days)
Age (yea rs )
Seven patients survived to discharge in the group starved for >5 days. 
Compared to patients starved 0-5 days they had a longer period of 
starvation (7 days) and hospital stay (33 days). Table 3.5 shows hypothetical 
cost savings based on the assumption that if these patients had received 
NG feeding seven days earlier they could have achieved hospital discharge 
after a similar period to patients starved 0-5 days. Non-survivors were 
excluded from this analysis because the duration of NG feeding they would 
have required, had they survived, cannot be known. Furthermore, early 
mortality would reduce the cost of delayed feeding.
Table 3.5 Cost of patient stay and earlier NG feeding, and hypothetical cost 
saving based on data for 7 survivors.
Speciality Hypothetical 
cost of delayed 
feeding (£)
Extra cost if NG 
feeding started 
7 days earlier 
(£)
per
patient
day
per
patient
per
patient
per
day
total per
patient
n total
General 150 4997 6 47* 4950 3 14850
medical
General 200 6660 6 47* 6613 3 19839
surgical
Acute
elderly
128 4262 6 47* 4215 1 4215
Total - - 6 329* - 7 38904
Hypothetical cost saving 
(£)
* Including the cost of one fine-bore NG tube per patient.
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This study population comprised mainly medical patients (77%) so that the 
results do not necessarily apply to patients undergoing abdominal and 
thoracic surgery. Mortality was very high (51%) reflecting a high incidence of 
severe disease. Multiple regression analysis showed that age (p = 0.009) 
and starvation (p = 0.038) were independently associated with mortality; sex 
and diagnosis of CVA showed no association with mortality. In addition, the 
duration of starvation was associated with the duration of NG feeding (p =
0.027). Only the diagnosis of a CVA was associated with LOS (p = 0.002). 
None of the explanatory variables reached significance when analysis was 
limited to patients suffering CVA. However, when this group was analysed 
using starvation as the only explanatory variable, the models explained 
relatively large and significant proportions of variability in the duration of NG 
feeding (22%) and LOS (30%). There is a steep increase in mortality in 
patients starved >5 days (50%) (Figure 3.5) and aged >69 years (40%) 
(Figure 3.6). These may be thresholds above which the physiological 
reserve fails, thus impairing recovery from the primary condition and 
predisposing to secondary disease such as hospital acquired infection. 
However, since disease severity was not measured, starvation and age may 
only be components of increased risk or merely markers for increased 
disease severity. Nevertheless, the above tendency prompted analysis of 
patients starved 0-5, versus >5 days, in groups aged 0-69 and > 69 years.
In patients starved 0-5, versus >5 days, mortality was lower during NG 
feeding and total LOS, whether analysed by total or CVA groups or by age.
3.5 Discussion
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This confirms that mortality is associated with starvation, independent of 
age. However, the difference in mortality between patients starved 0-5, 
versus > 5 days, was stronger in patient groups aged >69 years. This may 
indicate that older patients are particularly vulnerable to the effects of 
starvation on the underlying disease because of reduced physiological 
reserve. However, this result does not exclude the possibility that in patients 
with severe disease, NG feeding was delayed because they were initially 
expected to die. This, rather than starvation, may be the cause of increased 
mortality in those starved >5 days. Nevertheless, Linn et al (1988) found that 
old age was associated with a worse outcome only if combined with 
malnutrition. Thus if starvation independently exacerbates mortality, early EN 
may disproportionately reduce mortality in old patients.
The association between starvation and mortality during NG feeding is 
consistently stronger than during the total LOS in all patient groups. 
Starvation for >5 days may have worsened the clinical state and thus 
hastened death. Conversely, starvation for 0-5, and by implication earlier 
EN, is associated with a shorter period of NG feeding. This may indicate 
reduced debilitation and thereby reduced risk of mortality. However, there 
was a tendency for patients to survive NG feeding only to die later as a result 
of their underlying disease process; comparing patients starved 0-5, versus 
>5 days, mortality during NG feeding was 18% versus 67% rising to 41% 
versus 77%, respectively, during the total LOS (Figure 3.5). Thus, once NG 
feeding had ceased its benefit appeared to decline. Nevertheless, this 
suggests that early NG feeding greatly reduces early mortality which, in
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patients with a potentially survivable condition, may lead to improved long­
term survival.
In survivors, simple regression analysis of starvation against the 
subsequent duration of NG feeding and LOS showed positive associations. 
The residual prediction by the regression models for CVA patients alone 
were of lower statistical significance, possibly due to smaller numbers. 
However, the regression lines were steeper which could be a result of 
disease-type homogeneity. Furthermore, in all patients starved for 0-5, 
versus >5 days, the durations’ of NG feeding and LOS were shorter by 17 
and 33 (ns) days, respectively. The statistical significance of these 
differences might increase with larger study numbers. In addition, 5 days 
may not be the critical cut-off point for these outcomes. In a study of CVA 
patients, LOS was shorter when EN was started within 72 hours, versus 
after 72 hours, of the CVA (20 versus 30 days, respectively) (p< 0.036) 
(Nyswonger and Helnchen, 1992). This was despite the fact that LOS was 
independent of disease severity (GCS). In the present study the reduction in 
LOS was much larger (33 days).
The principle clinical and nutritional criteria for cessation of NG feeding were 
imminent death and increasing oral intake. Patients starved for longer had a 
longer duration of NG feeding, possibly because they were debilitated and 
took longer to wean back onto oral feeding. Starvation in fit people usually 
takes one to three months to cause fatal debilitation (Apfelbaum, 1975), 
whereas in this study 0-24 days of starvation was associated with a 51%
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mortality after a median of 24 days. These discrepancies are reflected in 
nitrogen loss from pure starvation, after the first week, being 3-4g of nitrogen 
per day (Cahill, 1976) compared with a moderately catabolic hospital 
patients losing more than 12g of nitrogen per day. If such a loss is not 
balanced by nitrogen intake critical physiological processes can quickly 
become impaired and fatal debilitation may result. The effect of malnutrition 
on debilitation was investigated by Axellson et al (1988). In a study of 100 
patients suffering acute CVA it was found that malnourished patients were 
less likely to return home. In the present study more patients starved for 0-5, 
versus >5 days, were discharged on oral feeding (all patients, 56 vs. 20%, 
p< 0.002; CVA, 50 vs. 11%, p< 0.01). This reflects that more patients starved 
for 0-5 days survived to discharge but in addition they had a more rapid 
transition to oral feeding. This in turn indicates some degree of recovery and 
quality of life.
Overall the efficacy of NG feeding may have been reduced by sub-optimal 
delivery of nutrition (ie. under- or over-nutrition). The estimate of nutritional 
requirements used in the study protocol was largely determined by body 
weight. Body weight may be spuriously affected by oedema and dehydration. 
In addition, weight often had to be estimated from the patient's past weight 
or apparent weight. Furthermore, nutritional requirements can vary for 
individuals of the same weight, age, sex, and clinical and nutritional 
conditions. Unfortunately, neither the study resources nor routine dietetic or 
nursing records allowed for collection of actual nutritional intake or 
estimation of nutritional status. Without these data, the effects of pre-existent
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malnutrition and nutritional support on outcome could not be determined. 
Another factor affecting the efficacy of EN is the duration of NG feeding. 
Although the median period of NG feeding (7 days) was comparable with 
other studies (Rees et al, 1988), the cessation of feeding was often 
unplanned. For example, a tube becoming blocked or inadvertently removed 
would often precipitate ‘commencement’ of oral intake. Such patients may 
initially be unable to meet their requirements leading to partial starvation 
following the cessation of NG feeding. This could explain why the reduction 
in mortality associated with 'early* NG feeding was weaker once NG feeding 
ceased. Lastly, this study omitted to test the effect of nutritional support on 
the incidence of major complications (see 3.6).
There is a biphasic trend in time to death versus starvation; high initially, 
falling to a minimum in patients having a few days starvation and then 
increasing again in patients starved for >5 days. Higher mortality in patients 
starved for 0 days may be due to higher disease severity in patients fed from 
admission. This tends to be confirmed by the higher percentage of patients 
in this group previously receiving TPN and/or admitted to ITU. On the other 
hand high mortality in those suffering prolonged starvation may be due to 
the adverse effect of starvation or that poor prognosis was associated with a 
clinical decision to delay NG feeding (discussed above). Disease severity 
must be measured to determine whether such relationships exist. Finally 
the lack of an age-related association in the median time to death suggests 
that disease-type and severity overrode any age-related effect.
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In conclusion, this study showed strong associations between starvation, 
prior to NG feeding, and increased mortality and duration of NG feeding. By 
inference, early EN should reduce mortality, dependence on NG feeding and 
patient cost. However, these associations could not be differentiated from 
the effects of disease severity, because of the lack of suitable disease 
severity scores.
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Subsequent studies should re-examine the efficacy of early nutritional 
support but should control for disease-type, and severity, and age. 
Furthermore, it is possible that nutrition affects different outcomes in 
different clinical groups. For this reason a more comprehensive list of 
outcome variables should be tested in burned and head-injured patients, in 
whom pre-existent malnutrition is rare, and in patients undergoing 
colorectal surgery for malighancy some df whom are malnourished. Some 
studies have indicated that early EN is preferable to PN, therefore 
subsequent studies tested the feasibility and effect of early aggressive EN.
3.6 Recommendations for Future Study
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4Aggressive Early Enteral Feeding in 
Burn Patients Requiring IV Fluid 
Resuscitation
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This is an observational study of aggressive early EN in patients suffering 
burn injury necessitating IV fluid resuscitation. This section gives a general 
background to the physical effects of burn injury and its modern treatment. 
The characteristics of burn injury are described in order to understand the 
importance of the extent of burned body surface area (BBSA), full-thickness 
lesion (FTL) burn, and inhalation injury in determining disease severity. 
Medical and surgical treatments are briefly described including early 
excision of the burn and selective decontamination of the digestive tract 
(SDD). The mechanisms of hypermetabolism and hypercatabolism 
following burn injury are outlined. These changes in intermediary 
metabolism make nutritional support, following serious burn injury, 
essential. Finally, current knowledge of the effect of nutrition on outcomes is 
described with its success and difficulties to date. During the course of the 
study, the protocol for EN at Frenchay hospital was changed. This allowed 
analysis of the effect of different nutritional regimes, while controlling for 
disease severity, early wound excision and SDD, and forms the basis of the 
present study.
4.1.1 General Background
Major burn injury is one of the most serious forms of trauma. It causes pain, 
psychological suffering, deformity and ultimately threatens life. Advances in 
treatment have ameliorated these consequences over the past few decades 
with great improvement in survival (Table 4.1). Treatments include 
aggressive fluid resuscitation and nutritional support (Taylor and Fettes,
4.1 Introduction
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1996a), and use of topical antimicrobials to delay the onset of sepsis. 
Furthermore, in prospective randomised controlled trials, early debridement 
has been shown to improve survival by reducing blood loss and diminishing 
the occurrence of sepsis (Herndon etal, 1989; Desai etal, 1990; Desai et 
al, 1991). Lastly, modern treatment has reduced mortality secondary to 
inhalation injury, pulmonary oedema and pneumonia (Shirani et al, 1987; 
Herndon et al, 1987; Herndon et al, 1988), in part by use of SDD to reduce 
the incidence of nosocomial infection (Buckley, 1992).
Table 4.1 Percent of burned body surface area (BBSA) for an expected 50% 
mortality in 1952 and 1993*(Herndon etal, 1996).
Age
1952
%BBSA
1993*
0-14 49 98
15-44 46 72
45-64 27 51
>65 10 25
* Galveston burn unit, Texas. USA. In the UK it is rare for a burn of >85% 
BBSA to survive.
The cause of major burn injury follows certain patterns. Deaths from burns 
are most frequent in residential fires, especially in multi-family dwellings 
and in low income areas (Pruittetal, 1990). House fires account for 80% of 
unintentional deaths and 73% of total deaths (Baker et al, 1992) with a 
higher incidence in children and the elderly. Thus the incidence of burn 
injury is highest in the very young and very old and flame injury from a house 
fire is likely to be severe and associated with inhalation injury.
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4.1.2 Characteristics of burn injury 
A burn is characterised by its depth, size and presence of inhalation injury. 
These latter characteristics determine the disease severity and the 
treatments which may be required.
4.1.2.1 Evolution of burn injury 
A burn injury changes in appearance and its physiological effect over time. 
Direct burn injury produces an initial volume of irreversibly damaged tissue 
surrounded by a region of reversibly damaged tissue. The final depth and 
lateral extension of the injury depend upon the extent to which these 
adjacent sublethally injured tissues recover.
When a burn wound heals spontaneously the dead tissue (eschar) 
separates as new epithelium covers the injured area. With partial-thickness 
lesion (PTL) burns, skin regeneration occurs rapidly from uninjured 
epidermal elements, hair follicles, and sweat glands within the injured 
tissue. Healing of PTL burns should be complete within one month. 
However, with a FTL burn the epidermis and much of the dermis is 
destroyed, and epithelialisation starts from the edges of the wound or from 
the scattered integumental remains. This process is very slow and unless 
skin grafting is prompt, disfiguring or disabling scars result. Thus burn 
depth would affect outcomes such as LOS.
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Grading of a burn as first, second (PTL), third, or fourth degree (FTL) refers 
to the depth of the irreversible tissue damage (Figure 4.1). Frequent wound 
observation by a knowledgeable clinician over the initial 3 to 5 days 
following injury allows accurate assessment of the size and depth, which 
are important in determining treatment and prognosis. The depth of injury 
can be determined from the appearance of the wound (Appendix 8.4.1).
Figure 4.1 Schematic demonstrating the degree and severity of burn 
injury in relation to skin anatomy (Morris and Malt, 1994a).
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The physiological impact of the injury and severity of the burn can be judged 
from the size and depth of injury (Figure 4.2). A small injury will generally 
require little treatment and often does not greatly alter the cardiovascular 
and metabolic state.
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Figure 4.2 Assessment of the extent and severity of burn injury 
(Harvey Kemble and Lamb, 1984).
IGNORE SIMPLE ERYTHEMA
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In about 20-30% of fire victims, smoke inhalation and carbon monoxide 
intoxication complicate the burn injury. Inhalation injury contributes heavily to 
morbidity and mortality in burned patients (Shirani etal, 1987). Three distinct 
injuries - carbon monoxide intoxication, upper airway injury, and pulmonary 
inhalation injury - may occur individually or concurrently (Heimbach and 
Waeckerle, 1988). Figure 4.3 illustrates sites and mechanisms of inhalation 
injury.
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Figure 4.3 Mechanisms of inhalation injury at various sites 
within the tracheobronchial tree (Quinby, 1988).
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Hot air
Smoke 
/  Hot particles 
'  Aspiration
Irritant gases
Effects
Laryngeal obstruction
Mucosal slough 
Infection
Bronchiolar plugging 
Atelectasis
Pulmonary edema 
Alveolar capillary defect
Signs
Stridor
Voice
Soot
Fever
Rhonchi
Sputum
Rales
Hypoxia
Cyanosis
Victims trapped in burning buildings or vehicles become hypoxic from 
breathing an oxygen-deficient gas mixture that contains carbon monoxide; 
this is the commonest cause of death at the scene (Larsen, 1989). Carbon 
monoxide also shifts the oxyhaemoglobin dissociation curve to the left, 
inhibiting the release of oxygen to the tissues (Goodwin et al, 1980). 
Neurological and cardiac impairment may result from tissue hypoxia 
(Somogyi et al, 1981).
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4.1.3 M edical and surgical treatment
4.1.3.1 Resuscitation
If the total burn is more than 15% of BSA in an adult or 10% in a child, then 
IV fluid replacement is indicated. With burns of 30% or more, IV fluid 
replacement is essential if the patient is to survive. Immediate treatment of 
burns includes irrigation of the wounds with water to minimise skin damage 
and removal of harmful agents, ensuring that the patient’s airway is clear 
and treating for shock. If there is evidence of laryngeal oedema, the patient 
is assessed for endotracheal intubation and mechanical ventilation. 
Humidified oxygen is given to patients with carbon monoxide poisoning. To 
combat shock, caused by extravasation, the fluid (4.5% human albumin 
solution) requirement for resuscitation is initially assessed using the 
formula:
total % BBSA x weight in Kg 
2
ie. 0.5mL/ Kg/ %BBSA to be infused in each resuscitation period. The Muir 
and Barclay regime divides the 36h post injury resuscitation period into six 
successive periods of 4, 4, 4, 6, 6, and 12 hours. Subsequent volume 
delivered is determined from empirical measurement of cardiovascular and 
renal parameters.
4.1.3.2 Treatment of the wound
The skin is normally an impermeable barrier to bacterial infection whereas 
a burn wound permits local and systemic infection to occur. This may delay
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healing and threaten survival. Treatment is aimed at preventing colonisation 
of the wound by pathogenic organisms until healing or successful grafting 
have taken place. Wounds are cleaned aseptically using warm saline, and 
dressed to prevent colonisation. Small burns can quickly heal or be grafted, 
so do not present a high infection risk. The eschar of large FTL burns are 
debrided and grafted in order to rapidly reduce the risk of infection and 
improve cosmetic appearance. Excised wounds are autografted from 
unburned donor sites for permanent closure or given temporary coverage 
with cadaveric skin or skin substitutes (Figure 4.4). Flammacerium® 
dressing was used on wounds when a patient was unfit for surgery. 
Flammacerium® obscures the demarcation of PTL burns which might heal
without surgery and FTL burns which should, if possible, be debrided. Thus, 
for burns which cannot be immediately debrided, the wound is covered with 
Jelonet and gauze soaked in iodine. Skin grafts and donor sites require 
more specialised treatment (Muller et al, 1996).
Figure 4.4 Schematic arrangement of the ‘Sandwich” technique for wide 
area coverage. Homogaft overlies widely meshed autograft and 
seals the wound (Alexander et al, 1981).
---------------- ^ g r a n
Autoqraft
Excised wound
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4.1.4 Mechanisms of hypermetabolism and hypercatabolism  
Burn injury is associated with an increased REE and increased nitrogen
loss (Taylor and Fettes, 1996a), concurrent with altered amino acid,
carbohydrate and fat metabolism. Nutritional support can ameliorate some
of these changes but overfeeding can exacerbate metabolic derangement.
4.1.4.1 Hypermetabolism
Hypermetabolism following burn injury is multifactorial. One cause is heat 
loss as evaporation (Caldwell et al, 1981) and radiation (Caldwell et al, 
1966). Occlusive dressings and high room temperature (~32°C) minimise 
heat loss, despite continued evaporation. In addition, for each 1 °C of pyrexia 
there is a 10% increase in REE (Wilmore and Aulick, 1978). Wbffe et al 
(1987) proposed that increased heat production is due to the stimulation of 
ATP hydrolysis in substrate cycles. Treatment to date has ameliorated but 
not prevented hypermetabolism (Wilmore et al, 1974).
4.1.4.2 Protein breakdown and nitrogen loss
Burn injury induces large and generalised muscle protein catabolism as 
indicated by increased urinary nitrogen loss (Grecos et al, 1984). Nitrogen 
loss is proportional to wound size (Carlson et al, 1991). 15N-amino acid 
tracer studies indicate an increase in protein turnover with a simultaneous 
increase in protein synthesis and catabolism, the latter being predominant 
(Jahoor and Wolfe, 1987). This reflects increased muscle proteolysis and 
hepatic acute phase protein synthesis. Amino acid release from muscle 
increases during the first 48h (ebb) phase, due to tissue destruction 
(Cynober, 1989). However, during the flow phase, amino acid extraction for
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gluconeogenesis outstrips muscle release. Specifically, glutamine is 
metabolised at an increased rate, to maintain acid-base homeostasis, and 
becomes the rate-limiting substrate for immune cell function (Parry-Billings 
etal, 1990). TNFand glucocorticoids may be responsible for this peripheral 
catabolism after injury (Fischer Hasselgren, 1991). Furthermore plasma IL- 
6 levels correlate positively with protein catabolism (evaluated by the urinary 
3-methylhistidine:creatinine ratio) (De Bandt et al, 1994) and IL-6 is the 
main effector of hepatic acute phase protein synthesis (Andus et al, 1990).
4.1.4.3 Altered glucose flux 
Bum injury increases glucose flux, in proportion to burn size, due to 
anaerobic glycolysis by the burn wound and aerobic degradation in 
surrounding tissues (Wilmore and Aulick, 1978). This effect becomes 
systemic in large burns (Clark et al, 1984). Eighty percent of the glucose 
consumed by the burn wound is converted to lactate (Wilmore and Aulick, 
1978) accelerating the Cori cycle (Wilmore et al, 1980). Stimulation of 
gluconeogenesis maintains a normal or elevated glucose level. However, 
episodes of hypoglycaemia occur during sepsis due to continued peripheral 
glucose utilisation in the face of reduced hepatic production (Wilmore et al, 
1980; Pomposelli etal, 1988). Gluconeogenesis is not suppressed during 
hyperglycaemia, suggesting insulin resistance (Wolfe et al, 1979). This 
state is partly mediated by IL -1, IL-6 and TNF (Beisel, 1991).
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4.1.4.4 Lipid metabolism 
Burn injury induces increased fatty acid flux with increased levels of plasma 
fatty acid and glycerol (Wolfe et al, 1987). Catecholamines stimulate lipid 
utilisation but, in burned patients, there was no correlation between 
palmitate flux and circulating catecholamine levels (Galster et al, 1984). 
Conversely, Batstone et al (1976) found a strong positive correlation 
between cortisol and glucogenic substrates plus free fatty acids (FFA), and 
a strong negative correlation between insulin and FFA, glycerol and ketone 
bodies on days one to five post-burn. This suggested that elevated cortisol 
levels and insulin insufficiency play an important role in the metabolic 
response to burn injury.
4.1.5 Effect of nutrition
Severe catabolism in burn injury can induce nitrogen losses exceeding 30g 
per day, equivalent to 900g of muscle per day. This combined with drain or 
exudative protein losses would quickly lead to death due to protein 
depletion: A 70Kg man has only 4500g of skeletal muscle and 8500g 
committed to visceral and plasma proteins (Widdowson, 1965). Loss of 
50% usually results in death (Owen et al, 1969). Lack of nutritional support 
following burn injury is associated with weight loss in relation to burn size 
(Figure 4.5) and in children and toddlers growth may stop (Childs et al, 
1990). Finally, bed-rest specifically exacerbates muscle loss. Nitrogen 
balance may not be achieved until the third week after severe burns 
(Sutherland, 1976). Non-fat weight gain only occurs once the catabolism
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has resolved (Streat et al, 1987). Furthermore, wound, donor and graft 
healing is directly dependent on an anabolic state and therefore substrate 
supply. Nutritional support should therefore be started early to minimise 
losses and enhance anabolism once it is achievable.
Figure 4.5 Weight loss after a burn injury related to TBSA burn (%) and 
without enteral or parenteral feeding (Wilmore, 1974).
Admission 
weight (%)
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70 -
2 3 4 5 6
Post- burn time (weeks)
TBSA burn %
— 0-  19%  
- 2 0 -  29% 
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— 40% +
In the UK burned patients requiring IV fluid resuscitation are admitted to 
regional burn units of which Frenchay Hospital is one. These patients were 
admitted to either one of two specialist burns wards or ITU. Historically, EN 
was started slowly and in most patients took several days to attain their 
estimated nutritional requirements. These patients suffer severe, often life 
threatening sequalae possibly associated with poor nutrition. The increased 
nutritional requirements of burned patients can be met by EN or PN.
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However, PN, in the absence of EN, is associated with gut atrophy and may 
increase bacterial translocation (see 1.4.4.2.3). Furthermore, since early 
aggressive EN has been shown to be practicable (see 1.4.4.2.2) in the 
majority of patients, the author (ST) changed the Frenchay enteral feeding 
policy to one of early aggressive EN on two burn wards. The ITU feeding 
policy did not change as the medical staff thought that patients would not 
tolerate early aggressive EN. This policy change began to cause a 
difference in clinical practice from June 1992 and allowed a study of the 
effect of the delay before attempting aggressive EN on clinical outcomes, 
LOS and treatment cost. This was done in the single centre (Frenchay 
hospital) on patients in whom the investigator had direct access as a 
practising dietitian.
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4.2 Methods
4 .2 .1  Aims and Objectives 
The aim of this study was to determine whether the delay before early 
aggressive EN was associated with the outcomes: mortality, major 
complications (excluding and including mortality), LOS (survivors) and ‘drug- 
IVfluid-PN cost’ (cost of drugs, IV fluids and PN for the whole hospital stay) 
(all patients and survivors only) in burn patients requiring IV fluid 
resuscitation. Study objectives included:
1. Determination of which explanatory variables predict clinical outcomes, 
LOS and treatment cost.
2. Determination of the association between the explanatory variables:
• Delay before admission
• Delay before attempting EN perse
• Attempting aggressive EN before versus after 24 hours
• Delay before attempting aggressive EN
• EN feeding routes refused
• Age, Sex
• BBSA%, FTL%
• ‘Bull’, ‘Clark’ and ‘Inhalation’ scores (see 2.2.1.1)
9 Pre-burn morbidity
• Year of admission: 1989, 1990, 1991, 1992, 1993, 1994, 1995
• Early debridement
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• SDD use
and the outcome variables:
• Mortality
• Major complications (excluding and including death)
• LOS
• ‘Drug-IV fluid-PN cost’ (all and survivors only).
3. To explore associations between the delay before attempting aggressive 
EN and the outcomes:
• Treatment cost:
• Drugs only and drug components
• pn
• Duration of EN and PN
• Complications:
• By time and component
• Intolerance to EN
• Organ support
• ITU stay.
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4 .2 .2  Selection c rite ria  
Consecutive burn patients requiring IV fluid resuscitation were recruited 
when admitted to the two burn wards and ITU at Frenchay Hospital. Specific 
exclusions included:
1. Patients who were moribund and in whom active treatment ceased 
within 24h of injury, and
2. Patients in whom nutritional and medical information was not 
ascertainable.
4. 2. 3 Study design  
This study followed an observational design with information collected 
retrospectively from January 1989 to June 1992 and prospectively from June 
1992 to October 1995. In all patients the aim was to meet their full estimated 
nutritional requirements via EN (see 2.2.6). However, until June 1992 the 
feeding policy was to increase intake, via EN, up to individual energy and 
nitrogen requirements, over a period of two to three days. This practice 
came about because of two main assumptions:
1. That gastroparesis or ileus preclude early EN; or
2. That oral nutritional intake would resume quickly and therefore tube 
feeding would be unnecessary.
Since June 1992, the policy, on the two burn wards, has been to attempt to 
meet an individual’s hourly requirements, within 24h, by EN (termed 
aggressive EN in this study- see below). However, ITU remained unwilling 
to initiate aggressive EN (Table 4.2).
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Table 4.2 Enteral feeding protocol on the Burn wards and ITU.
Ward Protocol Time post- 
EN p erse
-burn to attain: 
Aggressive EN
Pre- June 
1992
ITU • Commence minimal NG feeding (adults, 
15mL/ h).
• Aspirate 4 hourly. If 2 consecutive 
aspirates are <50ml feeding rate is doubled 
until the required rate is attained. If aspirate 
is >150mL feeding rate is reduced down to 
15mL? h.
• <24h. • 24-48h,
• >48h if 
aspirates 
are
>150mL.
Burns
wards
• Tube feeding started at about 3 days post­
injury with a BBSA of >20% and was 
gradually increased up to requirements 
over 48 to 72h.
• Supplementation policy was not systematic.
• 12-72h • 96-120h
Post- June
1992
ITU • as for Pre-June 1992. • as for 
Pre- 
June 
1992.
• as for Pre- 
June 1992.
Burns
wards
• any patient with a BBSA of >10% burn who 
may be unable to take adequate oral intake 
was to be given aggressive early EN 
equivalent to 75-100% of the patient’s 
hourly energy or nitrogen requirement.
• <24h • <24h
The different policies meant that within the study population there would be 
patients in whom there was a wide range in the delay before EN, including
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aggressive EN, was commenced. Nutritional treatment fell into three broad 
groups characterised by:
1. A long delay before attempting EN perse (mostly patients recruited early 
in the study on the two burn wards);
2. An early attempt to give EN that was initially insufficient (mostly ITU 
patients); and
3. An early attempt to give aggressive EN (ie. >50% of estimated hourly 
energy and nitrogen requirements) (mostly patients recruited late in the 
study on the two burn wards).
Disease severity tends to be higher in ITU patients and would therefore 
determine feeding policy in these patients. For this reason, statistical 
comparison between two patient groups defined by the criteria (1-3) above, 
would have incurred an analytical bias due to the inherent differences in 
disease severity. Bias was minimised by using multivariable analysis (see 
4.2.6) to analyse the effect of the following three (EN) nutritional variables on 
clinical outcome:
1. Delay before attempting EN pe rse  as a continuous variable: Defined as 
‘the delay before attempting EN amounting to at least 6.25g of protein in 
the subsequent 24h\ EN includes tube or oral feeding since they are 
physiologically equivalent.
2. Aggressive EN attempted before, versus, after 24h as a discrete 
variable. Aggressive EN was defined as \attempting to feed, for at least 
1h, more than 50% of a patient’s estimated hourly energy and nitrogen 
requirements’.
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3. Delay before attempting aggressive EN as a continuous variable. 
Examples of how patients would be categorised follow:
1. Patient ‘A’ was fed sips of milk, orally, from 5h post-bum and amounting 
to 10g of protein in the 24h subsequent to the first sips of milk. This 
would be defined as a delay before attempting EN per se of 5h, 
regardless of whether the milk was vomited.
2. Patient ‘B’ commenced minimal NG feeding from 4h post-burn. The 
feeding rate was gradually increased until, at34h post-burn, >50% of his 
estimated hourly energy and nitrogen requirements were being met. 
Patient ‘B’ would have the delay before attempting EN per se defined as 
4h and the delay before attempting aggressive EN defined as 34h (ie. 
categorised as after 24h).
3. Patient ‘C’ commenced NG feeding providing >50% of his estimated 
hourly energy and nitrogen requirements from 6h post-burn. At 10h post­
burn the NG tube was aspirated and 400mL was removed. The rate of 
NG feeding was reduced and the patient tolerated <50% of his energy 
and nitrogen requirements in the first 24h post-burn. Nevertheless the 
delay before attempting EN per se AND aggressive EN were defined as 
6h (ie. categorised as within 24h).
The above definitions use the delay before attempting EN, in preference to 
the delay before tolerance of EN, and therefore ignore gastric losses 
(gastric residual + vomit) due to GI intolerance. This was done because 
gastric losses are commonly greater in patients with severe disease, 
therefore analysing by the ‘delay before tolerance’ could cause bias. 
Furthermore, the ‘attempt’ was defined as >1h rather than several hours
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because after several hours of feeding EN might be reduced because of Gl 
intolerance. This could cause the average delivery of energy and nitrogen to 
fall below the 50% cut-off, thus prolonging the delay before the attempt was 
defined as successful. Aggressive EN was defined as meeting >50% of a 
patient’s estimated (hourly) energy and nitrogen requirements because, 
with the feed composition used, it will meet the obligatory glucose 
requirement, make a disproportionately large reduction in the negative 
nitrogen balance (Shaw et al, 1983) and therefore maintain the acute phase 
protein response. Patients also received IV energy and sometimes nitrogen 
(amino acids). However, it was hypothesised that enteral energy and 
nitrogen are more critical in determining outcome.
Lastly, any associations found between the delay before attempting EN 
(aggressive or not) and an outcome, are not, per se, directly related to a 
nutritional affect. For this reason, the association between the delay before 
attempting EN and the delay before EN was tolerated was tested. A strong 
association between these variables means that an association between 
the delay before attempting EN and an outcome is, implicitly, an association 
between the delay before tolerance of EN and that outcome. Lastly, positive 
associations between the delay before attempting EN and complications or 
cost, imply that earlier EN would reduce complications or cost.
The use of an observational design and historical data weaken the test of 
the study hypothesis. However, a PRCT was precluded because the p o jj^  
of aggressive early EN was not acceptable to ITU staff and the plastic
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surgeon wanted all patients on the burn wards to receive early aggressive 
EN from June 1992.
Nutritional requirements were estimated, as described in 2.2.6, to meet 
energy and nitrogen requirements. Feed type was chosen on the basis of its 
NPE:gN ratio so that both energy and nitrogen requirements were met 
without the need to overfeed. Feed was delivered by continuous infusion 
over 18 or24h. ITU stop feeding from 24.00 to 6.00 in order to allow gastric 
pH to fall and reduce gastric colonisation (Jacobs et al, 1990). Conversely, 
the burn wards stop feeding from 8.00 to 12.00. The latter can achieve the 
same reduction in gastric pH and, in addition, allows mobilisation of the 
patient, and coincides with times of surgery, thus reducing interruptions to 
feeding. Recommendations have been made for vitamin supplementation 
in burned patients (Manning et al, 1996) but require controlled trials to 
confirm efficacy. Vitamin and mineral supplements were not routinely given. 
Lastly, the adequacy of nutritional input and state of protein catabolism were 
estimated from nitrogen balance as described in 2.2.6.5.
4 .2 .4  Study size
There is no formal method for estimating study size for regression analysis. 
However, multivariable analysis is more powerful than a simple test of the 
difference in outcome between two groups. Therefore it was decided to 
calculate putative study size on the basis of a two group comparison since 
such numbers should be more than sufficient in multivariable analysis.
145
From 1989 to 1990 29% of 48 burn patients requiring IV fluid resuscitation 
died. There was a range in the delay before EN in this group although few 
received aggressive EN within 24h. If mortality was 13% in patients given 
aggressive EN before 24h versus 39% in those given aggressive EN after 
24h post-burn, a total study size of 102 patients would be required for 2-way 
analysis to achieve a power of 80% at a significance level of p < 0.05. 
Frenchay hospital admitted 15-20 burned patients requiring IV fluid 
resuscitation per year during the period of the study. Thus retrospective J
recruitment from 1.1.89 to 31.5.92 and prospective recruitment from 1.6.92 
to 31.10.95 yielded the required number of patients (129) included in the 
analysis.
4.2.5 Data co llection  
Data collection included burn size and thickness, inhalation score, major 
complications (see Table 2.2), length of ITU stay and hospital stay (LOS), 
requirement for organ support and antibiotic, GI and nutritional drugs cost 
(Table 4.3). LOS was defined as the time (days) to discharge home or home 
visit where healing of the burns and donor sites were beyond the need for 
further debridement, grafting or anti-microbial dressings. Data was 
collected from medical, nursing and ITU notes retro- or prospectively 
depending on when the patient was recruited. Drug cost was determined 
retrospectively from the drug chart and adjusted to pharmacy costings in 
April 1996. Costing did not include EN; EN did not consistently represent an 
additional treatment cost compared to hospital food.
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Table 4.3 Data collected on patients in the Burn study.
Data item Definition or time of collection
© Patient details: At admission
© Name and hospital number tt «
© Age t t  it
Burn: %BBSA, %FTL u  it
© Inhalation score tt tt
© Burn Severity score:
• Bull U tt
Clark tt tt
0 Weight (Kg) tt tt
o Height (cm) tt tt
© BSA m2 t t  tt
0 Nutritional requirements (Kcal, g 
nitrogen)
Estimated at day 1 and 29
© Serum total protein As measured for clinical reasons
• Serum albumin U tt  Cl it it
Time (h) of:
Burn • At admission
• Admission to Frenchay hospital •  » “
• EN (oral or tube feeding) •  During the course of treatment
• Delay before attempting 
agg resave EN
m t t  tt  t t  tt tt
•  Tube feeding attempt 9  it  tt  tt tt  tt
© Routes refused by patient or not 
feasible
During the course of treatment
© Patient intolerance to aggressive EN 
(gastroparesis, ileus)
tt  t t  t t  u  tt
© Operations tt  it  tt u  tt
G Reasons for exclusion During the course of treatment
© Cessation day EN, PN Retrospective
© Duration EN, PN «
O Energy and nitrogen intake from: During the course of treatment
• Diet i t  tt it  it  tt
• Commercial fluid supplements t t  tt  tt tt tt
EN feeds »  tt t t tt ft
•  PN solutions tt  tt tt tt tt
«  IV hydration fluids tt  u  tt t t  tt
•  Propofol sedative t t  it  K tt It
© Gastric fluid input (mL) t t  i t  tt  tt tt
0 Aspirate volume (mL) tt  tt  tt tt tt
© Total N output ft H i t  tt it
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Table 4.3 continued.
Data item Definition ortime of collection
• IV Fluids:
for resuscitation (36h) Retrospective
• post-surgery (day 1 and 2,
excluding resuscitation fluids)
• up to 28 days and >28 days (excl. u
36h post-burn/ post-surgery)
• Complications and organ support i t
Pyrexia (days) During the course of treatment
Complications up to 28 days and > 28 Retrospective
days
• ITU:
• days (ITU-LOS) “
• day of admission, ventilation “
and dialysis
• Death and time to. it
• Drug usage up to and after 28 days
• Antibiotics “
Gastrointestinal t t
Nutritional tt
• Operations
Debridement/ grafting i t
• Dressing changes only or t t
release of contractures
4.2.6 Statistical an a ly s is  
First it was determined whether variables had a normal distribution and, if 
not, whether they could be transformed or would require non-parametric 
analysis. Death was assumed to follow a binomial distribution. Other 
outcome variables were tested for Normal distribution using the Shapiro- 
Wilktest and found to diverge from Normal distribution. Transformation was 
only possible with LOS (square root) and the duration of EN (log) and time 
to death (log). To determine the relationship between the delay before 
attempting aggressive EN, and tolerance of aggressive EN these variables
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were log transformed. The principle outcome variables (4.2.1) were tested 
against all the possible explanatory variables by univariate multivariable 
regression analysis in order to determine possible associations (Table 4.4) 
and eliminate systematic bias from disease severity, early debridement and 
SDD use. Associations described in the results section should read as 
‘positive’ unless otherwise specified. The number of explanatory variables 
was usually restricted to not more than the V n to avoid creating an over- 
optimistic model. This was not always possible with sub-analysis and the 
problem was noted. Separate analyses were done on survivors for outcome 
variables which would be paradoxically improved by early mortality, giving an 
impression of better outcome which was not real. These variables included 
complications (excluding death), duration of stay (LOS, ITU) and duration of 
feeding (EN and PN). Separate analyses were also done when including 
early debridement and SDD-use as explanatory variables. These treatments 
are intrinsically associated with increased disease severity. Thus, to avoid 
bias, analysis was restricted to the patients in whom these treatments were 
thought to be useful; patients with FTL burns of >10% are thought to benefit 
from early (<72h post-burn) debridement, and those requiring ventilation are 
thought to benefit from SDD.
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Table 4.4 Univariate multivariable regression analysis.
Dependent variable All Survivors
only
Method of 
regression 
analysis
Explanatory variables used in 
each analysis
1. Mortality V - logistic © Delay before admission
2. Major V V median . • Delay before attempting
complications: EN per se
(excluding and © Attempting aggressive EN
including death) within 24 hours
9 Delay before attempting
3. LOS V V linear aggressive EN
4. ‘Drug-IV fluid-PN V V median © EN feeding routes refused
cost’ © Age
5. Treatment cost: © Sex
0 drugs only V V median © BBSA%
9 drug V V median © FTL%
components © Bull score
6 PN V V median « Clark score
6. Duration of EN V V linear • Inhalation score
and PN. © Pre-burn morbidity
7. Complications: © Year of admission: 1989,
© by time V V median 1990, 1991, 1992, 1993,
1994, 1995
© by component V V median Early debridement (FTL
>10% only)
© SDD use (ITU patients only)
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4.3 Results
4.3.1 Population Characteristics
4.3.1.1 Nutritional data available
Between January 1989 and October 1995, 129 burned patients, admitted to 
Frenchay hospital, required IV fluid resuscitation. Data from these patients 
were used to find which variables best determined disease severity. Five of 
this group were moribund and received no treatment. Seven had no 
nutritional data available. These 12 patients were excluded from all 
nutritional analyses. Thus, it was known whether EN was attempted before 
or after 24h in 117 patients (Table 4.5) of which the ‘delay before attempting 
aggressive EN’ was known in 106 patients (Table 4.6). Table 4.6 shows that 
after the change in feeding protocol, introduced in June 1992, the delay 
before attempting aggressive EN was reduced from 45 to 34.5h. Failure to 
reach the goal of 24h occurred because feeding policy was not applied on 
ITU and was not always adhered to on the two burn wards. This blurring of 
the proposed change in protocol reduced the possibility of temporal bias 
which could have arisen due to use of retrospective data. However, as 
anticipated, there was a sub-group of ITU patients with high disease 
severity who were given early but inadequate EN. This justified the use of 
multivariable analysis as a means of assessing the impact of EN on clinical 
outcomes. Lastly, the delay before attempting aggressive EN was strongly 
associated with delay before EN was tolerated (Figure 4.6), the linear 
regression model predicting 87% of variability. Thus, when the delay before
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attempting aggressive EN is associated to an outcome, there is an implicit 
association between the delay before the patient tolerated EN and that 
outcome.
Table 4.5 Attempt to give aggressive EN after burn injury (before and after 
24h) by feeding policy and year of recruitment.
Intended EN Year of Patients given early aggressive enteral
feeding admission feeding
policy
< 24h >24h total
Late start of 1989 1 18 19
EN and slow 1990 1 8 9
build-up. 1991 0 17 17
1992 1 7 8
Total 3 50 53
Early 1992 1 8 9
aggressive 1993 12 12 24
EN on burns 1994 11 6 17
wards. 1995 3 11 14
Total 27 37 64
All patients 30 87 117
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Table 4.6 Delay before attempting aggressive EN by feeding policy and year 
of recruitment.
Intended EN Year of Delay before attempting aggressive EN
feeding admission (hours)
policy
n median
range 
minimum maximum
Late start of 1989 10 41.5 7.5 92.3
EN and slow 1990 8 58.9 30 117
build-up. 1991 16 67.25 24 240
1992 8 182 11 345
Total 42 45 7.5 345
Early 1992 9 46 4.5 217
aggressive 1993 24 23.9 3 155
EN on burns 1994 17 17 5 107.5
wards. 1995 14 45 9.5 139.5
Total 64 34.9 3 217
All patients 106 45.3 3 345
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Figure 4.6 Relationship between the delay before attempting aggressive EN (log h) and 
tolerance of aggressive EN (log h) (n = 100 survivors until EN was tolerated).
Delay before attempting 
aggressive EN (log h).
4,3, L2. PQP.ykti,QQjdiam£teri,^ g,§,^ Y,j[)uiri.liQnal group 
Population characteristics are described by total population (n = 129) (Table 
4.7), patients for whom the delay before attempting aggressive EN is known 
(n= 106) (Table 4.8), and non-moribund patients excluded because the 
delay before attempting aggressive EN was not known (n = 18) (Appendix 
8.4.2). For binomial variables in which the median was 0, the mean was 
used. All other variables are better described by the median, range and 95% 
confidence interval. In the total study population all patients were admitted 
within 24h of burn injury, the majority within 2h. The percentage of the group 
admitted in any year varied between 10% and 19%. Only 3% refused a 
feeding tube whereas 19% had pre-burn morbidity. Patients were aged
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between 0.6 and 90 years with the majority between 23 and 32 years. There 
is a disproportionate number of males due to attempted suicide. Most burns 
were 20 to 26% BBSA with between 6% and 12% as FTL. Most patients had 
not suffered inhalation injury and had low Bull and Clark disease severity 
scores. The majority of patients received EN within 24h but aggressive EN 
was not attempted until almost two days post-burn. Of the total group 23% 
were given early burn debridement and 18% SDD. Mortality was 27% (n = 
35). Death occurred a median of 11.5 days post-burn. The majority of 
patients had one complication. LOS was about one month reflecting the 
healing time of PTL burns. In the 39 patients admitted to ITU their stay was 
short mostly due to the high incidence of mortality. Similarly the median 
duration of EN and PN was only 14 and 11 days, respectively, but ranged 
from one day in those dying quickly to 115 and 68 days, respectively. Lastly 
the median cost of IV fluids, antibiotics and GI and nutritional drugs was 
£942 but ranged from 0£ in those dying on day one to £24976 in a patient 
remaining on ITU for three months.
The 106 patients, for whom the delay before attempting to give aggressive 
EN was known, have similar characteristics to the total population but with 
fewer patients from 1989 and 1990 because of missing data. The non- 
moribund patients excluded due to missing data (n= 18) were similar in 
terms of explanatory variables. Thus the 106 patients used in the main set 
of analyses were representative of non-moribund burned patients admitted 
to Frenchay Hospital and requiring IV fluid resuscitation.
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Table 4.7 Characteristics of the total study population (129).
Variable n* mean SD median Range 95%
confidence
min max interval
1. F a cto rs  a ffec tin g  
d is e a s e  s e v e r ity
© Delay before admission 
(hours)
122 2.5 2.6 1.8 0.2 17 1.5 2.3
© Feeding route refused 
(%)
124 3 0 0 1 0 0
© Year of admission (%) 129
• 1989 16 - 0 0 1 0 0
0 1990 10 - 0 0 1 0 0
- 1991 16 - 0 0 1 0 0
• 1992 14 - 0 0 1 0 0
0 1993 19 - 0 0 1 0 0
0 1994 13 - 0 0 1 0 0
« 1995 11 - 0 0 1 0 0
© Pre-burn morbidity (%) 129 19 - 0 0 1 0 0
© Age (years) 129 30.6 25.1 27 0.6 90 23 32
© Sex (male) (%) 129 69 - 0 0 1 0 0
© BBSA (%) 129 28.3 17.9 23 8 98 20 26
Q FTL (%) 129 16.1 20.2 10 0 98 6 12
O Inhalation score 128 1.27 1.83 0 0 7 0 1
6 Bull score 128 0.23 0.30 0.10 0 1 0 0.2
Clark score 128 0.16 0.29 0.02 0 1 0.01 0.03
2. T r e a tm e n t v a r ia b les
© Delay before attempting 
EN per se (h)
120 18.3 17.4 12.5 0.7 117 10 14
© Attempting aggressive 
EN before 24h (%)
117 26 ~ 0 0 1 0 0
© Delay before attempting 
aggressive EN (h)
106 61.7 62.4 45.3 3 345 36 49.8
© Early debridement (%) 129 23 - 0 0 1 0 0
© SDD use (%) 129 18 - 0 0 1 0 0
3. O u tco m e v a r ia b le s
© Death (%) 129 27 - 0 0 1 0 0
© Time to death (days) 35 14.7 19 11.5 1 100 7.1 13.9
© Complications 
excluding mortality (n°.)
129 1.3 1.7 1 0 11 0 1
© Complications including 
mortality (n°.)
129 1.5 1.9 1 0 11 1 1
© LOS (days) 129 34.7 27.8 28.5 1 148 22.6 38.4
• ITU- LOS (days) 39 13.3 16.4 6 1 82 3.9 14
o Duration of EN (days) 79 21.9 20.1 14 1 115 12.3 21.7
© Duration of PN (days) 21 15.9 16.4 11 1 68 6 18.6
© Drug, IV fluid cost (£) 129 2342 4099 942 0 24976 686 1346
* n is less than 129 where data were missing or not applicable for that variable.
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)Table 4.8 Characteristics of patients for whom the delay before attempting 
aggressive EN was known (n = 106).
Variable n* mean SD median Range 95%
confidence
min max interval
1. Factors affecting 
disease severity
© Delay before admission 
(hours)
106 2.6 2.7 1.8 0.2 17 1.3 2.5
0 Feeding route refused
(%)
106 4 0 0 1 0 0
0 Year of admission (%) 106
• 1989 9 - 0 0 1 0 0
• 1990 8 - 0 0 1 0 0
* 1991 15 - 0 0 1 0 0
® 1992 16 - 0 0 1 0 0
8 1993 22 - 0 0 1 0 0
8 1994 16 - 0 0 1 0 0
• 1995 13 - 0 0 1 0 0
© Pre-burn morbidity (%) 106 21 - 0 0 1 0 0
& Age (years) 106 31.7 23.9 30 0.8 90 25 32.6
© Sex (male) (%) 106 68 - 0 0 1 0 0
© b b s a |% ) 106 26.9 15.4 22.5 8 90 20 26.6
0 FTL (%)"' 106 15 17.2 10 80 90 8 12
0 Inhalation score 106 1.2 1.8 0 0 7 0 1
© Bull score 106 0.26 0.1 0.1 0 1 0.1 0.2
© Clark score 106 0.14 0.26 0.02 0 1 0.02 0.03
2. Treatment
© Delay before attempting 
EN per se (h)
106 16.7 15.9 11 0.7 117 10 13.7
Attempting aggressive 
EN before 24h (%)
106 28 - 0 0 1 0 0
Q Delay before attempting 
aggressive EN (h)
106 61.7 62.4 42.3 3 345 36 49.8
© Early debridement (%) 106 25 - 0 0 1 0 0
© SDD use (%) 106 22 - 0 0 1 0 0
3. Outcome variables
0 Death (%) 106 24 - 0 0 1 0 0
© Time to death (days) 25 18.7 21.0 12 2 100 8.2 15.8
© Complications 
excluding mortality (n°.)
106 1.4 1.8 1 0 11 0 1
© Complications including 
mortality (n°.)
106 1.6 2.0 1 0 11 1 1
© LOS (days) 106 37.3 28.2 30.5 2 148 25 39
• ITU- LOS (days) 33 15.5 16.9 11 1 82 5 16
© Duration of EN (days) 78 22.1 20.1 14.5 1 115 12.8 22
© Duration of PN (days) 21 15.9 16.4 11 1 68 6 18.6
« Drug, IV fluid cost (£) 106 2697 4412 1074 0 24976 825 1566
* n is less than 106 where data were missing or not applicable for that variable.
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4.3.2 R egression analyses 
The results have been tabulated from each regression analysis and 
presented by:
1. Outcome variable tested by the model.
2. Explanatory variables attaining a p value < 0.05 (all variables used in the 
model are listed in the table title).
3. n for the number of patients for which data are complete for the variables 
tested.
4. P value.
5. Regression model p-value (Chi-square or F-test, for logistic or linear 
regression, respectively) is given in the text. The statistics program does 
not return a p-value for a median regression model.
6. Adjusted variability presented as the percentage of the residual predicted 
by the regression model.
The results are shown in Tables 4.9-4.19.
4.3.2.1 Determining the variables of disease severity which best predict outcome 
(Tables 4.9 and 4.10)
These analyses were done in the whole study population (n = 129). The 
number of subjects analysed is lower where data was missing or where 
analysis was restricted to survivors (n = 92). As expected, the Bull and 
Clarke scores contribute little (0.24%) to prediction of mortality when their 
component factors (age, BBSA, FTL, and inhalation score) were present. 
Delay before admission, year of admission, sex and pre-burn morbidity 
were not associated with mortality (Table 4.9). However, the delay before
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admission in this study only varied between 0.2 and 17h therefore time of 
admission may still be important. Death was best predicted from age. BBSA 
was consistently associated with all outcomes, whereas year of admission 
was inconsistent in its associations. Inhalation score was associated with 
complications (including and excluding mortality), LOS and ‘drug-IV fluid-PN 
cost’ (all patients). Age was associated with complications including 
mortality and ‘drug-IV fluid-PN cost’ (survivors). Pre-burn morbidity and FTL 
were associated with LOS. The variability predicted by the regression 
models were highly significant for death and LOS (p < 0.0001). The 
regression models for death predicted 50% of variability, 19% and 21% for 
complications excluding mortality (survivors) and including mortality, 
respectively, 56% for LOS, 16% for ‘drug-IV fluid-PN cost’ in all patients and 
33% in survivors. In medicine, where variability due to unmeasured 
variables is normally very high, a good model might be expected to predict 
>20% of variability.
When year of admission is omitted as an explanatory variable the outcomes 
were only associated with age, BBSA, FTL, inhalation score and pre-burn 
morbidity (Table 4.10). These regression models predicted only 2-3% less 
of the variability compared to those presented in Table 4.10; the exception 
was LOS where the model predicted 46% compared to 56% when ‘year of 
admission’ was included in the analysis. This confirms that year of 
admission does not add greatly to the predictive power of the regression 
models except in the case of LOS. Furthermore use of seven year of 
admission variables caused the total number of explanatory variables to
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exceed Vn which tends to cause model prediction to be over-optimistic.
‘Year of admission’ was therefore dropped from subsequent analyses. In 
subsequent analysis, age, BBSA, FTL, inhalation score and pre-burn 
morbidity were retained because of their proven predictive power, together 
with the delay before admission, sex and refusal of EN route, which were 
thought might prove to be predictive in sub-analysis.
Table 4.9 Univariate multivariable regression of outcome variables death, 
complications (excluding and including mortality), LOS (square 
root), and ‘drug- IV fluid- PN cost’ against explanatory variables, 
delay (h) before admission, year of admission (89, 90, 91, 92, 93, 
94, 95), pre- burn morbidity, age (years), sex, BBSA (%), FTL (%) 
and inhalation score.
Variable
outcome explanatory 
(where p < 0.05,
- = negative association)
n p value Model
Variability
(%) (p = )
Death Age
BBSA
111 0.000 
0.028
50 (< 0.0001)
Complications
excluding
mortality
Year of admission: 89
91
95
BBSA
Inhalation score
92 0.030 
0.000 
0.042 
0.000 
0.000
19
Complications
including
mortality
(survivors)
Year of admission: 91
Age
BBSA
Inhalation score
125 0.000 
0.004 
0.045 
0.000
21 (< 0.0001)
LOS (square root) 
(survivors)
Year of admission: 94(-) 
95 (-)
Pre- b u m  morbidity
BBSA
FTL
Inhalation score
92 0.044 
0.036 
0.001 
0.003 
0.004 
0.005
56
'Drug- IV fluid- 
PN cost' (all)
BBSA
Inhalation score
125 0.001 
0.003
16
'Drug- IV fluid- 
PN cost' 
(survivors only)
Year of admission: 89
Age
BBSA
92 0.062 
0.000 
0.001
33
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Table 4.10 Univariate multivariable regression of outcome variables death, 
complications (excluding and including mortality), LOS (square 
root), and ‘drug- IV fluid- PN cost’ against explanatory variables, 
delay (h) before admission, pre- burn morbidity, age (years), 
sex, BBSA (%), FTL (%) and inhalation score.
Variable
outcome explanatory 
(where p < 0.05)
n p value j Model 
Variability 
(%) (P = )
Death Age 
BBSA 
| FTL
125 0.000 j 
0.049 j 
0.043 |
47 (< 0.0001)
Complications 
excluding 
mortality 
survivors)
j BBSA j 
i Inhalation score
92 0.000 j 
0.000 |
17
Complications
including
mortality
! Pre-burn morbidity 
j Age
; BBSA | 
j Inhalation score
j 125 0.043 j
o.ooo i 
0.001 j 
0.000
| 18 (< 0.0001)
LOS (square root) 
(survivors)
; Pre-bum morbidity 
; Age 
| BBSA 
| FTL
| Inhalation score
92 0.033 
0.009 
0.007 
0.036 
0.000
46
'drug- IV fluid- 
PN cost' (all)
j Pre-bum morbidity 
| BBSA
: Inhalation score
[ 125 0.000 
0.000 
0.000
16
'drug- IV fluid- 
PN cost'
(survivors)
I Age 
I BBSA
I Inhalation score
j 92 0.000 
0.000 
0.001
30
4.3.2.2 Effect of nutritional variables on outcome: Delay before attempting EN per 
se and attempting aggressive EN within 24h post-burn (Table 4.11)
These analyses were done in the 117 patients (88 survivors) for whom the 
data were complete for the variables: ‘delay before attempting EN per se' 
and ‘attempting aggressive EN before or after 24h’. Neither the delay before 
attempting EN per se, nor attempting aggressive EN before 24h, 
significantly explain the main outcomes measured. As a result, the 
explanatory variables reaching significance and the variability predicted by 
the models were very similar between Table 4.11 and Tables 4.9 and 4.10.
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Table 4.11 Univariate multivariable regression of outcome variables death, 
complications (excluding and mortality), LOS (square root), and 
‘drug- IV fluid- PN cost’ against explanatory variables, delay (h) 
before admission, delay before attempting EN per se, 
attempting aggressive EN within 24h, pre-burn morbidity, age 
(years), sex, BBSA (%), FTL (%) and inhalation score.
Variable
outcome explanatory 
(where p < 0.05)
n p value Model 
Variability 
(%) (p = )
Death Age
FTL
117 0.000
0.039
45 (C0.0001)
Complications 
excluding 
mortality 
(survivors)
BBSA
Inhalation score
88 0.000
0.000
21
Complications
including
mortality
Age
BBSA
Inhalation score
117 0.008
0.000
0.000
21
LOS (square root) 
(survivors)
Pre- burn morbidity
Age
BBSA
FTL
Inhalation score
88 0.045
0.006
0.036
0.004
0.000
51 (<0.0001)
'Drug- IV fluid- 
PN cost' (all 
patients)
BBSA
Inhalation score
117 0.000
0.000
23
'Drug- IV fluid- 
PN cost' 
(survivors only)
Age
BBSA
Inhalation score
88 0.009
0.000
0.004
31
4.3.2.3 Delay before attempting aggressive EN 
The effect of the delay before attempting to give aggressive EN, as a 
continuous variable was investigated in 106 patients (81 survivors). Six 
principle outcomes were tested: mortality, complications (excluding and 
including mortality), LOS and ‘drug-IV fluid-PN cost’ (all and survivors only). 
Other tests were exploratory and will require separate study and testing. The 
regression models predicted a significant amount of the variability for death 
and LOS (p < 0.0001) (Table 4.12), which as in earlier analyses, was 
greater than that predicted for complications and ‘drug-IV fluid-PN cost’.
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Variability for ‘death’ was only significantly explained by age, despite the 
attempt to give aggressive EN almost always preceding mortality by more 
than 72h (Figure 4.7). Age, BBSA, FTL or the Inhalation score were 
associated singly or in combination with all the outcomes measured. 
However, the delay before attempting aggressive EN achieved significance 
for complications (excluding mortality in survivors and including mortality in 
all patients), LOS (survivors and all patients- footnote Table 4.12) and ‘drug- 
IV fluid- PN cost’ (all patients). Two results appear to be anomalous. 
Complications including mortality were negatively associated with the delay 
before attempting EN per se but positively associated with the delay before 
attempting aggressive EN. Thus earlier EN, per se, is associated with an 
increase in complications (when including mortality and considering all 
patients), whilst attempting earlier aggressive EN is associated with a 
reduction in complications. The second anomaly is that an attempt to give 
aggressive EN is associated with ‘drug- IV fluid- PN cost’ in all patients but 
not survivors alone. Refusal of feeding route, pre-burn morbidity, and sex 
universally failed to be significantly associated with the outcomes 
measured. Thus, actual delay before attempting aggressive EN, rather than 
an arbitrary 24h delay, is associated with complications, LOS and ‘drug- IV 
fluid- PN cost’ (all patients).
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Table 4.12 Univariate multivariable regression of outcome variables death, 
complications (excluding and including mortality), LOS (square 
root), and 'drug- IV fluid- PN cost’ against explanatory variables, 
delay (h) before admission, delay before attempting EN per se, 
delay before attempting aggressive EN, pre-burn morbidity, age 
(years), sex, BBSA (%), FTL (%) and inhalation score.
Variable
outcome explanatory 
(where p < 0.05,
- = negative association)
n p value Model
Variability
(%) (p = )
Death .M®.................................................. 106 0.000 39 (<0.0001)
Complications
excluding
mortality
Delay before attempting
aggressive EN
BBSA
Inhalation score
81 0.000
0.031
0.001
24
Complications 
including 
mortality 
(survivors)
Delay before attempting EN 
per se (-)
Delay before attempting
aggressive EN
Age
106 0.018 
0.000 
0.010
27 (<0.0001)
LOS (square root) 
(survivors)*
Delay before attempting
aggressive EN
Age
BBSA
FTL
Inhalation score
81 0.011
0.003
0.042
0.006
0.004
52
'Drug- IV fluid- 
PN cost' (all)
Delay before attempting
aggressive EN
BBSA
Inhalation score
106 0.000
0.000
0.000
23
'Drug,IVfluid,PN 
costlsurvivors)'
BBSA 81 0.008 30
*LOS— all, Delay before attempting aggressive EN n= 106, 0.019, model (p < 0.0001), 
R2= 9.
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Figure 4.7 Frequency distribution of the time between attempting 
aggressive EN and death (n = 25).
Percentage of those dying
Time to death (days)
Exploratory analyses were then done on all patients and survivors 
separately for complications or cost, by type, and whether before or after one 
month post-injury. One month was set as the cut-off point since by this 
stage, PTL bums are healed. Measuring outcomes after day 28 would 
therefore specifically measure the effect on FTL burns, which take longer to 
heal, and on late complications such as nosocomial infection. When 
analysing clinical outcomes in all patients, those regression models 
achieving convergence predicted between 6% and 40% of variability (Table 
4.13). The delay before attempting aggressive EN was associated with total 
complications (excluding mortality) and days of organ support before day 28. 
In addition, over the whole patient admission, the delay before attempting 
aggressive EN reached significance for infective complications, specifically 
sepsis, organ support up to day 28, intolerance to gastric feeding (ie. 
aspirates > 400mL per day), and, in stepwise analysis, ITU stay. None of the 
variables tested reached significance for any of the other complications (Gl,
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organ failure, wound infection) tested. Surprisingly, age never achieved 
significance. However, for the outcomes for which the delay before 
attempting aggressive EN achieved significance, one or more of BBSA, FTL 
or inhalation score also achieved significance. Sex (male) was positively 
associated with organ support up to 28 days but negatively associated with 
ITU stay. Thus an earlier attempt to give aggressive EN is associated with 
reduced incidence of complications (excluding mortality), particularly sepsis, 
and a reduced duration of organ support and ITU stay. Similarly an earlier 
attempt to give EN, not necessarily aggressive EN, was associated with 
reduced duration of organ support up to day 28 and shorter ITU stay. When 
the same outcomes were analysed in 81 survivors (Table 4.14) the delay 
before attempting aggressive EN was significantly associated with infective 
complications, over the LOS, and total complications up to day 28. These 
regression models predicted 21% and 25% of variability, respectively. 
Analysis of other outcomes failed to achieve convergence.
The duration of EN was analysed in 57 survivors and was associated with 
the delay before attempting aggressive EN and the FTL (Table 4.15). This 
regression model predicted 37% of the variance. The regression model for 
PN failed to achieve convergence, probably as a result of the fact that there 
were only 9 survivors of PN.
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Table 4.13 Univariate multivariable regression in all patients of 
complications by type and occurrence (before and after day 
28), and ITU days against explanatory variables, delay (h) 
before admission, delay before attempting EN per se, delay 
before attempting aggressive EN, pre- burn morbidity, age 
(years), sex, BBSA (%), FTL (%) and inhalation score.
Variable
outcome I explanatory i 
(where p < 0.05, j 
- = negative association)
n p value : Model
Variability
(%)
Complications I 
excluding death up j 
to day 28 i
Delay before attempting j 
aggressive EN 
Inhalation score
106 0.000 | 
0.000 !
27
Complications j 
excluding death E 
after day 28 ;
all ns i 106 " : 0
Infective E 
complications ;
Delay before attempting i 
aggressive EN ; 
BBSA j 
; FTL(-) | 
: Inhalation score :
106 0.000 j 
0.001 j
0.049 j 
0.048 \
20
Gl i all ns i 106 - : -
Sepsis j Delay before attempting 
| aggressive EN j 
| BBSA
i Inhalation score
; 106 0.000 ;
0.002 | 
0.000 j
6
Organ failure up I 
to day 28
|Delay before attempting EN p e r  se j 
1 (->j Delay before attempting 
! aggressive EN 
j pre- burn morbidity 
| BBSA 
| FTL(-)
1 Inhalation score
106 0.001 j
! 0.032
0.001 
0.001 
| 0.036 
0.000
25
Intolerance to 
gastric emptying 
during week 1 
post- b u m  (%)*
i Delay before attempting 
: aggressive EN 
■ FTL
[ Inhalation score
\ 30 0.004
! 0.012 
\ 0.033
: 40
Organ support up 
to day 28 (days)
[ Delay before admission(-)
: Delay before attempting EN p e r  se 
\ Delay before attempting 
i aggressive EN 
= Sex 
| BBSA
\ Inhalation score
j 106 0.035 
: 0.041 
j 0.037
| 0.000 
| 0.000 
0.000
j 15
Organ support 
after day 28(days)
1 all ns [ 106 j 0
ITU days (all)* : Delay before attempting EN p e r  se 
1 Delay before attempting 
j aggressive EN 
1 Sex(-)
: 31 0.000 
\ 0.000
I 0.011
i 26
*None of the explanatory variables reached significance using median regression 
therefore figures were included from stepwise median regression which attained the 
same value for Variability.
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Table 4.14 Univariate multivariable regression in survivors only of 
complications by type and occurrence up to day 28 and after 
day 28, and ITU days against explanatory variables, delay (h) 
before admission, delay before attempting EN per se, delay 
before attempting aggressive EN, pre- burn morbidity, age 
(years), sex, BBSA (%), FTL (%) and inhalation score.
Variable
outcome explanatory 
(where p < 0.05)
n p value Model
Variability
(%)
Infective
complications
Delay before attempting
aggressive EN
BBSA
81 0.041
0.002
21
Complications 
excluding death up 
to day 28
Delay before attempting 
aggressive EN 
Inhalation score
81 0.000
0.010
25
Complications 
excluding death 
after day 28
all ns 81 0
Organ support up 
to day 28 (days)
all ns 81 - 0
Organ support 
after day 28 
(days)
all ns 81 0
ITU days all ns 81 - 0
Table 4.15 Univariate multivariable linear regression of outcome variables 
log of duration of EN and PN in survivors against explanatory 
variables, delay (h) before admission, delay before attempting 
EN per se, delay before attempting aggressive EN, pre- burn 
morbidity, age (years), sex, BBSA (%), FTL (%) and inhalation 
score.
Variable
outcome explanatory 
(where p < 0.05)
n p value Model 
Variability 
(*> (P - )
Duration of EN 
(log h)
Delay before attempting
aggressive EN
FTL
57 0.028
0.010
37 (0.0002)
Duration of PN 
(log h)
all ns 9 - -
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Components of the £drug-IV fluid-PN cost’ variable were then analysed in all 
patients (Table 4.16). The delay before attempting aggressive EN was 
associated with ‘Drugs’ cost for the whole admission, particularly, antibiotic 
and GI drug cost, and the ‘drug-IV fluid-PN cost’ up to day 28. These 
regression models predicted between 5 and 27% of the outcome variability. 
All other analyses failed to reach convergence. The same analyses, done in 
survivors, only found associations between the delay before attempting 
aggressive EN and GI drug cost and, surprisingly, in view of the non­
significant result in ‘ail patients’, drug cost after 28 days (Table 4.17).
Table 4.16 Univariate multivariable linear regression in all patients of drug cost by 
component (antibiotic, GI, nutritional, total) and occurrence up to and after 
day 28 against explanatory variables, delay (h) before admission, delay 
before attempting EN per se, delay before attempting aggressive EN, 
pre- burn morbidity, age (years), sex, BBSA (%), FTL (%) and inhalation 
score.
Variable 
out c cane explanatory 
(where p < 0.05)
n p value Model
Variability
____________(%) ....
Drugs-total Delay before attempting
aggressive EN
BBSA
Inhalation score
106 0.016
0.000
0.015
22
PN all ns 106 - 0
Antibiotics Delay before attempting
aggressive EN
BBSA
Inhalation score
106 0.024
0.000
0.017
22
GI drugsDelay before attempting 
aggressive EN 
Pre- b u m  morbidity
106 0.000
0.000
8
Nutritional drugs all ns 106 - 5
'Drug-IV fluid-PN 
cost' up to day 28
Delay before attempting 
aggressive EN 
Inhalation score
106 0.000
0.000
27
Drug- IV fluid- PN 
after day 28
all ns 106 — 0
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Table 4.17 Univariate multivariable linear regression in survivors of drug cost by 
component (antibiotic, GI, nutritional, total) and occurrence up to and after 
day 28 against explanatory variables, delay (h) before admission, delay 
before attempting EN per se, delay before attempting aggressive EN, pre­
burn morbidity, age (years), sex, BBSA (%), FTL(%) and inhalation score.
Variable
outcome explanatory 
_(where p < 0.05)
n p value Model
Variability
(ft)
Drug's BBSA 81 0.015 31
PN all ns 81 „ 0
Antibiotics BBSA 81 0.016 31
GI drugs Delay before attempting
aggressive EN
Pre- b u m  morbidity
Age
BBSA
81 0.000
0.001
0.036
0.002
12
Nutritional drugs Pre- b u m  morbidity 81 - 0
Drug cost up to 
day 28
Age
BBSA
81 0.031
0.000
32
Drug cost after 
day 28
Delay before attempting 
aggressive EN 
Pre- b u m  morbidity 
Inhalation score
81 0.038
0.000
0.000
<1
Separate analyses were then done to examine the effect of early 
debridement in patients with a greater than 10% BSA FTL burn and SDD 
use in 39 patients requiring mechanical ventilation from day one post-burn 
(Table 4.18). Early debridement was not associated with any of the 
outcomes tested. However, SDD use and the delay before attempting 
aggressive EN were significantly associated with infective complications, 
especially sepsis, and ITU stay. In addition, the delay before attempting 
aggressive EN was associated with complications up to day 28 (survivors) 
and sepsis (survivors), LOS (survivors) and ‘drug- IVfluid- PN cost’ (ail) over 
the whole admission. The delay before attempting EN perse  was negatively 
associated with sepsis. None of the variables tested was associated with 
death or complications including mortality. The regression models 
predicted between 12% and 68% of the outcomes’ variability but this did not 
reach significance in the case of death or LOS. For this reason, and the 
small group size, the results should be viewed with caution.
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Table 4.18 Univariate multivariable linear regression of outcome variables 
death, complications (excluding and including mortality), LOS, 
‘drug- IV fluid- PN cost’, complications by type and occurrence up 
to day 28 and after day 28, and ITU stay against explanatory 
variables delay (h) before admission, delay before attempting EN 
perse, delay before attempting aggressive EN, pre-burn morbidity, 
age (years), sex, BBSA (%), FTL (%) and inhalation score.
Variable
outcome explanatory 
(where p < 0.05,
- = negative association)
n p value Model 
Variability 
<%) (P “ )
Death all ns 39 31 (0.097)
Complications
excluding
mortality
(survivors)
Delay before attempting 
aggressive EN
24 0.039 28
Complications
including
mortality
all ns 39 28
LOS (survivors) Delay before attempting 
aggressive EN
24 0.017 28 (0.135)
'Drug- IV fluid- 
PN cost'
Delay before attempting 
aggressive EN 
..£2®..........................
39 0.005 
0.011
23
Complications up 
to day 28 
(survivors only)
Delay before attempting 
aggressive EN 
Age 
Sex( -)
24 0.032
0.001
0.005
49
Infective 
complications 
(survivors only)
Delay before attempting
aggressive EN
Age
Sex(-)
FTL (-)
Inhalation score (- )
SDD use(-)
24 0.026
0.003
0.020
0.038
0.032
0.040
68
Sepsis up to day 
28 (survivors 
only)
Delay before attempting EN 
p e r  se
Delay before attempting
aggressive EN
Pre- b u m  morbidity
Age
Sex
BBSA
SDD use(-)
24 0.018
0.000
0.006
0.023
0.000
0.065
0.000
12
ITU days 
(survivors only)
Delay before attempting
aggressive EN
Age
SDD use(- )
24 0.001
0.023
0.061*
30
* p = 0.004 in stepwise analysis.
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To enable a direct comparison of patient characteristics and outcomes the 
population was divided into two groups: those in whom aggressive EN was 
attempted at < 45h, versus > 45h, post-burn (Table 4.19). As with the 
regression analyses, attempting to give aggressive EN earlier is associated 
with a reduction in complications (including and excluding mortality) and the 
duration of EN. Mortality, LOS and ‘drug- IVfluid- PN cost’ were also reduced 
in those in whom feeding was attempted earlier, but these did not reach 
significance. However, the group in whom aggressive EN was attempted at 
>45h had a higher inhalation score. This may be associated with a worse 
outcome and justifies the use of multivariable analysis.
Table 4.19 Comparison of patient characteristics and outcomes by the delay 
before attempting aggressive EN (< 45h versus > 45h).
Delay before attemf
< 45h 
n mean SD
iting aggressive EN
> 45h 
n mean SD
P
value
All p a tien ts  (n = 106)
Age (years) 53 28.8 21.6 53 34.7 25.9 ns
Sex (male) 53 0.75 0.43 53 0.60 0.49 ns
BBSA (%) 53 25.8 14.5 53 28.0 16.3 ns
FTL (%) 53 16.2 18.4 53 13.7 16.1 ns
Inhalation score 53 0.77 1.27 53 1.66 2.14 0.046
Death 53 0.19 0.39 53 0.28 0.45 ns
Complications (including mortality) (n°.) 53 1.11 1.5 53 2.17 2.33 0.011
‘drug- IV fluid- PN cost' (£) 53 2062 3915 53 3333 4812 ns
Delay before attempting aggressive EN (h) 53 23.0 13.4 53 100 68.1 0.000
S u rv iv o rs  (n = 81)
Duration of EN (days) 31 18.6 16.1 26 31.7 16.1 0.037
LOS (days) 43 36.8 21.3 38 50.0 21.3 ns
Complications (excluding mortality) (n°.) 43 0.70 1.14 38 1.5 1.15 0.048
‘drug- IV fluid- PN cost’ (£) 43 1369 1249 38 2347 1250 ns
Delay before attempting aggressive EN (h) 43 21.9 13.0 38 100 13.0 0.000
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The aim of this study was to determine the effect of early aggressive EN on 
mortality, major complications, LOS and treatment cost. The objectives were 
to determine:
1. Those variables which best explain disease severity. These could then 
be used in multivariable analysis to determine:
2. The effect of the delay before attempting EN per se (ie. including non- 
aggressive EN);
3. The effect of attempting aggressive EN before versus after 24h; and
4. The effect of the delay before attempting aggressive EN.
4.4.1 Determining the explanatory variables which best control for  
disease severity and treatment.
Age, BBSA, FTL, inhalation score, and pre-burn morbidity are important 
intrinsic determinants of disease severity. In most of the regression models 
these variables had highly significant associations with the outcomes 
measured although only BBSA was associated with all the outcomes: 
death, complications (excluding and including mortality), LOS, and ‘drug- IV 
fluid- PN cost’ (all patients and survivors only). It was considered 
reasonable to use age, BBSA, FTL and inhalation score to control for 
disease severity when examining the effect of nutritional variables on these 
and other outcomes and sub-groups of patients. Delayed admission did not 
affect outcomes but it might be expected to be more important, in future 
studies, where delay was longer than 17h, the longest delay in the present
4.4 Discussion
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study. Conversely the year of admission was not consistent in its effect on 
the outcomes measured. Furthermore, its use in multivariable analysis of a 
group of this size would give over-optimistic model predictions. In addition, 
results from analyses which included year of admission as an explanatory 
variable could not be compared with those generated at other centres. This 
variable was therefore omitted from analysis. Sex and, in sub-analysis, early 
debridement and SDD use, were included as explanatory variables to 
determine their usefulness.
4.4.2 Effect of the delay before attem pting EN per se  o r ag g ress iv e  
EN before 24h
The delay before attempting EN per se and attempting to give aggressive 
EN before 24h, versus after 24h, were not associated with the six main 
outcomes tested and therefore do not appear to significantly affect these 
outcomes.
4.4.3 Effect of the delay before a ttem pting aggressive EN
When the effect of the delay before attempting aggressive EN was analysed 
as a continuous variable it attains significant associations with:
• Complications (excluding and including mortality),
• LOS, and
• ‘Drug- IV fluid- PN cost’ (all patients).
When complications are analysed, in all patients, by component or time 
after injury the delay before attempting aggressive EN is associated with:
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• Complications excluding death up to day 28
• Infective complications
• Sepsis
• Days of organ failure up to day 28
• Intolerance to gastric feeding
• Organ support up to day 28 and
• ITU stay
The same analyses done in survivors (81) showed that the delay before 
attempting aggressive EN was associated with:
• Infective complications and
• Complications excluding death up to day 28.
Again in 57 survivors the delay before attempting aggressive EN is 
associated with the:
• Duration of EN (tube feeding)
When analysing treatment cost, in all patients, by component or time after 
injury, the delay before attempting aggressive EN was associated with:
• Drugs (all) (whole admission)
• Antibiotics
• Gl drugs and
• ‘Drug-IV fluid-PN cost’ up to day 28.
The same analyses done in survivors, showed that the delay before 
attempting aggressive EN was associated with:
• Gl drugs and
® Drug cost after day 28.
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Finally in 39 patients requiring mechanical ventilation from day one of injury 
and therefore suitable for SDD treatment, the delay before attempting 
aggressive EN was associated with:
0 Complications excluding mortality (survivors, n = 24)
• Infective complications (survivors)
• LOS (survivors)
• ‘Drug-IV fluid-PN cost’ and
• ITU stay (survivors).
When the population was analysed by patients in whom aggressive EN was 
attempted earlier or later than the median of 45.3h, those patients fed earlier 
had fewer complications (including or excluding mortality) and shorter 
duration of EN. However, patients fed later than 45.3h had a higher 
inhalation score confirming the need for regression analysis to remove 
bias.
4.4.4 Effect of early EN on clinical outcome and cost benefit 
These results show that early EN per se has little effect on outcome. This 
might be expected as nutrition is likely to have some dose-response 
relationship. This may be related to substrate demand for energy production 
or acute phase protein synthesis. Similarly, comparing the effect of 
attempting aggressive EN before 24h with that attempted after 24h is not 
likely to detect the relationship between nutrition and outcome. Again this 
relationship is likely to be continuous. This contrasts with the consistent
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reduction in major complications, primarily sepsis, and ‘drug-IV fluid-PN 
cost’ (especially antibiotic cost) implicitly associated with an earlier attempt 
to give aggressive EN. However, this study was not a prospective 
randomised controlled trial. Temporal bias was therefore possible since the 
delay before attempting EN per se (aggressive or not) was longer in patients 
admitted earlier in the study and data collected retrospectively was more 
likely to be incomplete. However, the year of admission was not consistently 
associated with a worse outcome, tending to exclude temporal bias (see 
Tables 4.9 and 4.10). Furthermore, omissions from the retrospective data 
would tend to cause an apparently lower complication rate, in patients 
admitted earlier in the study, to be associated with a longer delay before 
attempting EN per se. Temporal bias was therefore likely to weaken, not 
strengthen, associations between the delay before attempting aggressive 
EN and outcomes. Another problem is that organ failure was negatively 
associated with the delay before attempting EN per se but positively 
associated with the delay before attempting aggressive EN. This should not 
have occurred if early EN per se encouraged a trend to improved outcome. 
However, this analysis included patients who died, which allows early death 
apparently to reduce days of organ failure; there was no association with 
organ failure in survivors. Furthermore, a large ITU sub-population received 
early but inadequate EN through a wide-bore (14-18 FG) NG tube. Presence 
of wide-bore NG tubes is associated with increased incidence of ‘silent’ 
regurgitation (Mittal et al, 1992) which may increase the incidence of 
pneumonia, sepsis and lung dysfunction. This may be more than offset if 
the NG tube is used successfully to attempt to deliver more than 50% of
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estimated energy and nitrogen requirements. Finally the study was not 
‘blinded’, permitting the possibility of observer bias when interpreting 
outcomes. This was minimised by use of strict criteria for determining the 
occurrence of complications. Nevertheless, the study findings should be re­
tested in randomised controlled trials limited to one hypothesis per trial and 
where outcomes are measured by ‘blinded’ observers.
Notwithstanding the above, the delay before attempting aggressive EN is 
remarkably consistent in its significant association with an increased 
number of complications, LOS and ‘drug-IV fluid-PN cost’. As a ‘treatment 
variable’ it is associated more significantly with more outcomes than either 
early debridement or SDD use. By implication, an earlier attempt to give 
aggressive EN would reduce major complications, especially infective 
complications, LOS, ITU stay and drug cost. The majority of the regression 
models predicted between 20-50% of variability, meaning that variables not 
tested partly explain the outcomes. However, most of the models presented 
predicted >20% of outcome variability; a clinically important proportion. In 
addition, the levels of significance obtained in all of the main analyses 
would have a high power because univariate multivariable regression 
controlled for the principle explanatory variables and the study size was 
relatively large.
These data indicate that early EN improves clinical outcome if the attempt 
meets at least 50% of estimated energy and nitrogen requirements. This is 
implicitly supported by early feeding studies in burned animals where
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aggressive early feeding at24h versus 72h improved outcome, but a higher 
nutrient input at 72h partially compensated for the delay (Mochizuchi et al, 
1984). ITU patients were almost all given early but inadequate EN. These 
patients generally had higher disease severity but this was controlled for, 
reducing the risk of bias. Furthermore, the delay before attempting 
aggressive EN is still significantly associated with complications (especially 
infection), LOS, ‘drug-IV fluid-PN cost’ and ITU stay when analysis was 
restricted to the 39 ITU patients. Nevertheless it is still possible that 
unmeasured variables were operating. One such variable may have been a 
reluctance to attempt aggressive EN in a severely burned patient because of 
previous or anticipated intolerance to EN. This potential variability cannot be 
excluded, but its effect was minimised by the definition of the delay before 
attempting aggressive EN being an attempt of only 1h (see 4.2.3). Also, 
such intolerance to EN would be expected to be associated with higher 
disease severity (associated with higher morphine use) while the analyses 
showed the effect of the delay before attempting aggressive EN to be 
independent of such factors.
Absence of EN even in the presence of adequate PN is associated with an 
adverse neutrophil response (Meyer et al, 1988) and exaggerated cytokine 
response (Lowry, 1990). Also, in animal studies, survival is improved by EN 
over PN, independent of initial nutritional status (Kudsk et al, 1983, 1981). 
However, in human studies of multiple trauma, although early EN, 
compared with TPN, was associated with significantly lower incidence of 
infective complications (Kudsk etal, 1992; Moore et al, 1992), mortality was
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unaffected. This confirms the present data, suggesting that early aggressive 
EN can reduce a patient’s susceptibility to non-fatal complications without 
significantly reducing fatal complications. Bacterial translocation may be a 
cause of mortality and of non-fatal complications. It has been suggested 
that bacterial translocation occurs early post-burn (Alexander et al, 1990; 
Gianotti et al, 1994), is responsible for early mortality and can be prevented 
by early EN (Braga et al, 1994). However, a reduction in mortality has only 
been shown in animals where EN was given immediately post-burn (Braga 
et al, 1994) compared to a median of 45.3h in the present study. The 
difference between the median delay before attempting aggressive EN in 
survivors and non-survivors is small (43.5 versus 53 hours) but may be 
associated with a small reduction in mortality. A larger reduction may 
require earlier EN or additional treatments aimed at controlling early 
inflammatory response (eg. cytokine release). Reducing the severity of 
infective complications may in turn reduce late mortality.
Since aggressive EN was attempted before 24h in less than a third of 
patients, the feasibility of reducing the delay might be questioned. However, 
aggressive EN has been successfully initiated within 6h post-burn 
(McDonald et al, 1991). Intestinal absorption was normal after early EN 
(Sologub etal, 1992) and NG feeding was tolerated (McDonald et al, 1991) 
in all but the most severely burned patients. Thus, GI dysfunction or 
intolerance does not usually preclude early aggressive EN. Where 
gastroparesis occurs, jejunal feeding could be used. However, for
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aggressive EN to be started early enough to have a clinical effect it must be 
made an integral part of the admission and fluid resuscitation protocol.
Use of enteral novel substrates, post-burn, has been associated with a 
tendency to improve outcome (Braga et al, 1994). Glutamine 
supplementation (4 to 12 g per day) was used in only two patients in the 
present study. These patients had a delay before attempting aggressive EN 
of 77 and 144h, respectively. Since the median delay was 45.3h the 
glutamine supplement will not have artificially strengthened the association 
between the delay before attempting aggressive EN and outcomes. EN was 
otherwise provided as a standard feed type (ie. no novel substrates) based 
on estimated requirements and not on the time of initiating EN. Thus feed 
type perse  would not have influenced outcome in the present study.
The principle effects of attempting early aggressive EN are a reduction in 
major complications. This may account for the reduction in LOS, ITU stay 
and ‘drug-IV fluid-PN cost’ as a result of a more rapid recovery and a 
reduced need for medical intervention. Infection, especially sepsis, is the 
main component of the overall reduction in complications, paralleled by a 
reduction in antibiotic cost. This confirms previous studies which showed a 
tendency to fewer infections and days of systemic antibiotics in patients 
receiving early feeding (Jenkins etal, 1988; Jenkins etal, 1989). A reduction 
in the duration of burn care has previously been shown by Garrel et al 
(1991). In this small (n = 25) retrospective study, patients fed within 1, 
versus 7, days postburn received more energy and nitrogen in the first 2 and
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3 weeks post-burn, respectively. This was associated with a reduction in the 
length of burn care from 76 to 39 days. However, only the BSA grafted was 
independently related to length of care. Furthermore, length of care relating 
only to the burn, rather than total LOS, could be more open to observer bias. 
The present, much larger, study shows that the delay before attempting 
aggressive EN is independently associated with ITU and (total) LOS.
The reduction in GI drug cost associated with earlier aggressive EN may be 
explained by maintenance of GI function obviating the need for GI drugs. Nil 
or insufficient early EN may encourage GI dysfunction through gastroparesis 
or diarrhoea in the acute stage and constipation later. These problems (and 
an increased complication rate) may retard recovery. This is implied from 
the fact that the delay before attempting aggressive EN is associated with a 
longer duration of EN.
In conclusion, early EN which provide at least 50% of a patient’s estimated 
hourly requirement of energy and nitrogen is implicitly associated with a 
reduction in major complications, length of ITU and hospital stay and 
treatment cost. This is independent of disease severity and appears to have 
a greater overall benefit than early debridement and SDD use. Prospective 
randomised controlled trials are required to confirm the effect of early 
aggressive feeding on individual outcomes, though this may be difficult in 
the UK because of the relatively small burn population. If such trials do not 
occur, it is recommended that aggressive EN should be, routinely, initiated 
within 24h of injury in patients requiring IV fluid resuscitation.
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5The Effect of Perioperative 
Starvation and Early Enteral 
Feeding in Patients undergoing 
Major Lower GI Surgery
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Results from the Preliminary Investigation and Burn studies imply that 
earlier and aggressive EN would be associated with a reduction in 
complications, LOS and treatment cost. However, to strengthen the 
evidence for this hypothesis it was planned to conduct a prospective 
randomised controlled trial (PRCT) in patients undergoing major Gl surgery 
to test whether earlier aggressive EN is feasible and effective as an 
intervention.
Patients undergoing major surgery often suffer long periods of starvation 
(see 1.2) resulting in increased morbidity and mortality (1.3.2). Perioperative 
PN has been used with mixed success (1.4.2.1); it improves overall 
outcome in a small sub-population of severely malnourished patients, but 
causes a net increase in infective complications in moderately 
malnourished or well nourished patients (Veterans Affairs, 1991). Small 
bowel ileus occurs with intraperitoneal sepsis or distal bowel obstruction, 
both of which are a contraindication to EN. However, postoperative and post­
injury Gl dysfunction and ileus are largely confined to the stomach and 
colon, with preservation of normal small bowel motility and absorption 
(Page, 1987). Thus perioperative EN is feasible and presents a lower risk of 
infection. Jejunostomy feeding has been used with success in many units 
(Page 1987) but not without complications (Yeung et al, 1979; Delany and 
Lindane, 1988). NJ feeding has been associated with reduced 
postoperative weight loss, positive nitrogen balance, and reduced LOS 
(Sagar et al, 1979) but without occurrence of major complications. However,
5.1 Introduction
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most NJ feeding regimes usually start on the first or second postoperative 
day with a dilute feed and build up to a full- strength feed, at adequate 
feeding rates, by the fourth or fifth day (Hoover et al, 1980). Thus at least a 
week of EN is normally required to achieve a quantitatively important impact 
on nutritional status. Nevertheless early and adequate EN, compared to PN, 
would be more likely to successfully affect outcome (Kudsk et al, 1992; 
Moore et al, 1992).
To achieve a measurable clinical improvement as a result of early 
postoperative EN the patient population should have the following criteria:
A baseline incidence of major complications high enough fora 
reduction to be measurable;
• Major complications which are potentially treatable by nutritional 
support; and
A relatively homogenous clinical condition to avoid undue bias resulting 
from non-nutritional variables.
The potential groups of patients include those requiring:
• Vascular surgery
• Resection for upper or lower GI malignancy
• Cholecystectomy
• Resection for pancreatobiliary malignancy
• Resection for non-malignant bowel disease including inflammatory 
bowel disease (IBD) and
• Surgery following abdominal trauma.
With the exception of cholecystectomy, there is a relatively high incidence of 
complications with all these surgical procedures (Table 5.1, see also
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Appendix 8.5.1). However, non-malignant bowel disease and trauma are 
relatively heterogenous in terms of disease severity and, in addition, may 
involve the small intestine, precluding use of early EN. The majority of 
complications in patients undergoing vascular surgery are related to 
technique or co-morbidity; nutritional support is unlikely to affect their 
incidence (Buzby et al, 1988). Finally, patients undergoing gastro- 
oesophageal and pancreatobiliary surgery, by the general surgeons, are too 
few to achieve adequate numbers (Appendix 8.5.1). Furthermore, the higher 
incidence of complications and malnutrition in patients requiring resection 
of upper compared to lower GI malignancy at Frenchay hospital, precludes a 
combined study. It was therefore decided to study the effect of early EN in 
patients undergoing colorectal resection for malignancy. This is a large 
group of patients at Frenchay hospital which is clinically homogenous and 
in whom early EN may be feasible, and with a relatively high complication 
rate which is potentially reducible.
Table 5.1 Complication rates among patients undergoing major GI surgery 
(Buzby et al, 1988).
Surgical condition Fatal and non- fatal complications
(%)
Laparotomy for malignancy 30.9
Laparotomy for non- malignancy 35.9
Thorocotomy for malignancy 37.5
Vascular reconstruction 28.8
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5.2 Methods
5 .2 .1  Aims and Objectives 
The aim of this study was to determine whether early aggressive EN, in 
patients undergoing colorectal resection for malignancy would reduce major 
postoperative complications, LOS and ‘drug-IV fluid-PN cost’. Study 
objectives included:
1. Conducting an observational study to:
* Quantify the delay between surgery and initiation of oral intake or 
nutritional support, the period in which early aggressive EN may 
affect clinical outcome; and
• Test the feasibility of the data collection protocol.
2. Conducting a PRCT of early aggressive EN versus standard treatment to 
determine the effect on:
• Mortality
• Major complications (excluding and including death)
• LOS
• ‘Drug-IV fluid-PN cost’ (all and survivors only) and
• Functional recovery.
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5 . 2 . 2  Selection criteria
Table 5.2 Criteria for study eligibility.
1. > 16 years of age.
2. Life expectancy > 90 d if patient the survives surgery.
3. Major resective surgery of the colon and rectum anticipated on a non­
emergency basis for malignancy done by two general surgical teams.
4. No previous major abdominal surgery in the 30 days before 
recruitment takes place.
5. Ability to co- operate in the study.
6. No severe organ dysfunction.
7. Informed consent.
5 .2 .3  Study design
5.2.3.1 Observational study 
Consecutive patients admitted for planned colorectal surgery for malignancy 
were consented for an observational study to allow collection of data listed 
in the ‘detailed observations’ of Figure 5.1. ASA score (2.2.1.2) and the PINI 
were used to assess disease severity. Specifically, the PINI was to be used 
to determine the importance of pre-admission malnutrition and 
inflammation on outcome and rehabilitation. The ‘Clinical assessment’ and 
‘Surgeon’s assessment’ were used to assess the risk of postoperative 
complications (2.2.2.2). Nutritional intake was monitored during the hospital 
stay. Data on major complications (2.2.4.1), mortality, LOS, and drug cost for
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drugs not normally taken, were collected up to 90 days post-surgery. Lastly, 
assessments were made of the patients’ functional status. Distress and 
fatigue were scored (2.2A2) during admission and the Visick mobility index 
was scored at admission and one month post-surgery to determine the 
state of physical recovery.
5.2.3.2 Prospective randomised controlled trial 
Figure 5.1 shows the protocol of the interventional study. It was decided to 
randomise patients prior to consent to minimise loss of patients who did 
not want the less effective 'treatment' (ie. control group) (see Appendix 
8.2.1.1 for rationale). Patients were first stratified by pre-admission weight 
loss (< 10% or > 10% of body weight) to minimise any effect of pre­
admission malnutrition which might not be corrected by randomisation. 
Patients were then randomised separately by weight loss group in a 
treatment: control ratio of 1:1. Patient consent was then sought for 
participation in the respective protocol. Patients who withdrew from the 
groups to which they had been randomised were to have remained in their 
respective randomised groups for the purpose of monitoring and analysis of 
outcome. Data collection was identical to that in the observational study.
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Consecutive planned admissions
Figure 5.1 Protocol for the intervention trial.
♦
STRATIFY FOR WEIGHT LOSS
I
RANDOMISE
CONSENT
current practice postoperative enteral feeding
1. Type of operation
2. Clinical assessment2
3. ‘Surgeon’s 
assessment’4
4. ASA score4
5. Major complications1 
(see Table 2.2)
• GI
• Infective
• Organ failure
• Wound
6. Mortality
7. LOS
8. Drug cost (> normal 
usage)
1.intake - IV )daily
- enteral
- oral-
2. PIN!2 (2.2.2.4)
3. Weight3
(see 2.2.4.2)
1. Fatigue score3
2. Distress score3
3. Visick scale5
1. Recorded during course of hospital stay but scored by predetermined
2. On admission.
3. On admission and then day 10 postoperation.
4. Perioperatively.
5. On admission and at one month.
definitions.
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Tube feeding was used in preference to sip feeding to attain a higher 
nutritional intake. Nutritional requirements were calculated as in 2.2.6 and a 
high nitrogen feed was used to optimise nitrogen balance whilst minimising 
gut fluid load. A few hours before surgery an 8FG 109cm Silk® (Merck)
feeding tube was fluoroscopically placed just beyond the duodeno-jejunal 
(DJ) flexure, by a radiologist. EN was started as soon as the patient returned 
to the ward post-surgery and rapidly increased up to a maximum of 1500 
Kcal; oral supplementation was started once oral intake was allowed 
(Appendix 8.5.2). Control patients received standard postoperative IV 
hydration and 5 days nil by mouth. A placebo was not used because: a) 
placement and presence of a NJ tube, per se, potentially increases 
aspiration risk; and b) infusion of fluid and/or electrolytes into the jejunum 
may affect G! function, for example by improving the mucosal barrier to 
bacteria or, conversely, increasing the risk of anastomotic leakage (ie. it 
would not represent the usual state of ‘nil-per-gut’).
5.2.4 Study size for Intervention Trial 
Examination of the Frenchay hospital audit showed planned major lower Gl 
surgery by the general surgeons to be associated with a 31% incidence of 
major complications. PN has been shown to reduce the incidence of major 
complications associated with Gl surgery by 10 to 50% (Muller et al, 1982; 
Mullen etal, 1980; Williams et al, 1976; Blackburn, 1979). It was assumed 
that early EN would be more effective than PN and would be associated with 
a net reduction of major complications from 31 to 14%. For two-way analysis
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at a significance level of 0.05, with a power of 80%, the total study size 
required was calculated be 190. Since there were 63 patients requiring 
major lower GI surgery in 1992 it was projected that the study would take 
three years to achieve sufficient patient numbers to test the null hypothesis.
5.2.5 Statistical analysis 
Analysis of the observational study was limited to describing the data. It was 
intended to test the difference between groups using Chi square and t test 
for mortality and continuous variables, respectively. Groups were to have 
been retrospectively stratified for disease severity to determine its effect on 
outcome. Because the anticipated intervention study could not be completed 
(see below) analysis was restricted to description of the data; for these 
purposes patients from the observational study and control group of the 
interventional study were analysed together and compared with patients 
consenting to treatment.
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Eight patients were recruited into the observational study. Sixteen patients 
were recruited into the intervention study, and were randomised to receive 
early NJ feeding or standard practice (control). Of those randomised to the 
early EN (intervention) group (n = 8):
• 4 refused consent;
• 3 consented and received EN from as early as 6 hours post-surgery until 
day 5; and
• 1 was withdrawn because he unexpectedly had small intestinal surgery 
a contraindication to early EN.
Of the 7 patients randomised to the control group, all consented and 
completed the study protocol. The low consent rate among the intervention 
group was due to patient fear of nasal intubation. The cross-group 
contamination meant the study had to be stopped and precluded statistical 
comparison of randomised groups. The data for the observational study 
patients and controls are presented as a single group (‘non-intervention’) 
and compared with the three patients receiving NJ feeding (Table 5.3).
On admission the fatigue score and PINI tended to be higher in non­
intervention patients. This group also had a tendency to increased LOS, 
weight loss at day 30 (but not 10), and a slower recovery as measured by 
the Visick mobility index. Treatment patients had a higher distress score 
during the period of NJ feeding. The other variables measured were very
5.3 Results
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similar. ‘Surgeons’ assessment’ data were incomplete. Lastly, the energy 
and nitrogen intake shows the expected trends (Figures 5.2 and 5.3). Non­
intervention patients received a small percentage of their energy 
requirement from IV fluid but no nitrogen during the first five days post­
surgery, after which both energy and nitrogen intake increased with oral 
intake. A similar pattern is followed in intervention patients except that their 
energy and nitrogen requirements were met by EN during the first five days 
post-surgery.
Table 5.3 Summary of data on patients in the observational and intervention 
studies.
Parameters measured Non-intervention 
(n = 15)
median min max
Treatment 
(n = 3)
median min max
Baseline parameters
Age (years) 65 49 89 67 53 70
Weight change pre-admission (%) 0 -15 4 -2 -5 0
Clinical assessment 0.5 0 6 1 0 1
Fatigue score on admission 2.5 0 8 0 0 2
ASA 1 1 3 1 0 2
PINI 0.69 0.12 13.50 0.12 0.07 0.13
Outcomes
Complications including re-admission 0 0 4 0 0 0
Mortality 0 0 1 0 0 0
Pyrexia (days) 1 0 8 0 0 2
BNO (days) 6 0 10 6 5 7
LOS post-surgery (days) 10 7 18 8 8 10
Weight change day 10 (%) -4 -6 0 -4 -5 -1
Weight change day 30 (%) -6 -10 -1 -1 -2 1
Visick score day 30 0.5 0 2 0 0 1
Fatigue score change day 10 1.25 -1 7 2 0 3
Distress score: 
day 2 2 0 6 5 5 6
day 4 2 0 6 5 5 6
day 6 1 0 5 2 0 6
day before discharge 1 0 3 0 0 0
day 30 0 0 1 0 0 0
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Figure 5.2 Energy intake (Kcal) from day 1 to 10 post-surgery.
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Figure 5.3 Nitrogen intake (g) day 1 to 10 post-surgery.
Nitrogen intake
(g)
Days
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5.4 Discussion and Future Plans
Data from non-intervention patients confirm that, with current routine 
practice, patients undergoing colorectal resection for malignancy receive no 
nitrogen for five days post-surgery and by day 10 energy and nitrogen 
intakes meet only about 50% of their estimated requirements. The protocol 
for data collection was feasible with the exception of the ‘Surgeons 
assessment’. The surgeons failed to record this information due to 
pressure of routine work. The ‘Surgeons assessment’ was therefore 
dropped from the study protocol. Unfortunately, poor recruitment prevented a 
test of whether early aggressive EN was associated with a reduction in 
major postoperative complications, LOS and ‘drug-IV fluid-PN cost’. 
However, important lessons were learned from this failed study. These are 
discussed in the context of planning for the subsequent Head Injury study.
In this study, consent refusal due to fear of nasal intubation caused a large 
reduction in the group size and contamination of the intervention group with 
patients refusing intervention. Peroperative NJ tube placement has been 
used obviate this problem (Jensen et al, 1995) but is not practised at 
Frenchay hospital. Continued use of preoperative tube placement, which 
incurred a refusal rate of about 50%, would have meant that to achieve the 
required study population would take six years. This impractical, not least 
because of inadequate funding resources. It was therefore decided that the 
subsequent study would be in head-injured patients. Standard treatment for 
head-injured patients includes inadequate NG feeding immediately post-
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injury. This permitted comparison with an intervention group given early 
aggressive EN, and, since invasive nutritional support was mandatory, 
intervention was less objectionable. Furthermore, since the rate of consent 
refusal was unknown, consent was sought prior to randomisation to avoid 
contamination of the intervention group.
In addition, the lack of a standard disease severity score hampers studies 
of patients with GI disease. There are no widely accepted disease severity 
scores used for patients undergoing planned G! surgery. This made it 
difficult to ensure that groups were matched for disease severity. 
Conversely, the GCS specifically scores disease severity of head-injured 
patients. However, the PINI was retained as a measure of malnutrition and 
inflammatory response. Mortality, major complications and LOS were 
considered useful outcomes. In patients undergoing GI surgery, reduced 
LOS, as a result of early EN, was unlikely because surgeons needed to 
ensure that the anastomosis was patent before discharging the patient 
(Schroeder et al, 1991). However, LOS in head-injured patients usually 
exceeds 20 days. This period allows sufficient time to assess recovery from 
injury and attain early discharge as a result of nutritional intervention. 
Analysis of ‘drug-IV fluid-PN cost’ for the admission was not done in the 
present study because drugs used prior to admission formed a large 
proportion of overall drug use. These were unlikely to be affected by early EN 
and could not be easily differentiated from drugs used specifically because 
of the surgery. It was therefore decided that in the Head Injury study ‘drug-IV 
fluid-PN cost’ would be limited to the following drug classes: antibiotics, GI,
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nutrition, opiates, and neuroactive. The distress score, used in the GI study, 
gave little useful information about the patients clinical condition and the 
Visick mobility index was a non-specific measure of recovery. In place of 
these, the Glasgow Outcome Scale (GOS), a specific measure of 
neurological recovery, was used to measure the outcome in the subsequent 
Head Injury study.
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6The Effect of Early Enteral Feeding 
in Patients suffering Severe Head 
Injury and Requiring Mechanical
Ventilation
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6.1 Introduction
6,1.1 Incidence and  cause 
Head injury results in 300 per 100,000 of the population per year being 
admitted to hospital and accounts for about 10% of admissions to accident 
and emergency departments (Lindsay et al, 1991). About 0.5% of head 
injuries are serious (the patient either cannot obey a single command or 
has a GCS of <8); this approximates to 8000 serious head injuries per year. 
Nine per 100,000 die from head injury. This represents 5000 patients per 
year in Britain and is a leading cause of death in people under 30 years old, 
and the most common cause of death in children between 1 to 15 years of 
age (Morris and Malt, 1994b). Some of these deaths are inevitable, but 
others are potentially preventable.
The principle causes of head injury include road traffic accidents, falls, 
assaults, and injuries occurring at work, in the home and during sports 
(Table 6.1). The relative frequency of each cause varies between different 
age groups and by region in the country. Head injuries from road traffic 
accidents are most common in young males; alcohol is frequently involved. 
Road traffic accidents, although only constituting 25% of all patients with 
head injury, result in more serious injuries; they cause 60% of deaths from 
head injury, half of whom die before reaching hospital.
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Table 6.1 Patient characteristics and cause of injury (Bullock and Teasdale,
1991; Lindsay etal, 1991).
Characteristics and causes of injury ! 0/0
Characteristics: I
0 Male 1 70
6 Adult | 60
© Recently drunk alcohol j 25
Cause of injury:
@ fall j 14
© assault | 16
© road traffic accident I 25
© domestic \
© sport
: I (J
i 12
© work
I 8
In the UK many measures have been introduced to reduce the incidence, 
such as seat belt and crash helmet legislation. However, once a head injury 
has occurred, nothing can alter the impact damage. The aim of head injury 
management is to minimise damage arising from secondary 
complications.
6.1.2 B rain dam age caused by head in ju ry
6 .1.2.1 Blunt injuries
Blunt injuries are usually associated with acceleration and deceleration 
which results in two types of brain damage: diffuse and local. Diffuse 
neuronal damage to the cerebral white matter is due to rotatory shearing 
movements. When mild this is the pathological basis of concussion. When
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severe the patient is left demented with a spastic diplegia, reflecting the 
diffuse nature of severe brain damage (Figure 6.1). Local damage is 
caused by compression of the brain by skull fracture or haematoma.
Figure 6.1 Diffuse axonal injury
Brain distortion causes 
shearing forces to stretch
and tear axonal tracts within 
white matter- microspically 
damage is seen as retraction 
balls.
Secondary brain injury can be caused by swelling, due to axonal damage, 
and haematoma, both of which may raise intracranial pressure (ICP). 
Eventually the cerebellar tonsils herniate and compress against the 
medulla causing changes in respiratory pattern, cardiac arrythmia and 
ultimately cardiorespiratory arrest (Figure 6.2).
Figure 6.2 Cerebral herniation ( ■— ) (coning) compresses the
respiratory centre causing death
cerebeili
stem
anterior medullary
cerebelum
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6.1.2.2 Sharp injuries
These cause local brain damage without concussion. Brain damage is 
adjacent to the depressed fracture and consists of bleeding and swelling of 
the brain possibly followed by infection.
6.1.2.3 Long-term damage
Those who survive severe head injury suffer enormous problems; although 
the ability to walk and talk may suggest a satisfactory outcome, changes of 
personality and blunting of subtle ("higher”) intellectual activities 
responsible for tact and judgement may render such patients unemployable 
and difficult to live with.
6.1.3 Acute management of head injury
Baseline observations should start as soon as possible so that any change 
in ICP can be appreciated. Neurological state is assessed by the GCS, 
duration of amnesia if conscious, and pupillary reaction (2.2.1.3). Pulse, BP, 
respiratory rate, and temperature are measured at least half hourly.
The airway must be cleared, the patient placed in a semiprone position with 
the head of the bed raised and an airway inserted. In the absence of a 
cough reflex, a cuffed endotracheal tube is required. Patients with a GCS <8 
usually undergo a computerised tomographic (CT) scan within one hour of 
admission with immediate craniotomy for those with mass lesions. 
Craniotomy is performed to debride the wounds, elevate skull fractures, or
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remove haematoma within the first 24h after injury. ICP over 20mm Hg is 
treated by conventional means including intraventricular cerebrospinal fluid 
(CSF) drainage, hyperventilation (PaC02 = 35mm Hg), musculoskeletal 
blocking agents, or mannitol (0.25g/ Kg) infusion. If, despite this treatment, 
ICP rises above 25mm Hg, barbiturate therapy (thiopentone infusion, to 
achieve blood levels of 70- 90mg/ L), is started. Swan-Ganz catheters are 
placed and pulmonary capillary wedge pressure maintained >12mm Hg by 
infusion of crystalloid when barbiturates or mannitol are used.
6.1.4 Nutritional sequalae of head injury
6.1.4.1 Hypermetabolism 
Brain injury induces a hypermetabolic state which is roughly proportionate to 
the severity of injury, (Robertson et al, 1985) persists for 4 to 6 weeks 
(Borzotta et al, 1994) (Figure 6.3), and is still present at one year (Haider et 
al, 1975). Bruderetal (1991) reported an increase in metabolic rate of 77% 
from week one to week 2 to 3 post- injury. In contrast Weeks and Elia (1996) 
measured a substantial decrease in metabolic rate between the day 3- 5 
and week 2- 3 post-injury. This was partly due to the loss of body weight and 
partly to a reduction in the degree of hypermetabolism. The discrepancy 
between studies may be explained by the higher nutritional intake in 
patients studied by Bruderetal (1991). Thus energy expenditure is elevated 
by the injury, falls as the injury resolves, but may increase again as activity 
increases.
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Figure 6.3 Measured REE (MREE) and MREE as a percentage of estimated BMR
over time (Borzotta et al, 1994).
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In comparison with the estimated BMR (Harris-Benedict) MREE has been 
found to be between 129-150% (Robertson etal, 1984), 135-146% (Bruder 
etal, 1991) and 130-135% (Weeks and Elia, 1996). The latter study differed 
in that patients were either fasted or fed less than the MREE during the 
measurement and this may have reduced DIT. DIT appeared to represent 
less than 10% of MREE (Bruder et al, 1991). The present study therefore 
assumed an increment of 30%, above BMR, for the head injury and 10% for 
DIT.
The increase in energy expenditure may result from the post-injury 
inflammatory response. Comatose patients with isolated head injury have 
up to 7-fold higher noradrenaline levels (Clifton et al, 1981), with higher 
values in patients with lower a GCS (ie. more severe injury). Experimental 
brain injury in rats causes IL -1 production by the damaged tissues (Giulian 
and Lachman, 1985). Increased MREE (Borzotta etal, 1994) was probably
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causally associated with elevated circulating levels of counterregulatory 
hormones (cortisol, glucagon, catecholamines) found after brain injury 
(Bouzarth et al, 1972 ; Ott et al, 1987). Furthermore, isolated head injury 
seems to induce a full response in the secretion of counter-regulatory 
hormones (glucagon, cortisol, adrenaline and noradrenaline); additional 
non-cranial injury does not seem to enhance this response (Chiolero et al, 
1989a). Energy expenditure is reduced by administration of propranolol 
(Chiolero et al, 1989b), indicating the role of catecholamines. Treatment 
with steroids causes a transient rise in nitrogen excretion but has no effect 
on MREE (Robertson etal, 1985).
Several factors may affect energy expenditure during the post-injury course. 
In one study, curarization or heavy sedation reduced energy expenditure of 
non-sedated patients from 138% of BMR to 89% (Clifton et al, 1984a). In a 
second study curarization caused a 42% reduction in REE (Clifton et al,
1986). Similarly barbiturate therapy reduces energy expenditure. Conversely, 
weaning from mechanical ventilation may play a role in the increase in 
energy expenditure occurring from day 4 to 18 (Bruder et al, 1991). 
Spontaneous activity correlated with elevated REE. In patients who 
remained unchanged neurologically, the REE was constant for as long as it 
was measured, up to 28 days after injury (Robertson et al, 1984). However, 
as patients improved from responding only to painful stimuli to showing 
spontaneous activity, the REE often increased.
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6 .1.4.2 Hvpercatabolism 
Head injury is associated with large urinary nitrogen loss, up to 20.2g/ day 
(Haider et al, 1975) and 0.35g/ Kg/ day (Rapp et al, 1983). Nitrogen excretion 
increases from 0.199g/ Kg/ day during the initial phase after trauma to
0.357g/ Kg/ day with nutritional support (Gadisseux et al, 1984). Nitrogen 
balance remains negative in head-injured patients for the first 2-3 weeks 
after injury (Clifton et al, 1986; Gadisseux et al, 1984; Haider et al, 1975; 
Rapp et al, 1983), despite intakes of 20- 30g/ day. Protein is preferentially 
utilised as fuel by the body in the first weeks after injury (Francois et al, 
1984). This is reflected in the fact that 75% of the tissue lost is LBM (Weeks 
and Elia, 1996) compared to (usually) <50% in healthy individuals with a 
similar body composition on a restricted intake (Elia, 1992). Nitrogen 
excretion peaks during the second week post-injury and remains elevated 
throughout hospitalisation (Figure 6.4) (Borzotta et al, 1994; Clifton et al, 
1984; Robertson et al, 1984; Young et al, 1985). Nitrogen losses are rarely 
balanced by nitrogen intake, although an intake of Q.35g/ Kg/ day is more 
effective than 0.24g/ Kg/ day (Cerra et al, 1987; Twyman et al, 1985). 
Nitrogen excretion is not diminished by energy intake up to twice BMR (Vane 
etal, 1982) although giving 161% to 240% of BMR helped achieve nitrogen 
balance in severely injured patients. Nitrogen excretion is very variable (0.29 
to 0.73g/ Kg/ day) (Borzotta et al, 1994) suggesting that requirements are 
best estimated by empirical measurement of nitrogen loss. Thus head- 
injured patients have a high nitrogen requirement but losses, during the 
catabolic phase, can only be ameliorated not prevented.
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Figure 6.4 Urinary urea nitrogen (UUN) during EN and total TPN during the study 
(Borzotta et al, 1994).
UUN (g/ day)
Study days
64.4.3 NutritiQqal intake.,aiid..GI tolerance 
It is common for nutritional intake to be inadequate after head-injury. In two
groups of patients with a peak GCS of 4-10 in the first 24 hours, NG feeding
was inadequate fora mean of 11.5 days (Norton et al, 1988) and prolonged
gastric emptying persisted for 1-3 weeks post-injury (Ott et al, 1991) (see
1.4.4.3, Figure 1.7). Even when tube feeding commences by the second day
post- injury, 35% do not usually reach a target of 150% of REE until the
second week post-injury. Delayed gastric emptying correlated with daily
peak ICP (Norton et al, 1988), morphine or barbiturate use or severe
infections (Clifton et al, 1985), but did not correlate with low GCS or bowel
sounds (Norton etal, 1988). In most patients gastric emptying and ICP had
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returned to normal by week three (Ott et al, 1991). Overall 20 to 50% of 
patients do not tolerate gastric feedings within the first 2 weeks post-head 
injury (Clifton et al, 1985; Hadley et al, 1986; Rapp et al, 1983; Young et al,
1987). Poor gastric emptying is one reason for insufficient delivery of EN 
(Weeks and Elia, 1996). Negative energy and nitrogen balances are 
therefore due to the combined effects of increased REE, catabolism, poor 
nutritional intake and, exacerbating nitrogen loss, immobilisation.
Aspiration pneumonia is the most serious complication of enteral feeding. 
Mortality from nosocomial pneumonia occurs in up to 55% of ventilated 
patients (Craven et al, 1986) and can increase the requirement for ventilator 
support and overall cost of care. Pneumonia results from aspiration of 
infected feed or gastric secretions or infection secondary to aspiration. 
Reflux of gastric contents carries bacteria past the epiglottis or inflated cuff 
of the tracheal tube; 40% of gastric cultures coincide with pharyngeal and 
endobronchial cultures, suggesting the stomach is one source of 
oropharyngeal and bronchial bacterial colonisation (Torres et al, 1992). 
There is some evidence that continuous gastric feeding predisposes to 
pneumonia by raising gastric pH above 3.5 (Jacobs et al, 1990; Lee et al, 
1990). This may be a function of the buffering of acid by constant feed 
delivery into the stomach (Hopert et al, 1989). Use of an NG tube was 
associated with a 6-fold increase in aspiration (Vane et al, 1982). Recent 
studies suggest that the presence of a tube in the pharynx can produce 
transient lower oesophageal relaxation (Mittal et al, 1992), whereas another 
study suggests a more direct effect of head injury (Saxe et al, 1994). This
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last study also suggests that lower oesophageal sphincter dysfunction 
precludes safe gastric feeding after head injury. Sleep alone reduced upper 
oesophageal sphincter pressure in normal subjects (Kahriias et al, 1986), 
and therefore presents an increased risk to head-injured patients who are 
often NG fed during sleep. Furthermore, evidence of aspiration pneuminitis 
on autopsy examination is common in head-injured patients (5%) (Olivares 
et al, 1974) with a very high incidence in patients being fed by NG tube 
(46%) compared to post-pyloric feeding (6%) (Kiver et al, 1984).
6.1.4.4 Efficacy of nutritional support 
Patients suffering severe head injury commonly receive inadequate 
nutritional support for >5 days. Recent evidence suggests that this is 
associated with an increased mortality and poor long-term outcome 
(ASPEN, 1993). Such rapid loss of BCM can quickly impair immune 
response and increase infective complications. Early nutritional support can 
ameliorate these losses and has been associated with reduced catabolic 
response and improved clinical outcomes (see 1.4.4.3). This has been 
achieved with early PN which overcame the problems of gastroparesis post­
head injury. Unfortunately PN is associated with increased mortality. 
Furthermore, hyperglycaemia is usually more common during parenteral 
than enteral feeding. Hyperglycaemia before and during cerebral ischaemia 
can worsen outcome (Young et al, 1989) and is associated with a high 
mortality rate in patients with severe head-injury (Merguerian et al, 1981), 
possibly related to increased lactate production. In rats, on the other hand, 
PN did not significantly alter neurological outcome or formation of brain
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oedema (Shapira et al, 1992), or cause increased hyperglycaemia (Borzotta 
et al, 1994). Thus the safety of PN in head injury is under dispute. 
Nevertheless EN, compared to PN, has been associated with a lower 
incidence of complications (1.4.2.2) possibly by preserving gut function 
(14.4.2.3). EN can be introduced earlier (at 36h) using the jejunal route 
compared to gastric feeding which is necessarily delayed until 72h when 
gastric function has recovered (Grahm etal, 1989). Over 7 days, the jejunaily 
fed group had a greater energy intake compared with that of the gastric fed 
group, less cumulative energy deficit, and better mean nitrogen balance. 
Montecalvo etal (1992) retrospectively randomised 38 critically ill patients to 
receive gastric or jejunal feeding. Jejunal versus gastric feeding was 
associated with delivery of a higher percentage of daily energy requirements 
(61% versus 47%), but less clinically diagnosed nosocomial pneumonia (0 
versus 10%). Thus jejunal EN can improve the delivery of nutrition when 
compared with NG feeding, possibly with a reduced incidence of 
complications
In conclusion, the energy and nitrogen requirements of severely head- 
injured patients are increased for several weeks post-injury. Over this period 
gastric emptying is often poor, reducing the safety and efficacy of NG 
feeding. PN is feasible but has an attendant high risk of catheter-related 
sepsis, gut atrophy and high cost. On the other hand, intestinal EN has the 
potential to deliver most of the estimated energy and nitrogen requirements, 
and maintain GI and immune function, while minimising the risk of 
pulmonary aspiration and nosocomial pneumonia. Studies to date
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assessed the effect of early PN in improving outcome. This study was 
designed to test the efficacy of early aggressive EN (intestinal, ie. duodenal, 
preferably jejunal, where possible) versus standard gastric enteral feeding 
in a PRCT in severely head-injured patients requiring mechanical 
ventilation.
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6.2 Methods
6 .2 .1  Aims and Objectives
The study aim was to determine whether early EN reduced mortality, major 
complications, LOS and treatment cost in head-injured patients requiring 
mechanical ventilation and not taking oral nutrition within 24h. Study
objectives included:
1. Determining the difference in outcomes between:
• Intent to aggressively feed EN (intestinal or NG) versus 
standard NG feeding.
2. Stratification by disease severity allowed testing of whether nutrition- 
related associations were:
• Independent of disease severity, confirming the efficacy of 
EN;
• Apparent only at a specific level of disease severity
indicating that future studies and clinical practice should
target those patients who would most benefit from
nutritional support.
6.2.2 Selection criteria
Relatives of consecutive severely head-injured patients were asked to 
consider giving consent for the patient to be randomised to standard gastric 
and intestinal enteral feeding groups (Figure 6.5). Specific exclusions 
included patients who were moribund (GCS never above 3, fixed dilated
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pupils or other potentially fatal injuries), trauma that precluded use of enteral 
feeding, or severe head injuries that occurred > 24 hours before admission 
or where it was impossible to consent, randomise and commence 
intestinal EN within the 24 hour period. AIS, ISS and APACHE II were used in 
retrospective analysis to ascertain whether the treatment groups were 
balanced for overall disease severity. Long-term outcome was measured by 
the Glasgow Outcome Scale (GOS) (Appendix 8.6.1).
6.2.3 Study design  
This was a PRCT of early aggressive EN aimed at meeting full estimated 
energy and nitrogen requirements (see 2.2.6) (‘intervention’ patients), 
versus standard early gastric feeding (‘controls’) (Appendix 8.6.2). In 
intervention patients intestinal intubation was attempted (Appendix 8.6.3). 
Failing this ‘rapid’ NG feeding was commenced. Patients were randomised 
to intervention and control groups in a 1:1 ratio. Post-randomisation 
withdrawals remained in their respective randomised groups, were 
monitored and included in the analysis.
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Figure 6.5 Protocol
82 consecutive head-injured 
patients admitted to ITU.
Admission criteria:
• Head injury requiring mechanical ventilation.
• Unable to take oral nutrition within 24h.
• Possible to commence intestinal feeding within 24h postinjury.
• GCS at some time >3, pupils reactive to light and >10 years old.
*
Clinical Nutritional and Hormonal Functional status 
Assessments
1. Admission 1. Daily intake 1. 3 and 6 months:
• APACHE • IV • GOS
• GCS • enteral • Return to
• CT scan of brain • oral. normal oral
• pathological 2. Day 3, 6, 10, 15: nutrition.
diagnosis and • PINI
anatomical • Plasma cortisol,
region of growth
damage. hormone, IGF-1
2. Up to 6 months: • Nitrogen
• major complications
• mortality
• LOS/ ITU stay
• Antibiotic, GI, 
neurological and 
nutrition drug use/ cost 
(> normal usage)
balance
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The inflammatory response was examined by measuring the PINI and 
serum concentration of cortisol, growth hormone (GH), and insulin-like 
growth factor-1 (IGF-1). Blood sampling was done until day 15 
(Appendix 8.6.4), the first sample being taken on day three to avoid 
aberrations in blood protein levels due to IV fluid resuscitation and, 
whenever possible, between 6.00 and 10.00 to minimise diurnal 
variation.
6.2.4 Study size
Pre-study data found that in the first 11 months of 1993, 37 patients 
with severe head injury required NG feeding at Frenchay Hospital. All 
commenced on NG feeding within 24-48 hours. Overall mortality was 
22%; 11% in those enterally fed within 24 hours, and 35% in those fed 
after 24 hours. Estimated nutritional requirements had not been met at 
48 hours and 5 days in 100% and 70%, respectively. Nearly 10% 
required a course of TPN as a result of poor gastric emptying and 
intolerance to NG feeding. Mean duration of TPN was 6 days, at a cost 
of £100 per day and with a 47% incidence of catheter-related sepsis. 
Almost all these patients suffered hypercatabolism, with peak nitrogen 
output of 15-30g per day, this usually persisting for 2-3 weeks and 
resulting in significant muscle wasting (see 6.1.4.2).
Rapp et al (1983) found that adequate PN within 48h resulted in an 18 
day mortality of 0% compared with 44% for inadequate gastric feeding,
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and at 1 year good recovery/moderate disability of 39% and 63%, 
respectively. Experience of early feeding of head-injured patients is 
limited and it was thought that such a large reduction in mortality was 
unlikely to be repeated. The present study therefore tested a difference 
of good recovery/moderate disability, taken as a ‘good1 neurological 
outcome, at 6 months. In groups of patients, recovery at 6 months is 
similar to that at 12 months, commonly used as the follow-up period 
(see 2.2.4.3). An assumption was made that aggressive EN has a 
lower risk to benefit ratio than PN and can produce a good outcome at 
6 months in 70% o f‘intervention’ compared to 39% of'control' patients. 
By assuming the use of 2 - tailed analysis, study size was calculated to 
be 82 fora significance level of 0.05 and with a power of 80%. Annually 
there are 45-50 head-injured patients admitted to Frenchay hospital. 
Allowing for exclusion of 25% because of recruitment into another 
ongoing trial, the study should be complete, including 6 months follow- 
up, in 3 years. If recruitment was insufficient a fall-back test would be 
made on the expected difference in 18 day mortality assuming 35% 
and 5% for control and intervention groups, respectively. This gave a 
study size of 56.
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6.2.5 Data collection (Table 6.2) and Analysis 
Table 6.2 Data collected and frequency of collection.
Data item Time of collection
Patient details: Admission
Name and hospital number ct
Age ct
Disease severity: i t
*  GCS: tt
• best
•  worst
• best ITU- post resuscitation
• Pupillary reaction to light: tt
• temporarily unresponsive
• permanently unresponsive
•  APACHE II Retrospective
• ‘Leeds score’ t t
Consent and randomisation if suitable Admission
Weight (Kg) t t
Height, (cm)
Nutritional requirements (estimated)
• Kcal, N2 on day 1 and day 29 ct
Time of:
• injury Admission
• admission to hospital t t
•  admission to ITU tt
• nutrition (by route) Retrospective
Nutrition
Routes refused by patient or not feasible During the course of treatment
Reasons for:
• delayed EN t t  t t  t t  tt t t
• suboptimal input tt t t  t t  tt ct
• exclusion (pre- and post­ t t  tt tt t t tt
randomisation)
Cessation day EN, PN Retrospective
Duration EN, PN t t
Energy and nitrogen intake from:
• Diet During the course of treatment
* Commercial fluid supplements t t  t t  tt  t t tt
• EN feeds t t  t t  tt i t “
• PN solutions t t  t t  t t  tt ct
• IV hydration fluids i t  i t  tt t t tt
• Propofol sedative i t  t t  t t  t t t t
Gastric fluid in (mL) It tt tt tt tt
Aspirate volume (mL) t t  t t  ct tt ft
Urinary nitrogen output t t  t t  tt tt t t
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Table 6.2 Data collected (continued).
Clinical parameters
PINI and plasma cortisol, GH, IGF-1 Day 3, 6, 10, 15
WBC <4 >11 As measured for clinical reasons
Hb M< 13, F<11.5 (g/dL) u  tt u  a  tt
IV Fluids:
• for resuscitation (36h) Retrospective
• post- surgery (day 1 and 2, tt
excluding resuscitation fluids)
• up to 28days and >28 days (excl. n
resuscitation/ post- surgery)
Complications and organ support tt
Pyrexia (days) During the course of treatment
Complications up to 28 days and > 28 Retrospective
days
ITU:
» days (ITU- LOS) it
• admission day <t
• ventilation day u
Death and time to. 1
Drug usage up to and after 28 days:
• Antibiotics, GI, nutritional, tt
opiates, ‘neurosurgical’
Operations
• evacuation of haematoma U
• other neurosurgical tt
• other surgery tt
Follow- up
Nutrition: Kcal, N, route 3 and 6 months
GOS <{ it t u
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6.2.6 Statistical analysis 
It was first determined whether variables had a normal distribution and 
if not whether they could be transformed or would require non- 
parametric analysis. Death was assumed to follow a binomial 
distribution. Normal distribution of other outcome variables was tested 
using the Shapiro-Wilk test. The variables best GCS, Leeds score, and 
GOS at 3 months had normal distributions and were analysed by the t 
test having confirmed equal variance. All other outcome variables 
diverged from Normal distribution and the Mann-Whitney (Wilcoxon 
Ranksum) test therefore was used. The principle outcome variables 
(good neurological outcome and GOS at 3 and 6 months, death, 
complications excluding and including mortality, LOS and treatment 
cost) were tested against possible explanatory variables by univariate 
multivariable regression analysis in order to eliminate bias which 
occurred despite randomisation (Table 6.3). Associations described in 
the results section should read as ‘positive7 unless otherwise 
specified. The number of explanatory variables was usually restricted 
to not more than the V n to avoid creating an over-optimistic model. 
This was not always possible with sub-analysis, and this problem 
was noted. Separate analyses were done on survivors for outcome 
variables which would be paradoxically lowered, giving impression of 
better outcome, due to early mortality.
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Table 6.3 Univariate multivariable regression analysis.
Dependent variable All Survivors
only
Method of 
regression 
analysis
Explanatory variables used 
in each analysis
1. Mortality V _ logistic • Delay before admission
2. Major V V median • Nutritional intervention
complications: group
(excluding and • Best GCS
including death) © Worst GCS
3. LOS V V median • Post-resuscitation GCS
4. Drug-IV fluid-PN V V median © Pupils fixed <24h
cost’
5. Treatment cost: © Pupils fixed >24h
© drugs only V V median • AIS
ISS
© drug V V median © Leeds score
components
© FN V V median © Age
6. Duration of EN V V median
7. Complications:
© by time V V median
9 by component V V median
6.2.7 Study aims and future directions 
To date there have been no large randomised controlled trials testing 
the effect of early EN on clinical outcome in severely head-injured 
patients. It is accepted that any change in outcome in the early 
aggressive feeding group may be a combination of early adequate 
feeding and, specifically, intestinal feeding. These results and further 
trial by other groups will determine whether immediate intestinal 
enteral feeding should be considered a standard intervention 
treatment in patients suffering severe head-injury.
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At the time of the interim analysis, data on 43 patients was complete. 
In the same time period 78 patients were excluded because they did 
not meet the study criteria (Appendix 8.6.5). The study groups were 
found to be well matched in terms of disease severity; delay from injury 
to admission to Frenchay Hospital, GCS (best and worst prior to 
resuscitation and best post-resuscitation within 24h of injury), number 
of pupils fixed <24h or for >24h, AIS, ISS and Leeds score were all 
similar between groups (Table 6.4). There was a tendency to a 
younger age in the ‘control’ group.
6.3 Results
Table 6.4 Characteristics of the ‘control’ and ‘intervention’ groups.
Variables affecting Control Intervention p value
disease severity n median 9 5 %
confidence
interval
n median 9 5 %
confidence
interval
Delayed admission (h) 22 5 .5 (5 -8 ) 21 6 (5 -8 ) ns
GCS: best 22 8 (6 -9 ) 21 8 (6 -1 2 ) ns
worst 22 3 .5 (3 -7 ) 21 4 (3 -5 ) ns
post-resuscitation 22 5 (5 -6 ) 21 6 (5 -7 .5 ) ns
PERL absent: for <24h 22 0 (0-1) 21 0 (0-1) ns
for >24 h 22 0 (0) 21 0 (0) ns
AIS 22 6 (5-7) 21 6 (5-8 ) ns
ISS 22 26 (25-29) 21 26 (25-32) ns
Leeds score 22 5 (4-6) 21 5 (4-7) ns
Age (years) 22 31.5 (27-41) 21 40 (26-49) ns
Most nutrition was initially supplied by tube feeding together with some 
'non-nutritional energy’ from propofol and IV dextrose. These sources
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of nutrition decline, and oral nutrition increases from day 2 post-injury. 
Figures 6.6 and 6.7 show that the percentage of energy and nitrogen 
requirements met are higher in the intervention group on days 1, 2 and 
4, but not day 3. Four ‘controls’ had short courses of PN because of 
poor gastric emptying; PN was not used in intervention patients. 
Intestinal intubation was attempted in 14 ‘intervention’ patients and 
was successful in seven. Those intervention patients not having 
intestinal feeding received ‘rapid’ NG feeding. It therefore appears that 
the ‘intervention’ protocol effectively increased energy and nitrogen 
intake over the first four days post-injury. However, the increased 
delivery of feed did not significantly increase the number of aspirates 
larger than 150mL, when the stomach was aspirated four hourly. 
There was no difference in the duration of EN between groups.
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%Figure 6.6 Percentage of estimated energy requirements met by
enteral and oral nutrition from day 1 to 7 post-head injury.
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Figure 6.7 Percentage of estimated nitrogen requirements met by
enteral and oral nutrition from day 1 to 7 post-head injury.
%
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Data on APACHE II was incomplete to date. In addition, it has proven 
difficult to obtain accurate three day nutritional intakes at 3 and 6 
months. These data were therefore not used in the present analysis.
6.3.1 Analysis by nutritional group  
The intervention group tended to have a better neurological recovery 
(good neurological outcome and GOS) both at 3 and 6 months (Table 
6.5). Mechanical ventilation was routinely initiated as part of head injury 
management, not as a result of respiratory failure, and therefore was 
not used to define a major complication (ie. respiratory failure). There 
were six deaths: four (18%) controls and two (10%) intervention 
patients; this difference did not reach significance. There is a trend to 
reduced complications (excluding or including mortality) in the
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intervention group and reaching significance for infective 
complications up to 28 days (p = 0.0195). Again, in intervention 
patients, LOS and ITU-LOS tended to be shorter and reached 
significance for a shorter duration of ventilation (p = 0.019). These 
apparent clinical improvements are reflected in reduced cost for fluid, 
drugs and PN used (Table 6.6). When outcomes were re-analysed in 
survivors (Table 6.7), infection, and fluid and PN cost (all up to day 28) 
and the ‘drug-IV fluid- PN cost’ (total LOS) were significantly lower in 
intervention patients. In the sub-group of severely head-injured 
patients (best GCS <8), up to day 28 drug and fluid cost, and for the 
total LOS, antibiotic, total drug and ‘drug-IV fluid-PN cost’ were 
significantly reduced in the intervention group (Table 6.8). In both the 
survivor and severe head injury sub-groups, other outcomes tested 
(mortality, complications, LOS, ITU-LOS) tended to be reduced in the 
intervention group but differences did not achieve significance.
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Table 6.5 Incidence of major complications and neurological outcome (n = 43).
Variables affecting 
disease severity n
Control 
median 95%
confidence
interval
n
Intervention 
median 95%
confidence
interval
p value
Good neurological 
outcome at:
* 3 months 22 0 (32) (0-1) 21 1 (52) (0-1) ns
• 6 months 
GOS at:
22 1 (59) (0-1) 21 1 (71) (0.45-1) ns
® 3 months 22 3 (3-4) 21 4 (3-4) ns
• 6 months 22 4 (3-4) 21 4 (3.5-5) ns
Mortality 22 0 (0) 21 0 (0) ns
Complications 
excluding mortality (n°.)
22 1 (0-2) 21 1 (1-1.5) ns
Complications including 
mortality (n°.)
22 1.5 (0-2) 21 1 (1-2) ns
Infection (up to day 28) 22 1 (0-1) 21 0 (0-0.5) 0.0195
Mechanical ventilation (h) 
(survivors of ventilation)
21 79 (54-135) 21 47 (25-68) 0.019
LOS (days) (survivors) 18 49 (33-80) 19 34 (21-107) ns
ITU LOS (days) (survivors 
of ITU)
21 5 (2-8) 21 3 (2-5) ns
Table 6.6 Drug cost (£) (n = 43).
Variables affecting Control Intervention p value
disease severity n median 95% n median 95%
confidence confidence
interval interval
Fluid 22 150 (83-487) 21 81 (23-133) 0.038
Drugs 22 146 (57-374) 21 47 (33-106) 0.028
PN 22 0 (0) 21 0 (0) 0.043
Total 22 600 (241-1446) 21 141 (87-341) 0.006
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Table 6.7 Statistically significant outcomes in survivors (n = 37).
Variables affecting 
disease severity n
Control 
median 95%
confidence
interval
n
Intervention 
median 95%
confidence
interval
p value
Up to day 28:
® Infection 18 0 (0-1) 19 0 (0-0.31) 0.037
Fluid cost 18 127 (38-801) 19 81 (23-144) 0.014
° PN cost* 18 0 (0) 19 0 (0) 0.032
‘Drug-IV Fluid-PN cost’ 18 600 (231-1560) 19 147 (97-348) 0.031
* Mean: control £101, intervention £0.
Table 6.8 Statistically significant outcomes in severely head-injured patients 
(n = 25).
Variables affecting 
disease severity n
Control 
median 9 5 %
confidence
interval
Intervention 
n median 9 5 %
confidence
interval
p value
Cost of:
Drugs up to day 28 14 171 (1 2 2 -5 3 0 ) 11 9 2 (2 1 -1 4 2 ) 0 .0 2 2
Fluids up to day 28 14 7 0 (2 9 -1 4 8 ) 11 13 (8 -9 0 ) rf.0 4 6
Antibiotics 14 1 7 6 (7 6 -5 9 2 ) 11 5 5 (1 0 -1 2 2 ) 0 .0 4 3
Drugs-all 14 2 4 3 (1 2 8 -7 1 1 ) 11 1 0 5 (2 1 -1 4 4 ) 0 .0 2 2
‘Drug-IV Fluid-PN cost’ 14 1 0 7 0 (3 2 4 -1 8 7 4 ) 11 1 4 7 (9 3 -5 0 7 ) 0.0037
Despite being similar in terms of injury severity the estimated energy 
and nitrogen requirements of controls were higher, although this 
difference was not significant in the case of nitrogen (Table 6.9). EN 
tended to be delayed longer in intervention patients (ns), independent 
of any interruption to feeding caused bypassing a nasointestinal tube. 
Intervention patients also tended to have more gastric aspirates of
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>150mL (ns), but a shorter duration of EN (ns). The percentage of 
estimated energy and nitrogen requirements met by EN was greater in 
intervention patients on days 1, 2 and 4 post-head injury. Nitrogen 
output and balance were similar between groups.
Table 6.9 Nutrition: Estimated requirements, delay before and duration of EN, number of 
aspirates >150mL and percentage of requirements met from day 1 to 7.
Variables affecting 
disease severity n
Control 
median 95%
confidence
interval
n
Intervention 
median 95%
confidence
interval
p value
Estimated requirements:
• Kcal 22 2450 (2384-2595) 21 2352 (2090-2439) 0.028
* gN 22 17 (16-17) 21 16 (14-17) ns
Delay before EN (h) 22 12.5 (10-14) 21 14 (12-17) ns
Duration of EN (days) 18 13 (5-21) 19 7 (4-16) ns
(survivors)
Number of aspirates 22 1 (0-3) 21 2 (0-3) ns
>150mL per patient
Energy requirements
met (%) on day:
1 22 7.5 (3-10) 21 19 (15-27) 0.0000
2 22 21.5 (17-28) 21 43 (32-68) 0.021
3 21 39 (23-46) 20 48 (23-76) ns
4 19 32 (23-49) 18 54 (28-81) 0.019
5 19 50 (12-66) 17 62 (13-78) ns
6 19 52 (31-61) 19 56 (0-83) ns
7 19 58 (23-69) 19 24 (0-77) ns
Nitrogen requirements
met (%) on day:
1 22 7.5 (4-13) 21 22 (17-29) 0.0000
2 22 26.5 (19-30) 21 54 (38-78) 0.021
3 21 44.5 (26-53) 20 57 (32-82) ns
4 19 37 (24-57) 18 68 (44-92) 0.022
5 19 52 (12-74) 17 76 (34-92) ns
6 19 55 (37-74) 19 73 (39-97) ns
7 19 53 (27-82) 19 59 (44-96) ns
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There were no significant differences between nutritional groups for serum 
albumin, pre-albumin, CRP, AGP, cortisol, GH and IGF-1 and the PINI 
(Figures 6.8 to 6.15) (Appendix 8.6.6). Serum albumin tends to be 
maintained whereas CRP and the PINI tend to be lower in the intervention 
group, compared to controls, before converging by day 12. Serum pre­
albumin and AGP levels were very similar between groups. Cortisol and GH 
levels were initially higher in intervention patients than controls but 
converged by day 5, whereas IGF-1 levels were initially similar but then 
diverged, with levels being higher in the intervention group.
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Figure 6.8 Serum albumin concentration from day 1 to 17 post-head
injury.
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Figure 6.9 Serum prealbumin concentration from day 1 to 17 post-head 
injury.
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Figure 6.10 Serum CRP concentration from day 1 to 1 7 post-head
injury.
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Figure 6.11 Serum AGP concentration from day 1 to 17 post-head 
injury.
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Figure 6.12 PINI from day 1 to 1 7 post-head injury.
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Figure 6.13 Serum cortisol concentration from day 1 to 1 7 
post-head injury.
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Figure 6.14 Serum GH concentration from day 1 to 17 post-head
injury.
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Figure 6.15 Serum IGF-1 concentration from day 1 to 17 post-head 
injury.
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6 .3 .2  R egression  analysis  
The data were re-analysed using univariate multivariable regression 
analysis to check that associations were not due to a failure of
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randomisation (Tables 6.10 to 6.14). When none of the explanatory 
variables reached significance for an outcome, the data was re­
analysed using stepwise regression analysis. Initial analysis was 
done to determine which of the disease severity variables best explain 
the outcomes (Table 6.10). Death was only associated with age on 
stepwise regression. Complications, excluding mortality, were 
associated with patients having pupils fixed for less than 24h, 
whereas complications including mortality were associated with the 
number of pupils fixed for <24h and >24h. LOS was associated with 
post-resuscitation GCS, the number of pupils fixed <24h, AIS and age. 
However, ITU-LOS was only associated with the best GCS, ISS and 
age on stepwise analysis. The ‘drug-IV fluid- PN’ cost was associated 
with ISS (stepwise analysis). When analysis was restricted to 
survivors only, ‘drug-IV fluid- PN’ cost was associated with the delay 
before admission, post-resuscitation GCS, the number of pupils fixed 
<24h and AIS (all stepwise). Good neurological outcome at 3 and 6 
months was associated with the delay before admission (stepwise) 
and age, respectively. However, GOS, on which neurological outcome 
is based, was associated with the delay before admission, the 
number of pupils fixed >24h and age at 3 (all stepwise) and 6 months. 
The regression models predicted between 13% and 44% of variability, 
prediction being clinically significant (>20%) for most models. 
However, several models only found significant associations when 
stepwise analysis was performed and the less important variables 
were dropped. Surprisingly age was negatively associated with ITU-
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LOS. Other unexpected findings were the positive association between 
the delay before admission and GOS and the negative association 
between the number of pupils fixed >24h and complications including 
mortality. The latter may coincide with early mortality and paradoxically 
reduce late complications. Pupils may be temporarily fixed because of 
drug/alcohol intoxication but when the pupils are still unreactive at 
>24h the cause is usually neurological. The other anomalies cannot 
be explained. Age was most consistently associated with outcome. 
Together with age it was decided to retain the delay before admission, 
best pre-resuscitation GCS, the number of pupils fixed >24h and AIS in 
analysis to determine the effect of the intervention variable. It was 
considered that the number of pupils fixed <24h could be influenced by 
non-neurological factors (eg. drugs, alcohol) and the post­
resuscitation GCS by neurosurgical intervention. AIS was chosen over 
ISS because it describes the full extent of injury rather than just its 
threat to life. Finally the Leeds score was not found to associated with 
any of the main outcomes and was therefore dropped. In reducing the 
number of explanatory variables to less than the square root of the 
population size, for most analyses, overoptimistic model prediction 
was avoided.
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Table 6.10 Univariate multivariable regression of outcome variables good 
neurological outcome and GOS at 3 and 6 months, death, 
complications (excluding and including mortality), LOS and ITU- 
LOS, and ‘drug- IV fluid- PN cost5 against explanatory variables, 
delay before admission, GCS (best, worst pre-resuscitation, 
best post-resuscitation), number of pupils fixed (<24h or >24h), 
AIS, ISS, Leeds score and age (years).
Variable:
outccme explanatory
(where p < 0.05, and - = 
negative association)
n p value I Model 
Variability 
(%) (P = )
Good neurological \ 
outcome at 3 
months
Delay before admission* 41* 0.032 | 32 (0.0056)
Good neurological ; 
outcome at 6 
months
|Age (-) 41 0.048 ; 44 (0.0037)
GOS at 3 months I Delay before admission* 
Pupil(s) fixed >24h* (-) 
j Age (-)
43* 0.002 | 
0.015 j 
0.030 j
26
GOS at 6 months \ Delay before admission 
| Pupil(s) fixed >24h (-)
..................... i
43 0.029 j 
0.029 |
0.001 i
36
Death i Age* i 41* 0.015 : 41 (0.0011)
Complications
excluding
mortality
(survivors)
I Pupil(s) fixed <24h j 37 0.029 j 27
Complications
including
mortality
i Pupil(s) fixed <24h 
: Pupil(s) fixed >24h (-)
j 43 0.041 | 
0.010
28
LOS (survivors) | Post-resuscitation GCS (-)
| Pupil(s) fixed <24h 
j AIS
\ Age........................ j
j 37 0.003 j  
0.001 
0.006 
0.005
28
ITU-LOS (days) 
(survivors)
| GCS-best* (-) 
| ISS*
! Age* (-)
j 37* 0.046 
0.005 
0.043
26
'Drug- IV fluid- 
PN cost' (£) (all)
I ISS* | 43* 0.003 13
'Drug- IV fluid- 
PN cost' (£)
(survivors)
\ Delay before admission* (-) 
| Post-resuscitation GCS* (-) 
\ Pupil(s) fixed <24h*
I AIS*
j 43* 0.004 
0.019 
0.000 
0.001
13
* Variables only reached significance on stepwise regression.
When the main outcomes were re-analysed including the ‘intervention’ 
variable it was found that intervention was negatively associated with
238
complications (excluding mortality- stepwise analysis-, and including 
mortality), ‘drug-IV fluid-PN cost’ in all patients and GOS at 6 months (Table 
6.11). Intervention was not associated with Death, LOS, ‘drug-IV fluid-PN 
cost’ (survivors), good neurological outcome and GOS at 3 months. The 
same explanatory variables were then analysed against secondary 
outcomes: the number of aspirates >150mL, outcomes up to day 28 
(infective complications, antibiotic cost, total drug cost), and outcomes for the 
total LOS (cost of antibiotics, all drugs, fluid) (Table 6.12). Of these, 
intervention was only associated with the total drug cost. A similar analysis 
was then done in survivors using the outcomes: ITU-LOS, duration of 
mechanical ventilation, and outcomes up to day 28 (infective complications, 
antibiotic cost, total drug cost), outcomes for the total LOS (cost of antibiotics, 
total drugs and fluids) (Table 6.13). The intervention group was negatively 
associated with the duration of mechanical ventilation, the drug cost up to 
day 28 and the total LOS. When analysis was restricted to severely head- 
injured patients, intervention was negatively associated with fluid cost up to 
day 28, total drug and fluid cost and ‘drug-IV fluid-PN cost’ but not specifically 
drugs cost up to day 28 or antibiotics cost (Table 6.14).
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Table 6.11 Univariate multivariable regression of outcome variables good neurological 
outcome and GOS at 3 and 6 months, death, complications (excluding 
and including mortality), LOS and ITU-LOS, and ‘drug- IV fluid- PN cost’ 
against explanatory variables: intervention group, delay before 
admission, best GCS (pre-resuscitation), number of pupils fixed >24h, 
AIS and age (years).
Variable:
outcome explanatory
(where p < 0.05, and - = 
negative association)
n p value ! Model 
Variability 
(%) (p - )
Good outcome at 3 [ 
months
GCS-best 41 0.027 j 29 (0.0067
Good outcome at 6 j 
months
Age (-) 41 0.018 ; 34 (0.0037)
GOS at 3 months i Pupil(s) fixed >24h (-) 43 0.003 : 24
GOS at 6 months | Intervention 
Delay before admission 
j  Pupil(s) fixed >24h (-)
L ^ ..±ri............... ......j
| 43 0.018 j 
0.000 j 
0.000 j 
0.000 j
38
Death i  all ns ii  41 - ! 64 (0.0051)
Complications
excluding
mortality
j Intervention* (-) 
i GCS-best (-)
: Pupil(s) fixed >24h (-)
j 37* 0.014 j 
0.002 | 
0.000 |
16
(survivors)
Complications ! Intervention (-) ! 43 0.045 : 20
including j GCS-best (-) 0.016 1
mortality I Pupil(s) fixed >24h (-) 0.011 ;
LOS (days) j GCS-best (-) 1 37 0.003 j 22
(survivors) I Age 0.003
ITU-LOS (days) 
(survivors)
| AIS { 37 0.000 : 24
'Drug- IV fluid- j Intervention (-) j 43 0.031 13
PN cost' (£) (all) ■ AIS 0.000
'Drug- IV fluid- 
PN cost' (£) 
(survivors only)
| AIS* ; 37* 0.029 8
* Variables only reached significance on stepwise regression.
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Table 6.12 Univariate multivariable regression of outcome variables number of 
aspirates >150mL, and complications, organ support and treatment cost 
(by component and time after injury) against explanatory variables: 
intervention group, delay before admission, best GCS (pre­
resuscitation), number of pupils fixed >24h, AIS and age (years) in all 
patients.
Variable s 
outcome explanatory
(where p < 0.05, and - = 
negative association)
n p value
Model
Variability
(%)
Number of 
aspirates >150mL
Pupil(s) fixed >24h (-) 43 0.015 17
Infective 
complications up 
to day 28 (£)
Pupil(s) fixed >24h (-) 43 0.032 20
Antibiotic cost up 
to day 28 (£)
AIS 43 0.013 10
Drug cost up to 
day 28 (£}
AIS 43 0.035 14
Fluid cost (£) 
- total
ns 43 - 5
Antibiotics (£) 
-total
ns (-) 43 - 9
Drug cost (£) 
-total
Intervention (-) 
GCS-best (-)
AIS
43 0.035
0.031
0.041
13
* Variables only reached significance on stepwise regression.
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Table 6.13 Univariate multivariable regression of outcome variables number of 
aspirates >150mL, and complications, organ support and treatment cost 
(by component and time after injury) against explanatory variables: 
intervention group, delay before admission, best GCS (pre­
resuscitation), number of pupils fixed >24h, AIS and age (years) in 
survivors.
Variable: 
outcome explanatory
(where p < 0.05, and - = 
negative association)
n p value
Model
Variability
<%>
Infective 
complications up 
to day 28
ns 37 10
ITU-LOS (days) AIS 37 0.000 23
Mechanical 
ventilation (h)
Intervention (-) 
AIS
37 0.013
0.007
22
Antibiotic cost up 
to day 28 (£)
GCS-best* (-) 37* 0.005 7
Antibiotics (£) 
-total
GCS-best* (-) 37* 0.036 8
Drug cost up to 
day 28 (£)
Intervention* (-) 
GCS-best (-)
37* 0.034
0.001
12
Drug cost (£) 
-total
Intervention* (-) 
GCS-best (-)
37* 0.020
0.000
11
Fluid cost (£) ns 37 - 4
A Variables only reached significance on stepwise regression.
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Table 6.14 Univariate multivariable regression of outcome variables death, 
complications (excluding and including mortality), LOS and ITU-LOS 
(survivors only), and ‘drug- IV fluid- PN cost’, number of aspirates 
>150mL, and complications, organ support and treatment cost (by 
component and time after injury) against explanatory variables: 
intervention group, delay before admission, best GCS (pre­
resuscitation), number of pupils fixed >24h, AIS and age (years) in 
patients with a severe head injury (best GCS <8).
Variable
outccsne explanatory
(where p < 0.05, and - = 
negative association)
n p value
Model
Variability
(%>
Drug cost up to 
day..2? (£j.........
AIS 25 0.034 25
Fluid cost up to 
day 28 (£)
Intervention (-) 
Pupils fixed >24h
25 0.002
0.007
Antibiotics (£) 
-total
Pupils fixed >24h (-) 
AIS
25 0.003
0.017
21
Fluid cost (£) 
-total
Intervention (-) 25 0.045 12
Drug cost (£) 
-all
Intervention (-)
AIS
Age
25 0.019
0.001
0.007
21
'Drug-IV fluid (£) 
-PN cost'
Intervention (-) 
AIS
25 0.005
0.000
30
* Variables only reached significance on stepwise regression.
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The results presented are an interim analysis of data from 43 patients. The 
study is ongoing and must recruit 82 patients for the intended analysis to 
have a power of 80%. Comments on significant results and non-significant 
tendencies are therefore offered in the light of the above qualification.
6.4.1 Effect on neurological outcome
Early aggressive EN was associated with a tendency towards good 
outcome (intervention, 71% versus control, 59% at 6 months) and an 
improved GOS whereas studies of a similar size found a significantly 
improved neurological outcome at 3 months (intervention, 44% versus 
control, 18%) (Young et al, 1987) and 12 months (intervention 63% versus 
control 39%) (Rapp et al, 1983). These studies used a lower threshold 
before a ‘control’ was defined as being intolerant to NG feeding, and 
therefore controls received less feed with a greater deficit in their energy and 
nitrogen intake compared to ‘controls’ in the present study. Improved 
nutritional intake may have enhanced neurological recovery in the present 
control group and reduced the potential for improvement by early aggressive 
EN. Overall, early aggressive EN was associated with a better outcome than 
the studies using PN (Rapp etal, 1983; Young et al, 1987), despite a lower 
nutritional intake. However, this may be due to differences in the patient 
populations.
6.4 Discussion
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6.4.2 Effect on major complications
Only age appeared to be associated with mortality. However, infective 
complications occurring up to day 28 and the duration of mechanical 
ventilation are both reduced in intervention patients. This was confirmed by 
univariate multiple regression analysis for the duration of mechanical 
ventilation but not for infective complications. In addition regression analysis 
found negative associations between nutritional intervention and major 
complications (excluding or including mortality).
6.4.3 Treatment cost
Cost of IV fluids, drugs and PN was lower in intervention patients. 
Regression analysis confirmed that intervention was beneficial, it being 
negatively associated with ‘drug-IV fluid-PN cost’ in all patients but not 
survivors. Again, in analysis by group, treatment costs were lower in 
intervention patients when analysis was restricted to survivors or patients 
with severe head injury (best GCS <8).
6.4.4 Nutrition
Aggressive early EN was associated with a greater percentage of patients’ 
estimated energy and nitrogen requirements being met on days 1, 2 and 4 
without a significant increase in the number of aspirates >150mL. 
Furthermore, there was no increase in the incidence of aspiration 
pneumonitis or pneumonia in intervention patients. Results from day 3 are
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anomalous but may be due to the interruption of EN by inadvertent removal 
of the feeding tube by the patient following endotracheal extubation. After day 
4 the NG intake of control patients would have been increased up to the 
nutritional goal.
6.4.5 Serum protein and hormone levels
Borzotta et al (1994) found that EN and PN were equally effective at meeting 
nutritional goals (1.2 x MREE, 2.5g protein/ Kg/ day intake) and were 
associated with a reduction in the fall in albumin and transferrin. This tends 
to confirm the present results where there was a tendency for albumin 
levels to be maintained and CRP and the PINI to be lower in intervention 
patients compared to controls. Thus early aggressive EN tends to be 
associated with amelioration of hepatic reprioritisation of protein synthesis 
from plasma transport proteins to positive acute phase reactants. This may 
result from reduced infection and catabolism in intervention patients. 
However, these ‘differences’ were not reflected in hormonal measurements.
6.4.6 General discussion
The results suggest that early aggressive EN can improve the delivery of 
energy and nitrogen over the first 96h post-injury. This is associated with a 
reduction in complications, particularly infective complications, possibly 
resulting from a nutrition-induced improvement in immunocompetence. 
Furthermore, fewer infections may have led to quicker weaning from
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mechanical ventilation seen in intervention patients. These improved clinical 
outcomes may explain the lower treatment cost associated with intervention 
patients compared to controls. Infective complications are common after 
head injury, occurring in about 50% to 70% of patients after initial 
hospitalisation (Helling etal, 1988). Of late deaths in this patient population, 
10% to 25% can be attributed to sepsis (Quattrocchi et al, 1991) and in 
another study about 60% of mortality after 48h was attributed to sepsis 
(Rapp et al, 1983). This high incidence of sepsis is associated with 
depression in CMI including depression in CD4 (T-helper/ inducer) surface 
antigens and an elevation in CD8 (T-suppressor/ cytotoxic) surface 
antigens, reducing the CD4: CD8 ratio (Hoyt et al, 1990; Lin et al, 1992). 
These studies did not use aggressive nutritional support and it is 
suggested that immunosuppression resulted from the hypermetabolic or 
hypercatabolic response to serious injury (Lin et al, 1992). However, 
patients given PN (2g protein/ Kg/ day and up to 40 non-protein Kcal/ Kg/ 
day) within 48 hours of admission did not experience a significant reduction 
in CD4 surface antigens nor a reduction in CD4: CD8 ratio (Kudsk et al, 
1994a). In a second study of 17 patients, those randomised to receive PN 
from day 1 post-injury had an increased CD4 count, CD4% and CD4:CD8 
ratio compared to those given PN after 5 days (Sacks et al, 1995). The 
findings in this study are weakened by its small size and because 4 patients 
from each group were withdrawn post-randomisation due to death or 
starting oral feeding before day 14. However, the authors postulate that 
successful NG feeding is precluded by gastroparesis, with subsequent
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energy and protein deficits, and recommend that PN be given in the first two 
weeks post-injury (Hunt et al, 1985).
Maintenance of immune function does not appear to be related to the route 
of nutritional support. Rapp et al (1983) found that more ‘early PN’ patients 
demonstrated positive skin test reactions compared to ‘late EN’ patients 
(40% vs. 14%) during the first week of hospitalisation. Reduced 
immunocompetance in the EN group was attributed to poor nutritional 
intake. However, CD4 surface antigens (time 0, 7 days) and T- lymphocyte 
proliferation are both reduced in severely head-injured patients given 
inadequate PN (1300Kcal/ day) (Hoyt et al, 1990). Thus it appears to be 
energy and nitrogen intake per se, not the route of administration, that is 
critical. Although sub-optimal, the energy and nitrogen intakes in the present 
intervention group were still associated with a reduction in infective 
complications. There is potential for further improvement if a higher 
percentage of patients’ nutritional requirements could be delivered, and at a 
lower cost compared to PN.
To date the present study has not achieved improvements in neurological 
outcome as have other PRCTs of similar size (Rapp et al, 1983; Young et al, 
1987). These studies used ‘early PN’ versus ‘late EN’. This resulted in a 
greater improvement in nutrition in the intervention group versus controls 
when compared to the present study which may explain the discrepancy. In 
the present study only 33% of the intervention group were initially fed by 
intestinal tube. The remainder were given aggressive NG feeding which in
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some cases was less well tolerated. Furthermore, the practice of stopping 
NG feeding for 6h to reduce the risk of ventilation-acquired pneumonia 
wasted potential feeding time and appears to be unnecessary (Bonten et al, 
1995). These factors tended to reduce the delivery of EN. Failure to place an 
intestinal tube was due to technical difficulty or imminent weaning from 
mechanical ventilation. Similarly, Kirby et al (1991) demonstrated that 
estimated energy and protein intake (3020Kcal/ 24h and 1.2g protein/ Kg/ 
day) was only achieved by 6.8 (2- 8) days after injury and 4.2 (2- 8) days after 
placement of an intestinal tube. In a further study, Grahm et al (1989) found 
that 15 jejunally fed patients had improved energy and nitrogen intake and 
nitrogen balance, and reduced infection rates compared to 14 NG fed 
patients. Target energy intake was achieved on day 3 and 6 with jejunal and 
gastric feeding, respectively. These studies tend to confirm data from the 
present study in demonstrating that the technical difficulty of intestinal tube 
placement often precludes optimal EN from day 1 post-injury. Nevertheless, 
intestinal feeding is better tolerated and enables earlier aggressive EN 
compared to NG feeding, and early aggressive EN is associated with 
improved outcome. A better technique of placement would lead to increased 
nutritional delivery and may further improve outcomes.
The interim analysis of these data shows that an attempt to give early 
aggressive EN, by intestinal or NG feeding, is associated with improved 
delivery of energy and nitrogen during the first 96h post-head injury 
compared to standard NG feeding. Furthermore, aggressive EN is 
associated with a reduction in infective complications, duration of
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mechanical ventilation and treatment cost. Similar improvements in 
outcome occurred in sub-groups of survivors and severely head-injured 
patients and were confirmed by univariate multivariable regression analysis. 
Nevertheless it is intended to continue recruitment up to 82 patients when 
analysis of the neurological outcome should achieve a power of 80%.
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7Overall Discussion
Malnutrition and nutritional deprivation in the presence of an inflammatory 
state are common in hospital patients. The combination of these conditions 
is associated with an increased incidence of major complications. 
Appropriate nutritional support is often delayed and/or does not meet the 
patient’s estimated nutritional requirements and therefore sub-optimal 
nutrition may be partly responsible for a poor outcome. The aim of the this 
thesis was to establish whether aggressive early EN was, (i) feasible and, if 
so, whether it was (ii) associated with improved clinical outcomes and^Hi) 
reduced treatment cost. To this end studies were designed to test the 
hypothesis in a progressively more rigorous manner (Table 7.1). The 
Preliminary Investigation (3.0) must be considered as a trawl for data. It did 
not control for disease type or severity and therefore the results could only 
serve as guidance for subsequent, more definitive studies. The Burn study 
(4.0) used a population homogenous for disease type and controlled for 
disease severity. In addition, the population size and type of analysis was 
statistically adequate to test the hypotheses and, for mortality, give a power 
of 80% if significance was taken at the 0.05 level. However, part of the data 
was retrospective. The patients ‘recruited’ retrospectively tended to have a 
longer delay before attempting aggressive EN. Thus any underestimation of 
complications due to poor records would have tended to reduce the chance 
of observing statistically significant findings. Despite this, the hypothesis 
was, for the most part, proven. The Head Injury study was a prospective 
randomised controlled trial. The similarity of the study groups in terms of 
disease severity was confirmed retrospectively, and differences in
7.1 Summary of thesis resuits
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outcomes between the groups was confirmed using univariate multivariable 
regression analysis. However, the study design was weakened by lack of 
observer ‘blinding’ during collection of outcome data which could lead to 
observer bias. This was minimised by ensuring that all outcomes were 
scored by pre-defined criteria. Such bias could be eliminated by using 
observers ‘blinded’ to the patient study group, but this was beyond the 
resource allocation for this study.
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The main findings of the Preliminary investigation, Burn and Head Injury 
studies are summarised in Table 7.2. In the Preliminary Investigation 
mortality was lower in patients starved <5 days (particularly if they were older 
than 69 years) compared to those starved > 5 days. However, in the Burn 
study there was only a trend to reduced mortality in burned patients in whom 
there had been an earlier attempt to give aggressive EN. Mortality in head- 
injured patients was relatively low and therefore it was difficult to assess a 
difference between groups. Complications, excluding or including mortality, 
were significantly reduced when aggressive EN was attempted earlier in 
burned patients, and there was a non-significant reduction in complications 
in head-injured intervention patients. Earlier aggressive EN in burned 
patients was associated with a reduction in LOS, whereas LOS only 
showed a non-significant reduction in the Preliminary Investigation and 
Head Injury study patients. ‘Drug-IV fluid-PN cost’ was reduced with earlier 
aggressive EN in both burned and head-injured patients. However, the 
number of head-injured intervention patients attaining a ‘good’ neurological 
outcome was not significantly increased, despite the fact that their GOS was 
higher at six months post-injury. This means that more intervention patients 
were in the ‘severely disabled’ rather than ‘dead’ or ‘persistent vegetative 
state’ categories, at six months.
Secondary outcomes were analysed to give guidance for future studies. The 
duration of EN was reduced in those fed earlier in the Preliminary 
Investigation and Burn studies but not in intervention patients in the Head 
Injury study. However, infective complications and antibiotic cost were both
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reduced in patients in whom aggressive EN was attempted earlier in both 
the Burn and Head Injury (severely injured sub-group) studies. Patients in 
whom earlier aggressive EN was attempted had less intolerance to gastric 
feeding in the Burn study but not the Head Injury study. However, survivors 
had a shorter duration of organ support and ventilation in the Burn and Head 
Injury studies, respectively.
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Table 7.2 Main findings: Effect of earlier EN* in the Preliminary Investigation,
Burn and Head Injury studies.
Outcome
Preliminary
Investigation1
Study
Burn2 Head Injury3
Primary
outcomes
• Mortality I  (esp. if >69 trend I ns
• Complication
years)
I trend I
s excluding 
mortality 
• Complication i trend I
s including 
mortality 
0 LOS I trend |
e ‘Drug-IV fluid- - I i
PN cost’ 
• Good - ns
neurological 
outcome 
0 GOS - - f  (improved)
Secondary
outcomes
• Duration of 1 1 ns
EN
® Infective I I
complications 
• Antibiotic cost I I  (severe head
• Intolerance to _ I
injury)
ns
gastric 
feeding 
* Duration of I I  (ventilation)
organ support
1. Preliminary Investigation- starvation for <5 days.
2. Burn study- associated with an earlier attempt to deliver >50% of 
estimated hourly energy and/or nitrogen requirements.
3. Head Injury- Intervention, ie. where an attempt was made to deliver 
estimated energy and nitrogen requirements as soon as possible post­
injury.
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Certain patterns emerge from these studies. Although mortality was 
reduced in patients (mainly medical and >50 years old) starved <5 days 
compared to those starved for longer (Preliminary Investigation study) such 
an effect was absent in the Burn and Head Injury studies. This may be 
because the association between the duration of starvation in the 
Preliminary Investigation was coincidental, and explained by, the 
unmeasured disease severity. However, there is evidence that early 
aggressive EN can also reduce complications in trauma patients without 
reducing mortality (Kudsk et al, 1992; Moore et al, 1992). It is possible that 
medical patients with non-catabolic conditions (eg. CVA) suffer more 
gradual debilitation as a result of starvation. Thus if EN is started early, it 
will, in many cases, maintain immunocompetence and prevent fatal 
infection. However, severe trauma, such as burns or head injury, may be 
associated with overwhelming infections which can kill despite a nutrition- 
enhanced immune response. In these patients, the number of infections 
was reduced, but without greatly reducing mortality. It may be that a 
combination of more effective medical treatment of septic shock (eg. use of 
monoclonal antibodies to ameliorate sepsis syndrome) and early 
aggressive EN, could reduce mortality in these patient groups in the future. 
Nevertheless, early aggressive EN is associated with a reduction in the 
incidence of complications, particularly infection. This probably explains the 
reduced cost of treatment in terms of IV fluids, drugs and PN, but particularly 
antibiotics. Again fewer infections would explain the reduced duration of EN,
7.2 Collation of the thesis results
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organ support and intolerance to gastric EN in burned patients and reduced 
duration of mechanical ventilation in head-injured patients.
Data from the Burn and Head Injury studies indicate that in order for EN to 
be associated with improved outcome, an attempt must be made to provide 
at least 50-60% of estimated energy and nitrogen requirements, by EN, 
within 24h of injury. Similarly, in patients undergoing GI surgery, a food 
intake of less than 50% of the estimated energy and protein requirements 
was associated with a reduction in wound hydroxyproline accumulation, an 
indirect measure of wound healing (Windsor et al, 1988). Furthermore, it is 
only when early EN is adequate, as opposed to minimal, that the effects of 
the catabolic response to trauma are attenuated (Sologub et al, 1992). 
These studies confirm findings in the Burn study (4.0); clinical outcomes 
improved and treatment cost was reduced when energy and nitrogen 
delivered by EN (al! routes) exceeded 50% of estimated requirements (see 
2.2.6) during the first 45h. Meeting the first 50% of a patient’s energy and 
nitrogen requirements has been shown to disproportionately reduce 
negative nitrogen balance (Shaw et al, 1983). This may enable a relative 
maintenance of BCM and immunocompetence. During the stress response, 
TNF or IL-1, or both, cause increased hepatic production of acute phase 
proteins and reduced albumin synthesis (Pomposelli et al, 1988; Stahl, 
1987) probably due to substrate competition (Moody et al, 1985). This 
reprioritisation has been shown to be attenuated by early EN but not PN, 
and results in a decrease in production of acute phase proteins, especially 
CRP, but an increase in plasma transport proteins, especially albumin
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(Peterson etal, 1988). The blood protein measurements in the Head Injury 
study tended to confirm this conclusion with intervention patients tending to 
have higher (ns) serum albumin levels and lower (ns) CRP level and the 
PINI up to day 12 post-injury. These differences may be due to a reduction in 
septic morbidity (Kudsk et al, 1994b). However, the differences in albumin, 
CRP and PINI are not, in the interim analysis of the Head Injury study, 
reflected by changes in plasma levels of cortisol, GH and IGF-1. In addition 
to the importance of giving early EN, other studies have shown that 
modifying enteral feed composition by addition of arginine, RNA, and «>-3
fatty acids may further improve immunocompetence, shorten the period of 
immunosuppression following trauma (Kemen et al, 1995) and reduce 
septic complications (Braga et al, 1996).
Until recently many burn and intensive care units delayed EN for several 
days because of concerns over delayed gastric emptying. In the last 10 
years this policy has changed, particularly in ITUs, to provision of early but 
minimal EN. This treatment has been successful in premature infants 
where it improves weight gain, but without increasing the risk of necrotising 
enterocolitis, which might be associated with full EN (Troche et al, 1995). 
However, the adult Gl tract, particularly the jejunum, often continues to 
function after severe trauma. Furthermore, excepting neonates, providing EN 
up to a patients requirements, within 24h of trauma, is both feasible and to 
be recommended (McDonald et al, 1991).
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Despite improved delivery, when EN is started both early and at ‘full’ rate the 
estimated energy and nitrogen requirements were usually not met in burned 
and head-injured patients. This was due to GI intolerance (almost always 
limited to poor gastric emptying) and interruptions to feeding because of 
surgery, investigations and inadvertent removal of the feeding tube by the 
patient. Patient removal of the feeding tube proved difficult to prevent. 
However, all other causes of reduced EN could be prevented, or 
ameliorated, if continuous EN, was delivered intestinaily, with simultaneous 
gastric drainage to prevent aspiration. However, many patients cannot be 
moved to facilities for fluoroscopic or endoscopic tube placement. In these 
cases, intestinal tubes would have to be placed ‘blind’ as was practised in 
the present Head Injury study. Unfortunately this technique was only 
successful in about half of the attempts. Equipment and technique for 
intestinal intubation must be improved if EN is to deliver close to 100% of a 
patient’s energy and nitrogen requirements. Lastly, there are cases where 
placement of an intestinal tube is inappropriate, for example when 
endotracheal extubation is imminent, and in which case aggressive NG 
feeding should be initiated. A mandatory daily period of 6h ‘nil per stomach’, 
intended to reduce the risk of ventilator-acquired pneumonia, is practised in 
the Frenchay hospital ITU. However, the necessity of this practice has been 
questioned (Bonten et al, 1995), and the break from EN should at least be 
moved from nights to mornings, to ensure maximal opportunity for 
continuous feeding, when most clinical interruptions occur.
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1. Giving EN, up to 100% of estimated energy and nitrogen requirements, 
within a few hours of burn injury requiring IVfluid resuscitation, and head 
injury necessitating mechanical ventilation, was safe.
2. There is an implicit association, not controlled for disease by type or 
severity, between early EN and both a reduction in mortality and duration 
of NG feeding in a mixed, mainly medical, population.
3. Early aggressive EN is associated with a reduction in complications, 
LOS and treatment cost in burned patients requiring IV fluid 
resuscitation, and a reduction in infective complications, duration of 
mechanical ventilation and treatment cost in patients suffering head 
injury.
4. Early aggressive EN is specifically associated with a reduction in 
infective complications and this effect may be responsible for 
improvements in other outcomes.
7.3 Conclusions
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1. The effect of early aggressive EN should be retested in prospective 
randomised controlled trials in which investigators measuring outcomes 
are ‘blinded’ to the patient group and one major outcome is tested at a 
time.
2. The effect should be investigated in specific patient populations:
• a homogenous medical population, for example those suffering 
CVA.
• patients suffering blunt and penetrating trauma, separately. For 
patients suffering burns a multi-centre study would be required in 
order to attain adequate numbers and reduce temporal bias.
3. The effect of early aggressive EN should also be tested as part of 
combined treatments. Specifically it should be combined with new 
medical treatments of major infection as part of a concerted attempt to 
reduce septic morbidity and mortality.
4. Technique and equipment for ‘blind’ intestinal intubation must be 
improved so that patients with poor gastric emptying can be fed without 
interruption.
7.4 Recommendations
263
8Appendices
8.1 Introduction
8.1.1 Refeeding syndrome
This comprises several metabolic aberrations occurring when a malnourished patient 
does not adapt to an increased substrate load. These changes include: increased 
metabolic rate, increased blood volume, and movement of potassium and phosphate 
into cells. Hypophosphataemia causes the haemoglobin curve to shift to the left 
causing tissue hypoxia. These changes Increase cardiopulmonary workload which can 
lead to sudden death.
8.1.2 Level of evidence for clinical efficacy as defined by type of 
study and clinical of recommendation of use (Heyland et al,
1993) (Table 8 .1 .1 ) .
Level of evidence Clinical recommendation
1 Randomised controlled trials in critically ill • Use; does more good than
patients with low risk of error, ie. blinded, harm.
objective criteria used.
2 Randomised controlled trials in critically ill • Should probably be used
patients with risk of error, ie., no blinding, but adverse effects cannot
objective criteria not used. ruled out.
3a Non-randomised trial in a critically ill © No proven benefit in
population. critically ill.
3b Randomised controlled trials in non- © No proven benefit in
critically ill patients. critically ill.
4 Non-randomised controlled trials in non- © No recommendation.
critically ill patients.
5 Animal studies. 9 No recommendation.
6 Biological rationale. © No recommendation.
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8.2 Methods
8 .2 .1  General Methods for Intervention Trials
8.2.1.1 Randomisation: Gl and Head Iniurv studies
Randomisation will minimise bias, particularly observer bias. Interim results can show 
that the treatment group has a better outcome but this is not sufficient reason to stop 
randomising patients, since, by definition, early cessation of the study or a switch to 
clinical allocation would lower the statistical power of the study.
Requirement for patients to give consent prior to being randomised may iead to smaller 
trials particularly because patients refuse consent because they may receive the less 
effective 'treatment'. A ‘randomise-then-consent’ protocol may avoid this reduction in 
study size (Zelen, 1979). Randomisation assigns half the patients to receive standard 
treatment (C, group 1). These patients consent to take part in a study with standardised 
monitoring of nutritional state and record of outcomes. Patients randomised for 
intervention treatment (T, group 2) consent to early enteral feeding, but may have the 
standard treatment if they wish, if most patients choose to have the new treatment, then 
this design will probably be more efficient overall because controls are merely 
consenting to monitoring whereas intervention patients are consenting to a possibly 
improved treatment. It is essential to compare group 1 with group 2 rather than 
treatment C with treatment T to maintain randomised comparison. In theory the 
advantage of having virtually no refusers outweighs some loss of efficiency because 
group 2 is 'contaminated' by a minority undergoing treatment C. Unfortunately 
contamination of the 'treatment' group with refusers (effectively controls) in the Gl study 
necessitated a switch to the orthodox ‘consent then randomise* protocol for the Head 
Injury study.
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8.2.1.2 Exclusions and Withdrawals 
Analysis will include post-randomisation withdrawals. This includes patients deviating 
from treatment as removal of these patients from the study could result in bias that 
negates the effect of randomisation. Treatments in the GI and Head Injury studies 
began almost immediately after randomisation to minimise the number of pre-treatment 
outcomes.
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8.2.2 Background to m ethodology
8.2.2.1 Disease severity
8.2.2.1.1 Bull score (Table 8.2.1) (Bull, 1971)
8.2.2.1.2 Clark score 
The degree of smoke inhalation was determined from an aggregate score of the 
following factors:
1. A history of being trapped in a house or an industrial fire in an enclosed space;
2. Production of carbonaceous sputum;
3. Perioral facial burns-ie. affecting nose, lips, mouth, or throat;
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4. Altered level of consciousness at any time after the incident and including 
confusion;
5. Symptoms of respiratory distress, such as a sense of suffocation, choking, 
breathlessness, and wheezing or discomfort affecting the eyes, nose or throat 
indicating irritation of the mucous membranes;
6. Signs of respiratory distress including stertorous, laboured breathing, and 
tachypnoea or
7. Auscultatory abnormalities, such as crepitations or rhonchl; and hoarseness or loss of 
voice.
Stepwise linear logistic regression analysis determined the best equation for prediction
of mortality to be:
p = log ez , where
(1+ log ez)
z = -7.9 + 0.78 x symptom score + 0.094 x BBSA + 0.034 x age and 
p = probability of death on a scale from 0-1.
8.2.2.1.3 ASA score
Table 8.2.2 The ASA physical status scale.
ASA Physical status
Category
I Healthy.
II Mild systemic disease.
III Severe systemic disease that is not incapacitating.
IV Incapacitating systemic disease that is a constant threat to life.
V Moribund; not expected to survive 24h with or without surgery.
E Emergency operation.
Table 8.2.3 Mortality rates for each ASA physical status category (from Vacanti et al, 
1970).
ASA Classification Anaesthetic
procedures
Deaths Mortality rate (%)
I 50703 43 0.08
II 12601 34 0.27
III 3626 66 1.8
IV 850 66 7.8
V 608 57 9.4
Totals 68388 266 0.39
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8.2.2.1.4 Glasgow coma scale (Table 8.2.4) (Teasdale and Jennett, 1974)
Parameter
Adult
Response 
Child 0-5 years
Score
Eyes Spontaneous — 4
To speech St 3
To pain = 2
None = 1
Verbal Orientated + converses Smiles, oriented to sound, follows objects,
interacts
Crying Interacts
Confused but converses Consolable Inappropriate 4
Inappropriate words Inconsistently consolable Moaning 3
Incomprehensible sounds Inconsolable Irritable 2
None No response No response 1
Motor Obeys commands = 6
Localise to pain = 5
Flexion to pain-withdrawal = 4
Flexion to pain-abnormal (decorticate rigidity) = 3
Extension to pain-decerebrate rigidity = 2
None = 1
GCS out of
15
8.2.2.1.5 ‘Leeds’ score (Table 8.2.5) (Gibson and Stephenson, 1989).
Factor Weighting
Age (years): 
• 0-40 0
« 41-60 1
» > 60 2
Unreactive pupils (permanent) 
• unilateral 1
• bilateral 4
Intracranial pressure (mm Hg) (mean of admission and at 12h)
• < 20 0
• 20-40 2
• > 40 4
Systolic blood pressure < 80mm Hg (measured after resuscitation) 4
GCS (at presentation to accident centre) 
® >9 0
* 6-8 1
• 3-5 2
Other extracranial injuries: 3
• limb fractures (especially when multiple)
• chest trauma requiring thoracotomy/open operation/lung 
contusion
• abdominal trauma requiring peritoneal lavage or laparotomy 
High density lesions on CT
• intracerebral 2
• intracerebral and extracerebral 4
TOTAL SCORE
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8.2.2.1.6 Abbreviated injury score (Table 8.2.6)
AIS and injury! 
severity
Description of injury
1. Minor
General 1. aches all over
2. minor laceration, contusions, and abrasions
3. all 1st, 2nd and small 3rd degree burns
Head & neck 1. cerebral injury with headache; 
dizziness; no loss of consciousness
Chest • muscle ache or chest wall stiffness
Abdominal !• muscle ache, seat belt abrasion; etc.
Extremities • minor pains and fracture and/ or dislocation of digits
2. Moderate
General 1. extensive contusions; abrasions; large lacerations; avulsions (<3" wide) 
|2. 10- 20% BSA 2nd or 3rd degree burn
Head & neck 11. cerebral injury with or without skull fracture, <15 minutes 
unconsciousness, no post-traumatic amnesia (PTA)
|2. undisplaced skull or facial bone fractures or compound fracture of 
nose
|3. lacerations of the eye and appendages; retinal detachment 
;4. disfiguring lacerations
|5. 'whiplash'- severe complaints + anatomical/radiological evidence
Chest ji.  simple rib or sternal fractures
|2. major contusions of chest wall without haemothorax or 
pneumothorax or respiratory embarrassment
Abdominal
±pelvic girdle
ji.  undisplaced long bone or pelvic fractures
Extremities |1. compound fractures of digits 
\2. major sprains of major joints
3. Severe (not life- threatening)
General |1. extensive contusions; abrasions; large lacerations involving 
>2 extremities, or large avulsions (>3" wide)
2. 20- 30% BSA 2nd or 3rd degree burn
Head & Neck 1. cerebral injury with or without skull fracture, with unconsciousness 
>15 mins; no severe neurological signs; <3h post-traumatic amnesia
2. displaced closed skull fractures without unconsciousness or other 
signs of intracranial Injury
|3. loss of eye or avulsion of optic nerve 
4. displaced facial bone fractures or those with antral or orbital 
involvement 
;5. cervical spine fractures without cord damage
Chest |1. multiple rib fractures without respiratory embarrassment 
|2. haemothorax or pneumothorax 
|3. rupture of diaphragm 
|4. lung contusion
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Table 8.2.6 AIS, continued.
AIS and injury! 
severity
Description of injury
3. Severe (not life- threatening), continued
Abdominal 1. contusion of abdominal organs
2. extraperitoneal bladder rupture
3. retroperitoneal haemorrhage
4. avulsion of ureter
|5. lacerations of urethra
6. thoracic or lumbar spine fractures without neurological involvement
Extremities
.ipelvic girdle
|1. displaced simple iong-bone fractures, and/or multiple hand and foot 
fractures
;2. pelvic fractures with displacement 
|3. dislocation of major joints 
|4. multiple amputations of digits
|5. lacerations of the major nerves or vessels of extremities
4. Severe (life- threatening)
General 1. severe lacerations and/or avulsions with dangerous haemorrhage
2. 30- 50% BSA 2nd or 3rd degree burn
Head & neck 1. cerebral injury with or without skull fracture, with unconsciousness of 
>15 mins, with definite abnormal neurological signs; 3- 12h PTA
2. compound skull fracture’
Chest 1. open chest wounds; flail chest; pneumomediastinum; myocardial 
contusion without circulatory embarrassment; pericardial injuries
Abdominal 1. minor laceration of intra-abdominal contents (to incl. ruptured 
spleen, kidney, and injuries to tail of pancreas)
2. intraperitoneal bladder rupture
3. avulsion of the genitals
4. thoracic and/or lumbar spine fractures with paraplegia
Extremities
.±pelvic girdle
1. multiple closed Iong-bone fractures
2. amputation
5. Critical
General 
Head & neck
!• >50% burn
1. cerebral injury ± skull fracture with unconsciousness of >24h; PTA 
>12h; intracranial haemorrhage; increased ICP (reduced 
consciousness, bradycardia under 60, progressive rise in BP & pupil 
inequality.
!2. cervical spine injury with major respiratory embarrassment
Chest |i. chest injuries with major respiratory embarrassment (laceration 
of trachea, hemomediastinum, etc.) 
i2. aortic laceration
|3. myocardial rupture or contusion with circulatory embarrassment
Abdominal |1. rupture, avulsion or severe laceration of intra- abdominal 
vessels/ organs except kidney, spleen or ureter
Extremities |1. multiple open limb fractures
6. Fatal 
(within 24h)
{single fatal lesion
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8.2.2.2.1 ‘Clinical assessment* of surgical risk
Table 8.2.7 Clinical assessment of the risk of major complications (Based 
on Pettigrew and Hill, 1986).
8.2.2.2 Nutrition-related disease severity scores
Risk Factor Score if present
Minor
1. Bronchitis 1
2. Smoking 1
3. Treated hypertension 1
4. Mild angina 1
5. Past rheumatic fever 1
6. Past TB 1
7. High alcohol intake
8. Diabetes
1
Major
1. Severe obstructive airways disease 4
2. Post pneumonectomy 4
3. Current chest infection 4
4. Ml in last 6 months 4
5. Arrhythmias requiring pacemaker 4
6. Cardiac failure 4
7. Renal failure 4
8. Respiratory failure 4
9. Obstructive jaundice 4
10. Prolonged high dose steroids 4
11. Thrombocytopenia 4
12. Myeloma 4
13. Metastatic cancer 4
14. Major sepsis/peritonitis 4
15. Past major postoperative complications (eg. DVT or PE) 4
Subjective nutritional depletion:
1. Mild 1
2. Moderate 2
3. Severe 3
TOTAL > 6 = ‘High Risk’
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8.2.2.2.2 ‘Surgeon’s assessment’ of surgical risk (Figure 8.2.1)
The senior operating surgeon should mark the 2 linear analogue scales at any point (on 
or between numbers) which reflects the perceived risk of major postoperative 
complications:
a) Immediately Before commencement of surgery
Low
Risk
and
10
High
Risk
b)lmmediately After completion of surgery (ie. the actual extent of pathology 
and technical ease of the surgery may be better or worse than expected and 
therefore alter your perceived risk of complications.)
10
I I
Low High
Risk Risk
Print Surgeons initials
8.2.2.3 Nutritional assessment 
Table 8.2.8 Characteristics of four plasma transport proteins (Weisburg, 1983).
Serum Body pool Half-life Normal PEM PEM
protein size (g/ Kg plasma
body range (g/ L) moderate severe
weight) (g/L) (g/L)
Albumin 5 19 days 35-45 21-27 < 21
Transferrin 0.1 9 days 2.5-3.5 1.0-1.5 < 1.0
TBPA 0.01 2 days 0.16-0.30 0.05-0.1 < 0.05
RBP 0.002 12 hours 0.026-0.1 < 0.02 -
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8.2.2.4 Outcome Measures
The LAS was used in the ‘Surgeon’s assessment’ and ‘Distress score’. The LAS was 
chosen because it has a higher coefficient of reliability than discrete 5 and 6 point 
scales (Holmes and Dickerson, 1987). The scale in this study been modified into a 
hybrid of a LAS and a 'point' scale to allow serial measurement to be quantitatively 
compared Potential for a non-committal response at the mid- point or bias of the later 
score by comparison with earlier score may reduce sensitivity of this assessment. 
However, the large (0- 10) scale reduces the risk of the former while the latter is a 
necessity.
8.2.2.4.1 Modified linear analogue scale (LAS)
8.2.2.4.2 Distress score (Figure 8 .2 .2 )  (Magnusson et al, 1989)
How do you feel in yourself?
The following questions ask you how you feel in yourself. Read the question and then 
give a score for how you feel. A score of 0 means there is no problem, a score of 10 
means you are extremely distressed. You can give a score anywhere between 0 and 10 
if you feel you have a problem in- between 'no problem' and 'extremely distressed'.
Question Score (from 0- 10)
1. Do the tubes catheters cause you inconvenience or 
discomfort?
2. Are you nauseous?
3. Do you have abdominal distension?
4. Are you thirsty?
5. Do you have any sleeping problems?
6. Are you restricted in getting washed?
7. Are you restricted in getting dressed?
8. Are you restricted in getting moving about?
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8.2.2.4.3 Fatigue assessment (Figure 8 .2 .3 )
HOW TIRED DO YOU FEEL?
Please put a pen or pencil mark on the scale to show how tired you feel. Your mark 
can be on or between any of the numbers. To give you some idea what the different 
wording on the scale means read the following notes:
- Fit means that you feel as strong as before your present illness 
and you only need the amount of sleep that is normal for you; and
- Weak and Tired means that you feel physically much weaker than 
normal and have a much greater need for sleep.
0 1 2 3 4 5 6 7 8 9___ 10
I
WEAK 
and TIRED
Thankyou for your help.__________________________________________________
S.2.2.4.4 Modified Visiek index (Figure 8 .2 .4 )
Grading system of independence and mobility:
0. Fully active, able to carry out all pre-disease performances without restriction.
1. Restricted in physically strenuous activity but ambulatory and able to carry out work 
of a light, sedentary nature (eg. light housework, office work).
2. Ambulatory and capable of all self care, but unable to carry out any work activities- 
up and about >50% of waking hours.
3. Capable of only limited self- care. Confined to bed or chair > 50% waking hours.
4. Completely disabled, cannot carry out any self care, totally confined to bed or 
chair.
5. Dead
FIT
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8.2.2.S Feeding Protocol: Refeeding syndrome
Table 8.2.9 Metabolic effects of continuous (24h) infusion versus intermittent or bolus 
NG feeding and feeding sub- and supra-malntenance energy intakes.
Feeding regime 
(continuous = C, 
intermittent = 1)
n Protocol Subjects Metabolic effects Reference
C
1- 2 hourly bolus
- - 5 day post­
major head 
and neck 
surgery
f V02, | nitrogen 
balance
Campbell et at, 
1983
C- 24h,
1- 14h
1.7- 1.8 BMR
randomised major
resection of 
malignancy of 
buccopharynx, 
larynx
f V02, urinary 
catecholamine 
excretion, nitrogen 
balance 
4 08.30 blood glucose 
and insulin levels (all 
p < 0.05)
Campbell et al, 
1990
C- 3h infusion 
1- 5min. bolus
11
4
randomised
crossover
crossover
premature
infants
healthy males
absence of DIT (15% 
over baseline) (C, 
2.09± 0.05 vs 2.18± 
0.07 Kcal/ Kg/ h, p < 
0.5), I  4- 17% EE cf. 
bolus.
absence of DIT (116 
Kcal/ day)
Grant and Denne, 
1991
Heymsfield et al, 
1987a
C- 3h infusion 
1- bolus
2.3 x 
postabsorptive REE
10 healthy men 
and women
I  DIT (mean ± SEM, 
8.1± 0.5% versus 10± 
0.6%, p <0.01)
slower t in REE, RQ, 
plasma glucose, FFA 
levels
Nacht et al, 1986
submaintenance 
(1.02± 0.04 BMR , 
mean ± sem) 
maintenance 
(1.39± 0.01 BMR)
6 healthy males } no change in MR 
} compared to 
} fasting.
}
}
Heymsfield et al, 
1987b
supramaintenance 
(2.77± 0.2 BMR)
14 } f MR by 10% (p < 
} 0.05)
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Table 8.2.10 Cause and effect of refeeding syndrome.
Cause Effect Symptom Reference
High rate of VC02 exceeds hypercapnia Coveili et al, 1981
carbohydrate maximum
infusion excretion rate
Excess energy
intake:
8 1- 2 x EE t circulatory CCF Heymsfield et al,
volume 1988; Weinseir and
Krumdieck, 1980;
Heymsfield et al,
1978
• 2- 3 x EE given t circulatory sudden death Heymsfield et al,
during the first volume 1987a; Isner et al,
week 1985
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8.4 Bum Study
8.4.1 Burn characteristics
Table 8.4.1 Characteristics suggesting depth of injury (Morris and Malt, 1994a).
Depth Characteristics
First degree • Red, erythematous
• Very sensitive to touch
• Very painful
• Usually moist 
» No blisters
• Surface markedly and widely blanches to light pressure
Second degree • Erythematous or whitish with a fibrinous exudate
• Wound base is sensitive to touch
• Painful
• Commonly have blisters
• Surface may blanch to pressure
Third degree • Surface may be:
• white and pliable
• black, charred, and leathery 
pale and mistaken for normal skin
• bright red from haemoglobin fixed in the subdermis
• Generally anaesthetic or hypoaesthetic
• Subdermai vessels do not blanch
• No blisters
• Hair easily pulled from its follicle
Fourth degree • Involves deep tissues including fascia, muscle, bone and tendons.
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8.4.2 C haracteristics o f non-m oribund exclusions
Table 8.4.2 Characteristics of non-moribund patients (n = 18) excluded because the 
delay before attempting aggressive EN was not known.
n mean SD median Range 
min max
95%
confidence
interval
1. Factors affecting
disease severity
© Delay before admission 16 2.1 1.1 1.9 0.75 4 0.64 3
(hours)
« Feeding route refused 18 0 0 0 0 1 0 0
(%)
© Year of admission (%) 18
8 1989 0.61 0.50 0 0 1 0 0
8 1990 0.17 0.38 0 0 1 0 0
8 1991 0.22 0.43 0 0 1 0 0
8 1992 0 0 0 0 1 0 0
8 1993 0 0 0 0 1 0 0
8 1994 0 0 0 0 1 0 0
8 1995 0 0 0 0 1 0 0
e Pre-burn morbidity (%) 18 0.11 0.38 0 0 1 0 0
o Age (years) 18 22.4 31.1 20 0.6 79 3.35 56.2
9 Sex (male) (%) 18 0.72 0.46 0 0 1 0 0
© BBSA (%) 18 23.0 10.7 20.8 10 50 16.6 27.4
o FTL (%) 18 8.4 13.7 9.5 0 50 0.9 17.4
9 Inhalation score 18 1.1 1.8 0 0 5 0 0
© Bull score 18 0.22 0.34 0.05 0 1 0 0.54
9 Clark score 18 0.11 0.22 0.02 0.0003 0.81 0.0003 0.05
2 . Treatment
© Delay before 13 31.6 23.8 14 5.8 97 9.0 26.0
attempting EN per se(h)
© Attempting aggressive 11 0 0 0 0 0 0 0
EN before 24h (%)
9 Delay before 0 0 0 0 0 0 0 0
attempting aggressive
EN (h)
© Early debridement 18 0.17 0.38 0 0 1 0 0
(days until) (%)
© SDD use (%) 18 0 0 0 0 1 0 0
* n is less than 18 where data were missing or not applicable for that variable.
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8.5 Gl Surgery Study
8.5 .1  Patient Selection
Table 8.5.1 Mortality and major complications (%) and LOS (days) in patients 
undergoing planned major Gl surgery under Frenchay Hospital general 
surgeons: 1992.
Malignancy n Major complications 
mortality all
LOS (median, range) 
survivors all patients
Oesophageal 5 0 20 14 (11- 17) 14 (11- 17)
Stomach 9 0 44 12 (9- 43) 12 (9- 43)
Pancreas 1 100 100 - 47
Biliary 0 - - - -
Small intestinal 0 - - - -
Colon (excluding 41 2 29 15 (7- 36) 16 (3- 36)
rectum)
Colon (include rectum) 22 5 36 14 (10- 36) 16 (10- 36)
Total 78 4 40 15 (7- 43) 14 (9- 43)
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8 . 5 . 2  Feeding protocol
Table 8.5.2 Regime for early jejunal feeding.
Day in
relation
to
surgery
Feeding regime Volume 
(mL/ 24h)
Comments
0 1. Keep the patient's head and shoulders raised 30° 
to reduce aspiration risk.
2. Unless specifically contraindicated commence 
feeding at a rate of 20ml Fresubin 750/ hour 
continuously over 24 hours.
3. Flush the tube with 20ml sterile water 4 hourly.
480 Discuss with 
Drs whether iv 
fluid input 
should be 
reduced to 
compensate
1 1. If tolerated previous day's feeding, increase rate 
to 40ml/ hour continuously over 24 hours.
2. Flush the tube with 20ml sterile water 4 hourly.
960
2 1. If tolerated previous day's feeding, increase rate 
to 80m U hour of 1/2- strength Fresubin 750
(500ml feed + 500ml sterile water poured into a 
bag- fill the bag 2 times in a day but discard 
after 24 hours) continuously over 24 hours.
2. Flush the tube with 20ml sterile water 4 hourly.
1920
3 1. If tolerated previous day’s feeding, increase rate 
to 100ml/ hour of I / 2 - strength Fresubin 750
continuously over 20 hours.
2. Flush the tube with 20ml sterile water 4 hourly.
2400
4 1. If tolerated previous day's feeding increase rate 
to 125ml/ hour of I / 2 - strength Fresubin 750
continuously over 20 hours.
2. Flush the tube with 20ml sterile water 4 hourly.
2500 4h rest period 
8am to 12 
midday
Day Energy (Kcal) Protein (g) Na+ (mmol) K+ (mmol)
0 720 36 21 21
1 + 2  1440 72 42 41 
3 + 4 1500 75 44 43
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Table 8.5.3 Supplement Regime- To be offered as soon as free fluids are prescribed.
Stage after surgery Supplements to be offered
Free fluids Breakfast 
10 am 
Dinner 
3 pm
Evening meal 
8 pm 
10pm
200 mL Fresubin*
«  tt 
t t  tt 
t t  t i 
ct tt 
i t  tt  
t t  tt
Light diet Breakfast 
10 am 
Dinner 
3 pm
Evening meal 
8 pm 
10pm
* *
200 mL Fresubin*
***
***
t t  tt 
t t  it
Stage after surgery 1st option 2nd option
* Supplements/ free fluids use Fresubin 'Build- up' or 'Provide'
** Breakfast cereal with or without toast 200ml Fresubin
*** Lunch/ Evening meal no hospital soup 
(nutritional content is 
minimal -40Kcal, 
negligible nitrogen- but 
fills the patient up), offer 
main course with a 
pudding if they can 
manage
i f  t i
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8.6 Head- Injury Study
8.6.1 Glasgow outcome scale
Table 8.6.1 Glasgow Outcome Scale (GOS) at 3 and 6 month follow- up (Jennett and 
Bond, 1975).
GOS score and 
category
Ability Disability
1. Death After regaining 
consciousness?
• Time to
2. Persistent 
vegetative 
state
• After 2- 3 weeks they 
open their eyes and 
have cycles of sleeping 
and waking.
• Unresponsive and speechless 
for weeks- months until death 
after acute brain injury.
• Absence of function in the 
cerebral cortex, as judged 
behaviourally, but the cortex 
may be structurally intact.
3. Severe 
disability 
(conscious but 
disabled)
® Dependent for daily support 
due to mental &/or physical 
disability. Institutionalisation is 
not used as a criterion 
because families may care for 
such patients. Severe mental 
disability may occasionally 
justify this classification in a 
patient with little or no 
physical disability.
4. Moderate 
disability 
(disabled but 
independent)
Can travel by public 
transport 
• Work in a sheltered 
environment 
Independent in daily life
• Varying degrees of dyphasia, 
hemiparesis, or ataxia, as well 
as intellectual and memory 
deficits and personality 
change.
• Produce considerable family 
disruption.
5. Good recovery • Resumption of normal 
life even though there 
may be minor 
neurological and 
psychological deficits. 
Return to work is 
misleading criterion. 
Assessment includes 
leisure activities and 
family relationships.
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8.6.2 Feeding protocols
Figure 8.6.1 ITU and Ward- Intestinal Feeding Regime
Feeding 
Day 1 
onwards
Fine- bore Intestinal Tube
feed at mU
continuously over 24 
hours.
flush tube with 20mL 
sterile water 4 hourly.
if on metaciopramide/ 
Cisapride —> stop 2 days 
later when feeding 
established.
IF intestinal tube becomes 
displaced P.T.O. to use 
'Rapid NG Feeding Regime1 
and contact dietitian 
a.s.a.p..
4 hourly NGT
• Aspirate, if the aspirate 
is:
1. <200mL replace aspirate 
and continue feeding.
2. >200mL do not replace 
aspirate and i f ^ ^ g ^  
vomiting x 2
• Always give a 50mL 
bolus of Fresubin 750* 
after aspiration._______
Inject 10mL 'Ribena' 
down the intestinal tube, 
wait 5 minutes then 
aspirate the NGT. 
'Ribena' has appeared in 
the stomach?
measure pH of intestinal 
tube using pH meter. IF 
pH is < 5
7
6 am 
daily 
or pm
Intestinal tube
• Measure + note pH using
pH meter. If no pH meter
available test 0.5mL
aspirate from intestinal
tube. IF pH < 5?
NGT
* Measure and note pH
using pH stick.
1. Contact: Stephen Taylor_ 
Sheila Fettes 
bleep 1127 Mon-
Fri/ air- call 
w/end 9am-5pm)
2. Turnover to NG regimen. 
Take action according to 
the size of aspirate_____
Day 5 Are >50% of requirements Consider starting TPN by the
(dietitian) being met? NO end of the day.
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Figure 8.6.2 ITU- Rapid NG Feeding Regime
Day 1 r  Start feeding at: 
onwards 50mL Fresubin 7507 hour 
continuously over 18 hours. IF intestinal tube is 
successfully placed P.T.O. 
to use 'Intestinal Feeding 
Regime'.
4 hourly
6am
daily
Day 5 
(dietitian)
Are >50% of requirements 
being met?______
Consider starting TPN by the 
end of the day. _________
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Figure 8.6.3 ITU -Standard NG Feeding Regime
Day 1 Start feeding at:
15mL Fresubin 750*/ hour 
continuously over 18 hours.
• Use Fresubin standard if:
• 10-14 years
• the patient has evidence 
of renal dysfunction.
All head-injured patients
should initially be started on 
this standard feeding regime 
until consented and 
randomised.
Aspirate, if aspirate is:
* 0-50mL replace aspirate. l ® t  from:
After the 2nd aspirate of 
<50mL (ie. after 8 hours 
at the present rate).
W 15 to 30mL/ hour, 
then
® 30 to 60mL/ hour, 
then
• full feed rate 
mL/ hour.
Stop
metaclopramide/ 
Cisapride 2 days 
later.
t h • maintain present rate.
replace. W
® >150m L x 2 aspirates or ■ . _ ^ 1. do not replace and
2. 1 rate by 50%. Rate 
should not be reduced 
below 15mL/ hour.
patient vomiting w
6am
daily
* check and note pH
Day 3 Are >50% of requirements 
(dietitian) being met?
(_________ mL feed
'absorbed' = feed input 
aspirate)
Request ITU Dr to prescribe 
regular Cisapride.
Day 5 Are >50% of requirements Consider starting TPN by the
(dietitian) being met? m b N O w k end of the day.
hitask.phd
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8.6.3 Intestinal intubation
Table 8.6.2 Intestinal intubation protocol.
1. Gastric residual was aspirated prior to intubation:
• to minimise risk of vomiting and aspiration.
• to test the gastric pH. If the pH was >4 the intubation was delayed 
as it is required that there be a pH differential of at least <4 versus 
>6 for gastric and intestinal positioning, respectively, to be 
confirmed.
2. if the patient was close to consciousness a small bolus of Propofol and/or Vecuronium
was given just prior to the intubation procedure. This increased sedation or paralysis
and prevented restlessness which might increase the ICP.
3. About 400mL of air was insufflated into the stomach, through the Ryles tube (Figure 
8.6.4), to dilate the stomach and reduce the risk of the tube coiling in a fold in the 
gastric mucosa.
4. The pH sensor on the intestinal feeding tube was tested.
5. The patient was positioned on his/ her back and angled to the right so that the 
weighted tube tip gravitated towards the pylorus. The head was positioned slightly 
forward and raised to minimise the risk of tracheal intubation and raised ICP, 
respectively.
6. Tube lubricant was water-activated internally and externally and the 8FG 109cm 
Zinetics® tube connected to the pH meter.
7. Insertion commenced through a nostril unless base of skull fracture was present when 
an oral approach was used.
8. The tube was slowly inserted until the pH fell to <4, usually <2. Advancement was 
slowly continued until the pH increased, usually very rapidly, to >6. A slow change to a 
pH of 4-5 may indicate the tube tip had coiled in the cardia.
9. Once through the pylorus the tube was advanced about 5cm whilst holding the guide- 
wire still. The guide-wire is then inserted to full length and the procedure repeated 
until 80-90cm of tube has been inserted. This procedure alternately allows the pliable 
tube to advance around flexures and then checks for kinking and provides support 
close behind the tube tip.
10. An abdominal X-ray was taken to check final position, the guide-wire removed and the 
tube taped in place.
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Figure 8.6.4 NG suction tube sited in the stomach and a feeding tube sited 
in the duodenum or jejunum.
8.6.4 PINI
The sampling sequence was decided from Karatzas et al (1988) (Table 8.6.3). PINI did 
not return to normal by day 7 post-surgery when an acute cause of inflammation 
(complications or surgery) is superimposed on an underlying inflammatory state. After 
severe head-injury the inflammatory state persists for more than two weeks therefore PINI 
and serum hormones were measured up to day 15.
Table 8.6.3 PINI overtime following surgery and corresponding complications (Karatzas 
et al, 1988).
Group n (59) Day
-1 1 3 5 7
No complications 33 3 41 63 47 46
Complications 26 7 67 249 246 277
Benign 28 3 39 81 60 46
Malignant 31 7 64 197 198 229
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8.6 .5  E xclusions
Table 8.6.4 Patients excluded from the Head Injury study up to 1.11.95 (n= 78).
Reason for exclusion n* %*
Pre-randomisation exclusions
Not mechanically ventilated. 0 0
Oral intake likely to take place within 24h. 11 14
Potential recruitment only possible after >24h. 17 22
Contraindication(s) to EN present. 0 0
<10 years old. 13 17
GCS never > 3. 14 18
Pupils fixed from ITU admission to 24h post-injury. 20 26
Moribund or presence of chronic life-threatening 5 6
disease.
Recruited into concurrent drug study. 8 10
Consent refusai. 4 5
Post-randomisation exclusions 0 0
* Many patients were excluded for more than one reason.
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8.6.6 Change in PINI, serum proteins and horm ones over time
Table 8.6.5 Change in serum albumin, pre-albumin, CRP, and AGP over time.
Serum 
proteins 
(normal values)
Day
n
Control
median 95%
confidence
interval
n
Intervention
median 95%
confidence
interval
P-value
Albumin 1-2 21 24 (22-27) 20 27 (23-29) ns
(35-50 g/L) 4-5 22 23 (22-29) 19 27 (23-30) ns
5-10 20 25 (20-31) 19 27 (22-30) ns
12-17 16 28 (21-33) 14 26.5 (26-35) ns
Pre-aibumin 1-2 21 0.17 (0.15-0.19) 20 0.17 (0.16-0.19) ns
(0.1-0.4 g/L) 4-5 22 0.15 (0.13-0.19) 19 0.17 (0.14-0.20) ns
5-10 20 0.21 (0.15-0.26) 19 0.24 (0.20-0.28) ns
12-17 16 0.28 (0.20-0.34) 14 0.27 (0.19-0.32) ns
CRP 1-2 21 139 (116-167) 20 114 (82-151) ns
(<10mg/L) 4-5 22 100 (76-146) 19 74 (50-119) ns
5-10 20 76 (52-101) 19 35 (17-81) ns
12-17 16 24 (9-80) 14 27 (6-63) ns
AGP 1-2 21 1 (0.9-1.15) 20 1.15 (0.9-1.3) ns
(0.4-1,2g/L, 4-5 22 1.7 (1.5-2.1) 19 2.1 (1.9-2.3) ns
5-50 years) 5-10 20 2.4 (1.7-2.6) 19 2.3 (2.1-2.6) ns
12-17 16 2.1 (1.7-2.5) 14 2.25 (1.8-2.8) ns
PINI (<1) 1-2 21 37 (21-45) 20 31 (21-41) ns
4-5 22 46 (33-99) 19 28 (15-99) ns
5-10 20 35 (15-76) 19 10 (6-41) ns
12-17 16 6 (1.5-50) 14 8 (1-43) ns
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Table 8.6.6 Change in serum cortisol, GH and IGF-1 over time.
Serum \ Day 
hormones j 
(normal values) ! n
Control
median 95%
confidence
interval
n
Intervention
median 95%
confidence
interval
P-value
Cortisol (170- I 1-2 21 396 (94-472) 20 604 (260-714) ns
720ng/L, 9am) I 4 -5 22 590 (509-758) 19 699 (539-851) ns
j 5-10 20 548 (438-603) 19 474 (377-610) ns
| 12-17 16 530 (450-654) 14 490 (438-665) ns
GH j 1-2 21 4.9 (2.9-8.9) 20 7.4 (4-17) ns
(<3mg/L - adults) i 4-5 22 4.2 (3.2-6.5) 19 5.1 (2.6-6.5) ns
j 5-10 20 3.9 (2.0-5.7) 19 3.4 (2.1-5.2) ns
| 12-17 16 2.7 (1.8-6.1) 13 3.7 (1.6-5) ns
IGF- 1 | 1-2 21 118 (97-167) 20 121 (86-149) ns
(28-952ng/L) I 4 -5 22 126 (115-168) 19 137 (98-185) ns
! 5-10 20 126 (77-208) 19 157 (119-198) ns
I 12-17 16 148 (87-294) 13 166 (115-241) ns
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